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Abstract 
The routine health monitoring of living organisms and environment has become one of the 
major concerns of public interest. Therefore, there has been an increasing demand for fast 
and easy to perform monitoring technologies. The current available analytical techniques 
generally offer accurate and precise results; however, they often require clean samples and 
sophisticated equipment. Thus, they are not suitable for on site, real-time, cost-effective 
routine monitoring. To this end, biosensors represent suitable analytical alternative tools. 
Biosensors are analytical devices integrating a biological recognition element (i.e. antibody, 
receptor, cell) and a transducer able to convert the biological response into an easily 
measurable analytical signal. These tools can easily quantify an analyte or a class of analytes 
of interest even in a complex matrix, like clinical or environmental samples, thanks to the 
specificity of the biological components. Whole-cell biosensors among others offer unique 
features such as low cost of production and provide comprehensive functional information 
(i.e. detection of unclassified compounds and synergistic effects, information about the 
bioavailable concentration). 
During this PhD, several bioengineered whole-cell biosensors have been developed and 
optimized for environmental and point-of-care applications. Analytical performance of 
biosensors have been improved (i.e. low limit of detection, faster response time and wider 
dynamic range) thanks to synthetic biology and genetic engineering tools. 
Bacterial, yeast and 3D cell cultures of mammalian cell lines have been tailored at the 
molecular level to improve robustness and predictivity. Several reporter genes, i.e., 
colorimetric, fluorescent and bioluminescent proteins, have been also profiled for finding 
the best candidate for each point-of-need application. Furthermore, spectral  
resolution of different optical reporter proteins has been exploited and multiplex 
detection has been achieved. The inclusion of viability control strains provided a 
suitable tool for assessing non-specific effects on cell viability, correcting the analytical 
signal and increasing the analytical performance of ready-to-use cartridges with 
immobilized whole-cell biosensors. 
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In chapter 3, different reporter genes (fluorescent, bioluminescent and colorimetric) have 
been compared in both whole-cell and cell-free biosensors for mercury and quorum sensing 
molecule detection. Bioluminescent NanoLuc luciferase provideed the lowest limits of 
detection ≤ 50.0 fM HgCl2 for the mercury biosensors and ≤ 0.38 pM for  the signaling 
molecule 3-oxo-hexanoyl-homoserine lactone (3OC6HSL) for quorum sensing, in fastest 
response time, 30 min.  
In chapter 4 and 5, bioluminescent yeast biosensors for on-field application have been 
developed for the identification and quantification of (anti)estrogen-like compounds. A limit 
of detection of 1.08 ± 0.02 nM and 0.015 ± 0.001 nM have been obtained for hERα and hERβ, 
respectively, with an incubation time of 5 min. While, the best responses were obtained with 
30 min of incubation time, showing a limit of detection of 0.016 ± 0.001 nM and 0.0011 ± 
0.0002 nM for hERα and hERβ. 
Biosensors robustness improvement was addressed in  in chapter 5, with the 
implementation of a chimeric green-emitting luciferase (PLG2) as viability control. 3D 
printed devices based on Go-Pro Hero 5 camera (chapter 4) and OnePlus 5 smartphone 
(chapter 5) detection have been also implemented alongside a new straightforward whole-
cell immobilization procedure.  
In chapter 6, a whole-cell biosensor for (anti)inflammatory activity (NF-κB mediated) 
monitoring was developed based on genetically engineered 3D cell culture of human 
embryonic kidney cells. The reproducibility of mammalian cell biosensors was increased with 
a green-emitting luciferase as internal viability control; while NF-κB mediated activity was 
monitored with red-emitting luciferase. In optimized conditions, the biosensor gives a LOD 
of 0.15 ±0.05 ng/mL with TNFα as model analyte. 
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1 
Introduction
Adapted from: “Smartphone-Based Cell Detection” 
Maria Maddalena Calabretta, Laura Montali, Antonia Lopreside, Aldo Roda, Elisa Michelini 
Handbook of Cell Biosensors. 2019. 
Reproduced by permission of Springer Nature (License number 4697590179827) 
Adapted from: “Live Cell Immobilization” 
Antonia Lopreside, Maria Maddalena Calabretta, Laura Montali, Aldo Roda, Elisa Michelini 
Handbook of Cell Biosensors. 2019. 
Reproduced by permission of Springer Nature (License number 4750840086390) 
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1.1 Biosensors 
Biosensors are analytical devices that combine a biological recognition element with a 
transducer [1]. The combination of the transducer with the specificity and selectivity of the 
biological system offers a unique tool for the generation of a digital signal without any need 
of sample preparation. Thanks to this close connection, biosensors can be used for several 
analytical applications. During the last decades, multidisciplinary studies have been made, 
resulting in several different combination between biological recognition elements and 
transducers. Among others, antibodies, receptors, enzymes, aptamers and cells are the most 
commonly used biological recognition elements. While, electrochemical and optical signal 
are usually generated by the interaction between sample and biological recognition 
elements [2-6].  
A schematic representation of a biosensor is shown in Fig.1: 
Fig. 1: Schematic representation of a biosensor with some examples of the most used biorecognition 
elements (i.e. enzyme, antibody, MIP, aptamer, cell) and transducers (i.e. optical, electrochemical). [3] 
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The ideal biosensor should fulfil the following characteristics: 
• Robustness in different environmental applications;
• Miniaturization;
• Enable long-term storage;
• Short response time;
• Multiplexing detection;
• Low cost of production;
• Reusability.
All biological recognition elements allow high selectivity for the analyte among a matrix of 
other chemical and biological components as they are the results of naturally selective 
evolution processes. Despite this, some recognition elements are preferred over others 
depending on the application [7].  
Enzyme-based biosensors are the most used and widely studied biosensors. They are usually 
easy to be produced, cheap and sensitive. These biosensors can be also coupled with 
different transducers, as they are able to produce a variety of different quantitative dose-
dependent signals like light, heat, electrons or protons. In particular, enzyme-based 
biosensors for glucose and urease detection are largely used, due to the need for 
glucose/urea monitoring for medical and environmental applications [7-8].   
Several glucose biosensors have been produced over the years and until now they cover the 
majority of the biosensors’ world market. Nevertheless, a few modifications have been 
made from the first prototype with efforts for the development of implantable biosensors 
for non-invasive and continuous monitoring of glucose level in the blood of diabetic patients 
[9].  
Nowadays, most glucose biosensors use as recognition element the glucose oxidase, which 
catalyses the oxidation of glucose to gluconolactone with the production of H2O2. 
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Prussian blue and inorganic redox couples are also the most commonly used electrochemical 
mediators for H2O2 detection, as shown in the figure below (Fig.2) [7,10].  
Fig. 2: Schematic representation of enzyme-base glucose biosensor [10]. 
Another important class of biosensors use antibody as biological recognition elements and 
are called immunosensors. These biosensors are highly valuable in those situations in which 
there is the need to detect ultra-low concentrations of analyte. Indeed, the high specificity 
and sensitivity of the interaction between antigen and antibody is the main advantage of 
this class of biosensors. They are ideal for point-of-need identification of HIV, hepatitis, 
cardiovascular diseases and cancers biomarkers because of their low concentration in 
clinical samples. Furthermore, they are widely used for detecting toxins, explosives, 
pesticides’ residues and other micropollutants in environmental and food samples.  
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Thanks to recent advances in molecular biology, new and more stable antibodies and 
nanobodies can be easily produced, leading to more and more applications for 
immunosensors (as can be seen in Tab.1) [11-13].  
Tab 1. Examples of immunosensors applications [12-34]. 
Analyte Detection Techniques Detection Limits (LOD) 
Detection 
Time/ 
Reference 
Avian influenza virus (AIV) Impedimetric 103 EID50 mL–1 2h [14] 
Avian influenza virus (AIV) Fluorescence 3 ng μL−1 H5N1 [15] 
Avian influenza virus (AIV) Bulk acoustic waves (BAW) 0.0128 HA unit 2h [16] 
Avian metapneumovirus Conductometric 102 TCID50 mL−1 2 h [17] 
Bovine viral diarrhea virus 
(BVDV) 
Conductometric 103 CCID mL−1 8 min [18] 
Phenyl urea herbicide-
Diuron 
Electrochemical SWV 4.0 pM 
[19] 
Atrazine Conductometry 0.16 μM [20] 
Dengue virus Voltammetric 0.33 ng mL−1 [21] 
Japanese encephalitis 
virus (JEV) 
Impedimetric 0.75 μg mL−1 20 min [22] 
Rabies virus Impedimetric 0.5 μg mL−1 [23] 
Rabies virus SPR ~ 70 pg mL−1 [24] 
Picloram Electrochemical CA 5.0 ng mL−1 [25] 
Aflatoxin B1 absorbance detection 5 μg kg−1 [26] 
Aflatoxin M1 electrochemiluminescence 0.3 pg mL−1 [27] 
Ochratoxin A Amperometric 0.11 ng L−1 [28] 
Deoxynivalenol Chemiluminescence 10–7 mg L−1 [29] 
Bovine viral diarrhea virus 
(BVDV) 
Light scattering 10 TCID50 mL−1 
5 min [30] 
Feline calicivirus virus 
(FCV) 
Surface plasmon 
resonance (SPR) 
104 TCID50 mL−1 15 min [31] 
Feline calicivirus virus 
(FCV) 
Fluorescence 1.6 × 105 PFU mL−1 [32] 
Somatotropin 
Surface plasmon resonance 
(SPR) 
0.0034 μM [33] 
C-reactive protein (CRP)
Surface plasmon resonance 
(SPR) 
3 ng mL−1 [34]
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A variety of signal transduction, both optical and electrochemical, have been coupled with 
immunosensors, but colorimetric and chemiluminescent based detection are until now the 
most used.  
Indeed, the high catalytic capability of enzymes leads to a signal amplification and increased 
sensitivity of the assay. 
In the last few years, a new class of biosensors is becoming more popular especially for the 
identification of small molecules, the aptamer-based biosensors. Aptamers are short, 3D-
folded single strand nucleic acids (i.e. DNA, RNA and PNA) that are able to recognize an 
antigen by their conformation. Thanks to their self-annealing properties, they are more 
stable than antibodies. An aptamer specific towards an analyte is obtained by an in vitro 
artificial selection process called SELEX (Systematic Evolution of Ligands by Exponential 
enrichment) leading to a potentially unlimited range of applications (Fig. 3). Although, they 
cannot be used for the identification of low concentrated molecules as their specificity and 
selectivity for the analyte are still not competitive with those obtained with antigen-
antibody interaction [35-37].      
Fig. 3: Schematic representation of aptamer-based biosensors 
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Aptamers -based biosensors are appearing as highly promising biosensors for the 
identification of specific DNA/RNA sequences. These biosensors have great potential 
applications for sensitive early detection of several pathologies like cancer and genetic 
related diseases, for example those related with mutations in small non-coding miRNA and 
mRNA (Fig. 3) [37].  
The emerging ability to control new materials at nanometric length scale is triggering the 
development of new biosensor classes, i.e., implantable nano-biosensors for continuous, in 
vivo, non-invasive detection [38]. However, the applicability of this type of biosensor has 
still some limitations due to the expensive cost of production and short useable lifetime.  
1.1.1 Whole-Cell based Biosensors 
Whole-cell biosensors, relying on living cells as sensing elements, possess unique advantages 
compared to other biosensors [39-40]. Some of the main advantages of the whole-cell-based 
biosensors are here summarized: 
• Versatility (cells can be engineered to express biorecognition element for several
classes of analytes, even more than one in the same cell);
• They measure the bioavailable fraction (the fraction of analyte able to enter into live
cells and activate specific signalling pathways);
• They provide information about general toxicity;
• They provide information about synergic effects (nonlinear cumulative effects of two
or more analytes able to interact with the same cell pathway, or converging
pathways, leading to an increased biological outcome);
• They provide comprehensive functional information about pharmacology, toxicology,
and physiology;
• High sensitivity due to intracellular transcriptional and translational cascade
mechanism;
• Higher predictivity of human effects.
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Over the years, several comparisons have been made between the performance of whole -
cell biosensors and other standard analytical techniques. In many cases, some divergences 
have been found between the response of the different analytical methods, as it is shown 
in the figure below for phenanthrene identification using whole-cell biosensors and High-
Performance Liquid Chromatography (HPLC) (Fig. 4) [40-41].  
Fig. 4: Comparison of phenanthrene identification with whole-cell biosensor and HPLC [40-41]. 
Reproduced by permission of the MDPI (https://www.mdpi.com/1424-8220/17/7/1623) 
Bacteria, yeast and mammalian cell lines have been widely used for whole-cell biosensors 
application. Each cell line shown its own advantages and disadvantages.  
Naturally bioluminescent microorganisms (i.e. V. fischeri) have been the first whole-cell 
biosensors reporter to data as they can be easily cultivated and integrated with the 
transducers. Yeast based biosensors offer the same advantages of bacterial biosensors 
combined with an increased predictivity; due to the higher degree of conservation of cellular 
processes and molecular pathways with human cells. Mammalian cell lines are highly 
valuable when predictive information about bioactivity or toxicity to humans, is required.  
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However, their implementation in biosensors is less common as they have several 
disadvantages compared with yeast and bacterial cell. Mammalian cell lines are 
characterized by slow growth, requirement for cell culture facilities and their viability is 
highly affected by external factors. While microbial cells offer specificity and robustness, 
mammalian cells provide more predictive results [42]. 
Tab 2. Examples of whole-cell biosensors for different analytical applications [43-59]. 
Analyte Host cell Detection Techniques 
Detection 
Limits (LOD) 
Detection 
Time/ 
Reference 
Cadmium Chlorella vulgaris Conductimetric 1ppb 30 min [43] 
Bioavailable Arsenic E. coli Bioluminescence 0.012mg L-1 30 min [44] 
Methyl parathion Flavobacterium Spectrophotometry 0.3μM 3 min [45] 
Acrylamide 
Pseudomonas 
aeruginosa 
Amidase activity 4.48x10-5M 55 sec [46] 
Naphthalene in air 
Pseudomonas 
fluorescens 
Bioluminescence 20nmol L-1  [47] 
Biochemical oxygen 
demand (BOD) 
Bacillus subtilis Bioluminescence 25 mg L-1 [48] 
Biochemical oxygen 
demand (BOD) 
Microbial 
consortium 
Clark oxygen electrode 1 mg L-1 [49] 
Biochemical oxygen 
demand (BOD) 
Pseudomonas 
putida 
Fluorescence 0.5 mg L-1  [50] 
Copper ions S. cerevisiae Colorimetric 0.0067mg L-1 [51] 
3,5-Dichlorophenol V. fischer Bioluminescent 30–100 mg L-1 [52] 
Arsenite 
Rhodovulum 
sulfidophilum 
Colorimetric 3 μg L-1 [53] 
Surfactants Achromobacter Amperometric 0.25 mg L-1 [54] 
LAS 
Trichosporon 
cutaneum 
Amperometric 0.2 mg L-1 [55] 
Mercury arsenite 
Pseudomonas 
fluorescens 
Bioluminescent 0.003 μg kg-1 [56] 
Cupric ions Circinella spp. Voltammetric 0.0034mg L -1 [57]
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Whole-cell-based biosensors thanks to genetic engineering and reporter gene technologies 
can be tuned to detect a wider range of analytes for medical and environmental applications. 
Using these approaches, several whole-cell-biosensors have been developed that can detect 
heavy metals, organic xenobiotic, toxins and other biomarkers (tab.2) [43-59]. 
The well-known unsolved problems of whole-cell biosensors are related to their limited 
portability and scarce shelf-life due to the difficulty of keeping cells alive and responsive for 
long periods of time. The goal is to obtain cells in a ready-to-use format, in which cells can 
be stored for a long period of time (at least months) under controlled conditions and, once 
activated (i.e. by a defined temperature change or addition of nutrients), a constant and 
reproducible number of viable cells can be revitalized [60].  
1.2 Synthetic Biology for biosensing 
Synthetic Biology is a new interdisciplinary field that enables to (re-)design and optimize 
biological components by completely artificial or nature inspired approaches. In particular, 
two different approaches, a top-down and a bottom-up, are usually considered [61-62]. The 
top-down synthetic biology approach is more spread and widely accepted, as it is based on 
the well-established technology of genetic engineering. In this approach a protein/ biological 
pathway responsible for a specific response is transferred into a different host providing it 
with new functions and capabilities. This approach has completely changed whole-cell 
biosensor development by providing new and powerful tools in several fields, spanning from 
biosensing, to diagnostics, bioremediation and therapeutics. Rewriting a genetics circuit is 
highly valuable on the biosensor field as it combines the advantages of both the 
components, i.e., the donor strain from which genetic circuits are used and the recipient 
host strain. Indeed, during the last years, more robust host cells like prokaryotes or 
unicellular eukaryotes have been selected as chasses for human or mammalian complex cell 
pathway expression [63-64].  
These new developed biosensors are more robust and predictive leading to less false 
negative and false positive response. 
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 They are also more resistant to sample toxicity and easier to manipulate for on-field 
applications [65]. Another important advantage, in particular for diagnostic applications, is 
the absence of crosstalk between the endogenous systems present in the chassis and the 
introduced synthetic systems [61,66-67].  
Different biological components have been also integrated into the same cell allowing them 
not only to respond to different specific externa stimuli, but also to integrate more signals 
and perform logic operations. [68] Recently, a more specific signal amplification has also 
been performed through the design of artificial synthetic cascade inside a cell (Fig. 5) [68-
69].  
Fig. 5: Schematic representation of different synthetic biology top down-approaches for biosensors 
applications [68]. 
Several genes of the host organism can also be deleted in order to obtain a living organism 
with a minimum set of gene, reduce the host pathogenicity, or prevent the cell grow. In 
particular, the introduction of self-killing pathways could be an important feature in 
biosensor for point-of-need applications, in order to avoid spreading of genetically modified 
organisms into the environment.   
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The synthetic biology bottom-up approach is based on the possibility to generate a living cell 
from the basic components. In particular, one approach is trying to put together only the 
necessary genes for a new, completely synthetic, living -cell able to grow, perform fixed task 
and even duplicate. 
Another approach relies on the possibility to introduce all the necessary proteins to perform 
in vitro transcription and translation, as response of a precise input. These systems are call 
transcription-translation systems (TX-TL systems) (Fig. 6) [70-71].  
Fig. 6: Schematic representation of synthetic biology bottom-up approaches for biosensors applications 
[70] 
For biosensing applications, the new developed TX-TL systems offers a unique opportunity 
for analyte detection, particularly for on-field application. It’s high predictive like whole-cell 
biosensors, but it’s abiotic, can be lyophilized and stored for long time even at room 
temperature.  
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They do not have cell walls, that could be a problem if we want to identify the bioavailable 
concentration, but it offers a direct access to the inner workings of the cell [72-73].  
1.3 Optical reporter genes 
A reporter gene is a gene whose activity is easily distinguished, measured and quantified
over a background of endogenous proteins [74]. Reporter genes have been often used as 
markers for gene expression, for monitoring signal transduction pathways and regulation of 
translational efficiency in a cell or transgenic organism (Fig.7).  
Fig. 7: Schematic representation of reporter gene technology uses for monitoring of cis-regulatory 
sequence.  
Thanks to genetic engineering the sequence of a reporter gene can be easily fused to the 
protein of interest or its enhancer/cis-regulatory sequences providing an efficient tool for 
direct/indirect gene monitoring [75-76]. Several applications for this technology have been 
developed, such as continuous real-time monitoring of endogenous gene expression in 
specific cell or tissues, for monitoring of real-time response for diseases treatment, for in-
vivo monitoring of cell migration and drug delivery [77-81].  
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During the last years, several inducible promoters have been easily tailored to respond to 
specific analytes with several reporter genes for whole-cell biosensing applications. 
Thanks to their high sensitivity, optical reporter proteins are the most used reporter genes 
in whole-cell biosensors (i.e. colorimetric, fluorescent and bioluminescent). Each class of 
optical reporter genes has its own pros and cons [82]. In particular, fluorescent reporter 
genes need an external light source for signal detection, while colorimetric and 
bioluminescent reporters need the addition of a substrate. Furthermore, bioluminescent 
reporters show higher quantum yield emission and lower signal to noise ratio, due to almost 
zero background even in complex matrix and in living organisms.  
However, the substrate required for the bioluminescent reaction is generally not stable at 
room temperature for long periods of time [83-85]. 
Fig. 8: Emission spectra of different bioluminescent reporters and example of a whole-cell biosensor having 
two reporters: one specific for the analyte and one used as internal viability control.  
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The main limitations of reporter gene-based biosensors are the long assay time (several 
hours), which is required for the expression of the reporter protein, and scarce robustness 
due to changes of cell’s viability. In fact, non-specific effects of sample or matrix, or changes 
in temperature and pH, may lead to altered viability, thus affecting the analytical signal. To 
this end luciferases and fluorescent reporter genes emitting at different wavelengths can be 
used to improve robustness by addition of an internal viability control. To separate the 
bioluminescent signals spectral resolution by use of suitable optical fields can be exploited. 
[86-87] (Fig. 8).  
Another critical issue related to bioluminescence detection is the low level of light emitted 
by the cells which necessarily requires highly sensitive light detectors [88]. 
1.3.1 Bioluminescence 
Bioluminescence is the naturally occurring process through which living organisms are able 
to emit light. The light emitted in the bioluminescent reaction is a cold light (less than 20% 
of the light generates thermal radiation or heat) and it is the result of an undergoing 
radiative decay of an excited intermediate. In bioluminescence, unlike other luminescent 
processes such us fluorescence, the electronic excited state is not photoinduced, but is 
rather the product of a chemical reaction catalysed by an enzyme, generally called luciferase 
[89]. In theory, one photon of light should be given off for each molecule of reactant, this is 
equivalent to Avogadro's number of photons per mole of reactant. In actual practice, direct 
chemical reactions seldom exceed a quantum yield of 10-3-10-2, while the bioluminescent 
reaction catalysed by the Photinus pyralis luciferase showed the highest quantum yield 
emission efficiency reported (i.e. 0.41 ± 0.074) [90-93].  
This turns to be of great advantage for detecting analytes present at very low concentrations 
or when miniaturization for developing lab-on-a-chip platforms is required [94-95]. 
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 A large variety of marine and terrestrial organisms (bacteria, fungi, fish, insects, worms) 
express bioluminescent proteins, that are very different according to their evolutionary 
functions, reaction mechanisms, substrates used and bioluminescent properties (Fig. 9).  
Fig. 9: Examples of naturally bioluminescent emitting organisms. From left to right:  Aequorea victoria, 
Bathophilus digitatus, Agaricus gardneri and Photinus pyralis. 
Interestingly, the BL emission spectra of naturally occurring BL systems cover all the visible 
range between 400 nm and 650 nm, while all bioluminescent substrates studied till now 
share the same luminophore: a peroxide bond –O–O– [96-97].  
The most common biological functions of BL are: counterillumination camouflage, 
attraction, defense, warning, communication and mimicry. The naturally bioluminescent 
proteins can be grouped into two major categories: photoproteins and luciferases. 
Luciferases like firefly luciferase and click beetle luciferase catalyze oxidation of D-luciferin 
in the presence of ATP, Mg2+ and molecular oxygen (O2). As it shown in figure 10, adenylation 
of luciferin is followed by, cyclization, and decarboxylation of the adenyl-luciferin complex, 
resulting in the emission of CO2 and light [98-99]. Photoproteins such as Aequorea victoria’s 
aequorin are calcium-regulated proteins in which light emission is initiated by upon calcium 
binding [100].   
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Although more than 30 kinds of luciferases have been identified in nature, there are only 9 
natural luciferins reported up to date.  
Firefly luciferase is the most common luciferase used in bioanalytical applications; it emits 
yellow-green light (λem = 557 nm at pH 7.8) with glow-type kinetics and a broad emission 
band. 
Fig. 10:  Luciferase-catalyzed oxidation of D-luciferin [97] 
Among luciferases, Photinus pyralis luciferase (PpyLuc) is by far the most investigated and 
employed in bioanalytical applications and biosensors development.[101-102] PpyLuc is a 
61-kDa monomeric protein that does not require any post-translational modifications and it
does not show any toxicity to cells even at high concentrations, being thus suitable for 
heterologous expression in both prokaryotic and eukaryotic systems.  
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PpyLuc bioluminescence is temperature and  pH-sensitive, showing a remarkable red-shift 
at lower pH and higher temperatures.  
Half-life of this luciferase expressed in mammalian cells was calculated to be in the range 
from 1 to 4 hours in the presence of protease inhibitors. 
Firefly luciferin, among others, diffuses easily across biological membranes including cell 
membranes, the blood brain barrier and the blood placenta barrier. In particular, crossing 
of cell membranes is increased at low pH (e.g., 100 mM Na-citrate, pH 5.2) due to the 
protonation of the carboxyl group of D-luciferin [103-104]. Several studies evaluated 
luciferin cytotoxicity, showing no effect after 24 h [105]. 
D-luciferin must be stored in the dark as it is sensitive to light. It could be stored for long
periods of time at -80°C and for 8-24 hours at 4°C [106]. 
Thanks to recent advances in genetic engineering and in silico studies, directed evolution of 
new semi-synthetic luciferases and luciferins have been made leading to improvement of 
thermostability, altered spectral emission and increased quantum yield emission [107-109]. 
For example, mutants emitting at 460 nm and 620 nm have been obtained changing the
amino acid I288 from Isoleucine (nonpolar and neutral, MW= 131) to valine (nonpolar and 
neutral, MW= 117) and alanine (nonpolar and neutral, MW= 89) respectively. 
Because of this improvement, the luciferase reporter gene can be used for new 
applications, such as biosensors with multiplex capability, that allow to simultaneously 
measure more than one analyte. [99]  
Also, multiplex detection can be performed, by exploiting spatial, temporal, spectral 
resolution or by selecting luciferases such us firefly and NanoLuc luciferase that require 
different substrates (Fig. 11) [110]. 
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Fig. 11: Different strategies to develop multiplex cell-based assays relying on two different luciferases 
expressed in the same cell. [110]      
Reproduced by permission of Springer Nature (License number 4697591282423). 
NanoLuc luciferase is the newest semisynthetic luciferase available on market. The native 
luciferase from deep sea shrimp utilizes coelenterazine in an ATP-independent reaction to 
produce blue light (λmax= 454 nm) [111]. The native enzyme has a heteromeric stable 
structure consisting of two 35 kDa subunits and two 19 kDa subunits and high specific 
activity. Thanks to structural studies the bioluminescent activity was associated only with 
the smaller, but instable subunit (Oluc-19) [111-113]. 
Thanks to enzymatic evolution and substrate substitution the enzyme has been changed 
leading to a semisynthetic new enzyme with increased stability and improved 
bioluminescent properties.  
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The final enzyme results has a 10% of mutated aminoacids in comparison with the native 
primary structure with a brighter glow-type emission kinetics (claimed to be 150-fold 
brighter than firefly luciferase).  
The small size of the enzyme and the absence of post translational modification enables 
rapid synthesis and folding of the reporter upon induction even in prokaryotic organisms 
(Fig. 12).  
Meanwhile, the rapid protein degradation (through PEST sequence) avoids unnecessary 
overexpression and intracellular accumulation in cells that may lead to artefacts and toxicity 
[111].  
Fig. 12: Comparison between NanoLuc, Renilla and Firefly luciferase [111].      
Reproduced with permission of ACS Publications (https://pubs.acs.org/doi/10.1021/cb3002478) 
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1.3.2 Fluorescence 
Fluorescence is a luminescent phenomenon which describes the emission of photons by a 
compound after being illuminated with an electromagnetic radiation (i.e. visible light). 
(Fig.13) The first description of fluorescence occurs in 1852 by George Gabriel Stokes, when 
he observes the emission of visible light by calcium fluoride (CaF2) after being irradiated by 
UV light [114]. Fluorescent compounds are generally classified into four categories small 
organic compounds, synthetic polymers, proteins and multi-component systems [115-116]. 
Fig. 13: Jablonski diagram [115-116]. 
Unlike phosphorescence, in fluorescence the electron spin is still paired with the ground 
state electron and the light emission stops nearly immediately when the radiation source 
stops (0.5 - 20 nanoseconds of lifetime) [117]. 
Fluorescence signal is linearly proportional to the concentration of the fluorescent molecule. 
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In most cases, the fluorescent emitted light has longer wavelength and therefore lower 
energy than the absorbed radiation. The difference between the maximum excitation and 
maximum emission wavelength is called Stokes shift. Different compounds showed different 
stokes shift and fluorescent properties. A narrower adsorption/emission band with higher 
Stokes shift is desirable, as it avoids the overlap of the absorption spectrum and emission 
spectrum (Fig.14) [118-120]. 
Fig. 14: Examples of different Stokes shift and overlap area between absorption and emission area [120]. 
Over the years, fluorescence molecules, in particular proteins and nanoparticles have been 
extensively used for different applications such as lamps, mineralogy studies, chemical 
sensors, cosmic-ray detection and biological detectors (labelling protein of interest and 
reporter gene technology) [121]. 
Several naturally fluorescent proteins have been studied and modified at the molecular level 
to enhance their property and expand their applications, as shown in figure above (Fig.15) 
[122-123] 
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Fig. 15: Examples of fluorescent proteins used for reporter gene applications. Some fluorescent variants of 
the native proteins have been obtained with mutation of the aminoacidic structures [124-125].   
Reproduced by permission of Elsevier, licence number 4758850940327. 
1.4 Living cell Immobilization 
Maintenance of cell viability and physiological cellular activity is crucial in whole-cell 
biosensing. To this end, several cell immobilizations approaches have been explored over 
the years, each one having peculiar advantages and limitations (Fig. 16). Both microbial and 
mammalian cells were successfully immobilized on different surfaces or entrapped into 
suitable matrixes, depending on the goal of the immobilization and the type of cell. When 
dealing with whole-cell biosensors, several factors should be taken into consideration during 
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cell immobilization; for example, opacity of some matrices, such as PVA, is not an issue for 
electrochemical biosensors while it could interfere with optical signal detection [126-127]. 
Nature-inspired approaches are the most promising and widely exploited techniques in cell 
preservation. Among the most employed matrices for cell biosensor’s immobilization, three 
groups can be identified: ionic hydrogels, thermogels and synthetic polymers.  
Fig. 16: Different immobilization techniques methods categories for whole-cell immobilization approaches 
for biosensing. [131] 
Hydrogel entrapment, i.e. using agarose, acrylamide and alginate, represents the easiest and 
most exploited approach for cell biosensor immobilization [128-131]. In particular, bacteria 
and yeast entrapped into alginate beads or slices have been implemented into portable 
biosensing devices with intended use in remote area, showing possibility of long-term 
storage, low toxicity and good reproducibility [132-134]. However, several classes of 
positively charged surface coatings have been also employed such as polymers and 
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polyelectrolytes, to reduce the molecular crowding interactions between negatively charged 
bacteria.  
One of the longest storage times for bacterial cells, up to 8 months, was achieved by spore-
forming bacteria Bacillus subtilis and Bacillus megaterium for arsenic and zinc detection. 
Thanks to their amazing capability to survive to extreme conditions such as freezing 
temperatures, desiccation, dry and wet heat allowing easier storage and shipment even in 
remote area. Recently, spores were also exposed to extreme conditions, such us simulate 
Mars surface conditions, showing good survival rates [135-136].  
Current trends in bacterial biosensors are focused on the achievement of fine control over 
cells, to enable their manipulation, thus providing a new strategy to concentrate cells and 
separate them from complex media before measurement of the analytical signal. This leads 
to a reduction of matrix effect an increased analytical performance [137].  
Mammalian cell lines have several disadvantages compared with yeast and bacterial cell, 
however their implementation in immobilized conditions is highly valuable. Mammalian cell 
lines are also more effected by external factors and physico-chemical stressors. For these 
reasons, a suitable support is required to provide the cells not just an inert matrix for cell 
growth, but to confer them protection from external agents and to create of a suitable 
micro-environment (Tab. 3). Indeed, local concentration of cytokines and other soluble 
factors for paracrine signalling improves cell-to-cell communication and survival. 
Over the years different materials have been exploited as matrices to optimize the 
immobilization of mammalian cells, and in some cases were used approaches similar to 
those explored for microbial cells. Among others, agarose, natural and synthetic hydrogels 
and gelatine are the most promising. However, the lack of optimal culture conditions during 
storage (i.e. temperature, humidity and CO2) negatively affect cell metabolism and 
responsiveness leading to a rapid loss of their function. Up to now, the most promising 
strategy allows storage of mammalian cells with a 6-week viability during storage (in air, at 
room temperature) compared to 8 months obtained for microbial cells [138-143].  
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Table 3: Advantages and disadvantages of different techniques used to preserve cell viability. 
PRESERVATION 
METHOD 
ADVANTAGES DISADVANTAGES 
Freeze drying 
(lyophilization) 
Proven industrial performance record 
Easily rehydrated product 
Costly and complex technique 
Product sensitive to moisture 
Vacuum drying 
Yields potentially high survival rates and 
long-term stability 
Relatively low production costs 
Suitable alternative for freeze-sensitive 
microorganisms 
Less well-proven performance 
record 
Harsher drying conditions than 
freeze drying 
Encapsulation in organic 
polymers (e.g. hydrogels) 
Provides physical shielding and isolation 
Allows solute diffusion 
Biodegradable 
Bacterial growth may occur 
Opacity may hinder optical signal 
detection 
Encapsulation in 
inorganic polymers (e.g. 
sol-gel) 
Provides physical shielding and isolation 
Mechanical rigidity and good optical 
properties 
Allows solute diffusion 
Limits bacterial growth 
Tested for a limited variety of 
microorganisms 
1.5 3D-printing technologies 
3D printing is the process of making layer-upon-layer a three-dimensional solid object from 
a computer-aided design (CAD). (Fig. 17) Thanks to the development of this technology 
combined with additive manufacturing and affordable micro/nano-fabrication technologies 
new supports for point-of-need biosensing are becoming available. Indeed, 3D printing 
enables the production of complex and well characterized shape with several materials, 
spanning from polymers to metals [144-145]. The easy tunability with the possibility of 
cheap and rapid in-house prototyping have favoured the rapid spread of this technology.  
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Fig. 17: 3D printer Makerbot Replicator 2X and Makerware software for 3D printing of microfabricated 
device. 
There are different types of 3D printing depending on the mechanism by which materials 
are bonded together and the type of materials compatible with the technology. The most 
used categories for biosensors applications are photopolymerization, fused deposition 
modelling, powder bed fusion and material jetting [146]. The first applications of 3D 
printing technology for on-site biosensing have been related to the development of 
customized adaptor for biosensors integration into portable device using fused deposition 
modelling. Fused deposition technology is based on the depositing of layers of melted 
thermoplastic polymer such as acrylonitrile butadiene styrene (ABS) and polylactic acid 
(PLA). Several 3D printed devices have been made with this cheap and biocompatible 
polymer showing great advantages and versatility [42,146-148].  
More recently, material jetting method is becoming more and more employed in this area 
as it allows to print multiple materials at the same time achieving unique properties in the 
final 3D-printed structure. This technique allows the creation of not only a simple inert 
scaffold but also functional material with tuneable advanced properties. Indeed, 
mammalian cells can be successfully deposited and directly printed onto a scaffold [149-
150]. Increased storage, differentiation process and in vivo implants have been also 
exploited to obtain “living materials” [151].  
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In particular, a 3D fully interconnected porous architecture is an ideal requirement of a 
scaffold to ensure cell differentiation, nutrient exchange and removal of metabolic waste. 
Cells migration is followed by proliferation, maturation and differentiation to generate the 
tissue of interest (i.e. bone tissue formation). Increased performance of 3D-printed 
microorganisms has been also obtained in other fields including fermentation and 
bioremediation processes. For example, environmental impact and half-life have been 
improved with 3D printed hydrogel ink for P. putida and A. xylinum for pollutants 
identification and degradation as well as cellulose production. [152-153] 
1.6 Portable light detectors 
In a biosensor, the detector acquires and amplifies the signal produced by the interaction 
between the biological part and the analyte. Some detectors are also able to process the 
signal, others need an external system for data elaboration. Light detectors can be usually 
divided in laboratory-based instrumentation for highly sensitive detection (i.e. 
photomultiplier tubes) and compact instrumentation for on-field applications (i.e. 
photodiodes). Photodiodes and photomultiplier are semiconductor devices that convert 
incident light into an electrical signal. Unlike the photodiode, the photomultiplier tubes are 
characterized by an internal amplification system able to increase the acquired signal as well 
as increase the background noise.  Accordingly, photodiodes are characterized by low 
background noise, low sensitivity and slower response time. Photomultipliers are 
extremely sensitive in particular in the ultraviolet, visible and near-infrared ranges, but 
they have high background noise and require a more powerful energy supplier.  
During the last decade, a great effort has been made for the development of ultra-sensitive 
and miniaturised portable light detectors. Thanks to the recent development in this 
technology, new generation of silicon and organic photodiodes, complementary metal oxide 
semiconductors (CMOS) and charge-coupled devices (CCD) have been implemented into 
portable devices for on-field applications [154-156].  
39 
In particular, CCD and CMOS are the most promising light sensors for biosensing 
applications. Both sensors are pixelated metal oxide semiconductors that accumulate a 
signal charge in each pixel proportional to the local light intensity. In CCD, each pixel’s charge 
packet is sent sequentially to a common output structure, where there is a common 
amplifier and charge converter. In CMOS, the amplification and conversion process take 
place in each pixel and the final signal is sent in a parallel mode instead of sequential one 
(Fig. 18). These differences have significant implications for sensor architecture [157]. 
Fig. 18: Schematic representation of CCD and CMOS light transduction mechanism [157]. 
Among others, CMOS light detectors integrated into smartphone cameras have had a 
tremendous improvement due to the rapid diffusion of smartphones. 
Indeed, this kind of technology provides a powerful, low cost tool for several applications, 
including personalized diagnosis and health monitoring in every day’s life. These devices can 
transmit relevant data to experts such as physicians and can help self-management of 
common chronic diseases, such as diabetes and cardiovascular diseases. The same detector 
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can also be implemented for real-time on-site monitoring of pollutants in remote 
contaminated area where there are no equipped facilities. The use of smartphones for point-
of-care analysis is highly appealing, however, there are lot of challenges such as clinical 
validation, reproducibility, robustness and rapidity that need to be solved before these 
devices could significantly improve healthcare delivery and provide better health 
management tools globally (Fig.19) [158-160].   
Fig.19: Smartphone as portable light detector for on-site biosensing and online data transfer. 
Several analytical devices have been reported in the past implementing different portable 
light detector (CCD or CMOS) focusing on the different advantages of each technique. Side-
by-side comparison have also been reported to evaluate the sensitivity of smartphone 
implementing a CMOS sensor with a low-light luminograph equipped with a 
thermoelectrically cooled CCD.  As expected, a good correlation between light intensity and 
measured signal was reported for both systems; however, the signal-to-noise ratios (S/N) of 
the luminograph images were approximately three orders of magnitude higher than those 
obtained with the smartphone camera [161].  
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Several factors explain this lower detectability of the smartphone integrated camera, for 
instance the smaller pixel size and the absence of a sensor cooling system, which causes 
higher thermal noise. For every 6°C reduction in chip temperature the dark-current shot 
noise, which is the major source of noise, is cut approximately in half [162]. The variance 
due to dark current shot noise is described by the following equation: 
fqI dd = 2
2 (eq. 1) 
Where σd2 is the variance of shot noise, q is the charge of an electron, Id is the amount of
dark current, Δf is the electronic bandwidth of the sensing system. The implementation of 
cooled systems into portable devices is not straightforward, since additional components 
are required to avoid water vapor condensation on the camera window and also a larger 
power supply. The feasibility of using different portable CCD cameras as low-light detectors 
has been reported by cooling the sensor with a Peltier chamber down to -10 °C. This 
approach enabled the detection of different types of cells including magnetotactic bacteria 
and yeast; however, these approaches still require an external computer to handle the 
images and elaborate the signals [163-164].  
Smartphone based biosensors potential for clinical applications have been widely 
demonstrated by imaging P. falciparum-infected red blood cells, detecting M. tuberculosis-
infected sputum samples, performing immunoassays for urine analysis and prostate cancer 
diagnosis and quantitative analyses of lateral flow tests with electrochemical and 
colorimetric detection [165-167]. However, an important issue that need to be solved is 
related to the fact that each smartphone has a different (CMOS) camera with different 
performance. Several comparisons have been made between different Android and iOS 
smartphones and until now the best performance have been obtained with OnePlus devices 
[168-170].  
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2 Aim of the Thesis 
The goal of this PhD project has been the development and optimization of bioengineered 
whole-cell biosensors for point-of-need applications.  
Thanks to synthetic biology tools combined with genetic engineering and reporter gene 
technology whole-cells have been tailored at the molecular level to respond to specific 
analytes by the generation of measurable and quantitative dose-dependent signals. These 
tools have been also used to improve the analytical performance of the new developed 
biosensors, in terms of limit of detection, response time and dynamic range. The 
development of ready to use cartridges with immobilized and responsive whole-cell 
biosensors that could be stored for long time have been also exploited.  
In chapter 3, several optical reporter genes (fluorescent, bioluminescent and colorimetric) 
have been exploited for whole-cell biosensing thanks to their high sensitivity and 
straightforward procedure. In order to identify the best reporter gene in terms of sensitivity, 
response time and limit of detection, a battery of standardized whole-cell and cell-free 
biosensors have been developed. The analytical performance of eight reporters from the 
three reporter categories have been profiled for bought whole-cell and cell-free biosensors 
systems. Two representative bacterial biosensors for mercury and quorum sensing molecule 
have been selected as the monitoring of these compound in water is important for health 
of human and environment. The lowest detectable concentration of analytes and the fastest 
responses were achieved with bioluminescent NanoLuc luciferase. Notably, a LOD ≤ 50.0 fM 
HgCl2 for the mercury whole-cell biosensors and a LOD ≤ 0.38 pM of 3OC6HSL for quorum 
sensing biosensors were achieved with just 30 min of induction. 
NanoLuc luciferase and other bioluminescent reporters were therefore selected as reporter 
genes for the development of other whole-cell biosensors during this PhD.  
Whole-cell biosensors based on bacteria cells are important for environmental monitoring 
as they are easier to be used and more robust. But, cellular responses to some molecules 
are different in prokaryotes from those in eukaryotes and this limits their application in 
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toxicity evaluation and drug screening. While, other microorganisms like yeast provide the 
robustness of bacteria cell with the predictivity of eukaryotic cell pathways.  
During this PhD I have worked on the development of whole-cell biosensors based on yeast 
cell for the identification and quantification of (anti)estrogen-like compounds. In chapter 4 
and 5, S. cerevisiae yeast cells have been exploited as chassis for the recombinant expression 
of human estrogen receptors (hERα and hERβ), combined with the properties of 
bioluminescent NanoLuc luciferase. Thanks to synthetic biology tools and genetic 
engineering all genetics components have been optimized and a fast and sensitive biosensor 
have been developed. Indeed, even after 5 min a dose-response curve was obtained 
showing a LOD of 1.08 ± 0.02 nM and 0.015 ± 0.001 nM for hERα and hERβ, respectively. 
The best response was obtained with only 30 min of incubation time, showing a LOD of 0.016 
± 0.001 nM and an EC50 of 1.47 ± 0.06 nM for the ERα strain, while a LOD of 0.0011 ± 0.0002 
nM and EC50 of 0.10 ± 0.01 nM were found for the ERβ strain.  
New straightforward immobilization procedures and 3D printer adaptors have been also 
developed to prove the feasibility of integrating these new biosensors into portable devices 
for on-field application. Thanks to the new immobilization procedure a longer storage time 
and higher bioluminescent signal were achieved. While, thanks to 3D printer technology 
adaptors for biosensors integration with low-cost and user-friendly device have been 
developed. In particular, a Go-Pro Hero 5 camera and a OnePlus 5 smartphone have been 
used for image acquisition. Showing a limit of detection only 10 time higher compared to 
conventional laboratory instrumentations, which are much more expensive and cannot be 
used in on-field setting and need a trained user to carry out all the necessary procedure for 
signal acquisition. 
In chapter 5, a viability control strain was also developed based on a chimeric green-emitting 
luciferase, PLG2, expressed for the first time in S. cerevisiae. The integration of this viability 
control strain into the same portable device together with yeast reporter strains harbouring 
hERα and hERβ allowed a more reproducible and repeatable response about 
(anti)estrogenic activity via human estrogen receptor, as well as sample toxicity information. 
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All biosensors based on microorganisms, like yeast and bacteria, are characterised by many 
features like rapid growth on a broad range of substrates, ease of handling and are very 
cheap. Also, thanks to their high robustness they can be “easily” integrated into portable 
devices for on-field application. Yeast, being eukaryotic cells, can be used for obtaining a 
good predictivity, however some complex intracellular pathways can not be successfully 
reproduced into this cell. To this end, during this PhD I have also worked on the development 
of a portable device for on-field application based on human cell lines. 
 In chapter 6, 3D cell cultures of human embryonic kidney (HEK293T) cell line were 
genetically engineered for monitoring NF-κB signal transduction pathway with a bright red-
emitting luciferase (PpyRE-TS).  
Ready-to-use cartridges with 3D bioluminescent whole-cell biosensors for 
(anti)inflammatory activity monitoring were developed and a proof-of-principle device 
integrated with smartphone was obtained for point-of-care applications. In order to increase 
the reproducibility of mammalian cell biosensors an internal viability control was introduced 
with a green-emitting luciferase (PpyGR-TS), under the control of a weak  constitutive 
promoter. The inducible and constitutive promoters were successfully expressed into the 
same cell, to further improve the biosensors robustness by correcting the specific analytical 
signal according  to non-specific effects on cell viability as well as small variations in spheroid 
number and dimension. Nevertheless, the simultaneous detection of multiple colors 
emitted from the same well represented a challenge for a smartphone-based filterless 
device. Several luciferases have been tested and pH and thermostable mutant luciferases 
with a well separated emission spectra have been selected. 
Accordingly, the developed biosensor provides a green signal in absence of NF-κB activity, 
while emits red light which intensity is proportional to inflammatory stimuli. In optimized 
conditions, the biosensor gives a LOD of 0.15 ±0.05 ng/mL and an EC50 of 1.0 ±0.1 ng/mL 
with TNFα as model analyte. 
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ABSTRACT: Whole-cell and cell-free transcription-trans-
lation biosensors have recently become favorable alternatives
to conventional detection methods, as they are cost-effective,
environmental friendly, and easy to use. Importantly, the
biological responses from the biosensors need to be converted
into a physicochemical signal for easy detection, and a variety
of genetic reporters have been employed for this purpose.
Reporter gene selection is vital to a sensor performance and
application success. However, it was largely based on trial and
error with very few systematic side-by-side investigations
reported. To address this bottleneck, here we compared eight reporters from three reporter categories, i.e., fluorescent (gfpmut3,
deGFP, mCherry, mScarlet-I), colorimetric (lacZ), and bioluminescent (luxCDABE from Aliivibrio f ischeri and Photorhabdus
luminescens, NanoLuc) reporters, under the control of two representative biosensors for mercury- and quorum-sensing
molecules. Both whole-cell and cell-free formats were investigated to assess key sensing features including limit of detection
(LOD), input and output dynamic ranges, response time, and output visibility. For both whole-cell biosensors, the lowest
detectable concentration of analytes and the fastest responses were achieved with NanoLuc. Notably, we developed, to date, the
most sensitive whole-cell mercury biosensor using NanoLuc as reporter, with an LOD ≤ 50.0 fM HgCl2 30 min postinduction.
For cell-free biosensors, overall, NanoLuc and deGFP led to shorter response time and lower LOD than the others. This
comprehensive profile of diverse reporters in a single setting provides a new important benchmark for reporter selection, aiding
the rapid development of whole-cell and cell-free biosensors for various applications in the environment and health.
Whole-cell biosensors are cells that detect and report atarget or condition of interest.1−4 Due to being
renewable, environmental friendly, and cost-effective, they
have drawn increasing attention as viable alternatives to
electronic or chemical sensors over the last three decades.2,3
Notably, in the rising era of synthetic biology, a growing
number of engineered whole-cell biosensors have been
researched for a broad range of applications, such as
environmental assessment,3,5−7 clinical diagnosis8,9 and bio-
therapy,10,11 controlled bioprocessing,12,13 mineral surveying,14
and landmine clearing.15
Meanwhile the cell-free transcription-translation (TX-TL)
system is becoming a favorable technology for in vitro synthetic
biology study due to its capability of flexibility, stability,
portability, and fast prototyping as well as creating a minimal
cellular environment.16−19 Because the cell-free system (CFS)
contains no cells but only the basic biological machineries and
energy sources required for TX-TL,20 it has been proposed as a
feasible solution to circumvent the biosafety issues associated
with whole-cell biosensing.19 Hence, a number of cell-free
biosensors have been developed recently to detect heavy
metals,21 antibiotics,22 and pathogens.23,24
Both whole-cell and cell-free biosensors share a similar
architecture comprising a sensing module, a computing
module, and an output actuating module.1−3 Many reporter
proteins that produce light,8,25,26 fluorescence,5,15 colors,23,27
electrons,28 or gas vesicles29 can be used as genetic reporters in
the output module.
Like other genetic devices or gene expression studies,17,30
many biosensors were first built with fluorescent reporters as
the output actuator,3,5,15,24 thus simplifying their character-
ization in laboratory settings. Fluorescent proteins are
relatively stable and take a short time to mature, and their
light emission can be readily measured by a fluorimeter under
specific light excitation. In addition, they can be used to study
sensor cells at single cell level by fluorescence microscopy or
fluorescence activated cell sorting.
Colorimetric reporters are often used to allow direct
visualization of sensor output by the naked eye, which can
drive down the operating costs of readout machines. As the
first enzyme used to produce colorimetric output in engineered
biosensors,31 β-galactosidase (i.e., LacZ) from Escherichia coli
lac operon is the most popular enzyme used for both whole-
cell and cell-free biosensors.19,21,23 The LacZ-catalyzed
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hydrolysis is fast,19 but many bacterial strains contain an intact
lac operon, which will increase the background of the
colorimetric output.
Bioluminescent reporters are also based on biochemical
reactions which produce light without the need of an excitation
light source. Among them, bacterial (LuxCDABE or
LuxAB)8,32 and firefly (LucFF)33 luciferases are often used in
whole-cell or cell-free biosensors. Owing to its high
luminescent activity and small size (19 kDa), the recently
engineered NanoLuc luciferase has become a favored bio-
luminescent reporter for whole-cell biosensors.25,34 Many of
these bioluminescent biosensors have been coupled with
portable devices for field testing or on-site diagnosis.8,25,35
However, unless the whole luciferase cassette is present, an
external substrate such as D-luciferin, coelenterazine, or
furimazine is required, limiting their applications for
continuous monitoring.
Although a variety of genetic reporters have been thoroughly
studied, their selections for biosensor engineering were more
based on one’s experience rather than systematic side-by-side
investigations. A few prior studies have been carried out to
compare a couple of reporter categories; however, they were
either not from the view of biosensor applications or not in
directly comparable settings.7,36−38 To facilitate biosensor
engineering, it is of great importance to compare different
reporter categories systemically while evaluating their con-
tributions to sensing performance. To this end, here we
characterized and compared three widely used reporter
categories, i.e., fluorescent, colorimetric, and bioluminescent
reporters, under two representative biosensors of mercury- and
quorum-sensing molecule within two different sensor settings,
i.e., whole-cell and cell-free contexts. We investigated their
properties in terms of contributions to analytical performance
and key sensing features including limit of detection (LOD),
input and output dynamic ranges, response time, and output
visibility. Such a comprehensive profile provides a new
benchmark reference for reporter gene selection, which will
aid the rapid development of whole-cell and cell-free
biosensors for various applications.
■ EXPERIMENTAL SECTION
Strains, Chemicals, and Reagents. Plasmid cloning and
in vivo genetic circuit characterization were all performed in E.
coli TOP10. Cells were cultured in Lysogeny broth (LB)
medium (10 g L−1 peptone, 5 g L−1 NaCl, 5 g L−1 yeast
extract), with appropriate antibiotics. The antibiotic concen-
trations used were 50 μg mL−1 for both kanamycin and
ampicillin (for low copy number plasmid) or 100 μg mL−1 for
ampicillin (for high copy number plasmid). Antibiotics and
inducers (i.e., mercury(II) chloride (HgCl2) and N-(β-
ketocaproyl)-L-homoserine lactone (3OC6HSL)) were ana-
lytical grade and purchased from Sigma-Aldrich. They were
dissolved in ddH2O or nuclease free H2O (W4502, Sigma-
Aldrich) and were then filtered using 0.22 μm syringe filters
(SLGP033RS, Millipore).
LacZ substrate 5-bromo-4-chloro-3-indolyl β-D-galactopyr-
anoside (X-gal) (MB1001, Melford) was dissolved in dimethyl
sulfoxide (DMSO) (D8418, Sigma-Aldrich) to make 2% or 5%
(w/v) stock solutions. Substrate furimazine for NanoLuc
luciferase was from Nano-Glo Luciferase Assay System
(N1110, Promega).
Plasmid Circuit Construction. Standard molecular
biology techniques were used to construct plasmids containing
mercury- and quorum-sensing molecule-responsive genetic
circuits. All plasmids were constructed via BioBrick assembly39
and standard PCR. BioBrick vectors pSB1A3, pSB4A3, and
pSB3K3 were used for plasmids cloning, and pSB3K3 was used
for sensor circuit characterization (http://biobricks.org).
Plasmid maps and detailed configurations are provided in
relevant figures and summarized in Figure S1. Sequence details
and sources of relevant parts are listed in Table S1. All primers
used in this study, listed in Table S2, were purchased from
Sigma-Aldrich. All plasmids constructed in this study have
been confirmed by Sanger sequencing (Source BioScience).
Detailed plasmid construction procedures are described in
Supporting Information.
Reporter Gene Expression Assay in Vivo. For in vivo
reporter gene characterization, engineered E. coli with
constructed sensor plasmids were induced with HgCl2 or
3OC6HSL, and the reporter signals were measured using a
plate reader (BMG FLUOstar) post 30, 60, 90,120, 180, 240,
300, and 360 min induction and incubation. NanoLuc-
conducted bioluminescent and LacZ-conducted colorimetric
measurements were acquired in lysing and nonlysing
conditions using the same concentration of substrates (X-gal
= 0.04 mg mL−1 from 2% X-gal stock solution and 0.2 μL of
furimazine stock solution per 200 μL of culture). NanoLuc-
derived bioluminescent kinetics were measured for 30 min
after substrate addition, and the highest signal was chosen for
data analysis. Colorimetric signal measurement was preceded
by 30 min incubation at 37 °C, with orbital shaking at 300 rpm
in the plate reader. To determine the cell density, absorbance
(A600) was also read prior to each reporter measurement. For
the lux operon reporter, the bioluminescent signal was
measured immediately after absorbance measurement without
the addition of substrates. Unless indicated otherwise, each
reporter within different sensors was tested with three
biological replicates. All the data shown are mean values with
standard deviation as error bars. Detailed experimental
procedures, data analysis, and instrument settings for reporter
measurements and visualization are described in Supporting
Information.
Reporter Gene Expression Assay in Vitro. The cell-free
reactions were performed using E. coli S30 Extract System for
Circular DNA (L1020, Promega) according to the manufac-
turer’s protocol. Each reaction contained 40% (v/v) S30
premix, 10% (v/v) amino acid mix, 30% (v/v) S30 extract, and
2% (v/v) inducer. The remaining 18% (v/v) contained DNA
template with or without substrates. A 9.6 nM DNA template
was used for each reporter within the mercury-sensing circuit
and for the negative control (reaction with empty pSB3K3). A
9.2 nM DNA template was used for each reporter within the
quorum-sensing molecule-responsive circuit. Fluorescent and
colorimetric reporters within each sensor were measured
continuously using BMG FLUOstar plate reader after
induction. For LacZ reporter characterization, 5% X-gal was
supplied into cell-free mixture before incubation (with 0.042%
X-gal as the final concentration). For NanoLuc reporter
characterization, 0.5 μL of furimazine stock solution was added
to each well of the cell-free mixture after 20, 40, 60, 120, 180,
and 240 min incubation. Unless indicated otherwise, all the
reporters within different sensors were tested in two
independent experiments and each with three technical
replicates. All the data shown are mean values with standard
deviation as error bars. Detailed experimental procedures, data
analysis, and instrument settings for reporter measurements are
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described in Supporting Information. Calculation of sensor
detection limit, mathematical modeling, and data fitting for
both whole-cell and cell-free biosensors are described in
Supporting Information.
■ RESULTS AND DISCUSSION
Design and Standardization of Reporter Expression
Characterization for Biosensors. We characterized eight
different genetic reporters to compare their main advantages
and limitations contributing to the sensing performance of
both whole-cell and cell-free biosensors. Fluorescent reporter
genes gf p (gf pmut3), deGFP, mCherry, and mScarlet-I,
luciferase genes NanoLuc and lux operons from Aliivibrio
f ischeri and Photorhabdus luminescens, and colorimetric output
gene lacZ have been selected and profiled within the same
biosensor settings both in vivo and in vitro (Figure 1).
Two biosensing systems for the mercury ion and 3OC6HSL
quorum-sensing molecule have been designed and stand-
ardized to characterize and compare the selected reporters
(Figure S1). The medium copy number plasmid pSB3K3 (10−
12 copies per cell40) was used for characterizing all reporters to
limit the metabolic burden. The output actuating modules
coupled with selected reporters were placed in opposite
directions to the sensing modules to prevent potential
transcriptional read-through to the reporter from the sensing
module. All reporters within the two sensing systems were
tested under the same condition either in E. coli TOP10 or in
E. coli S30 CFS. LOD, input and output dynamic ranges,
response time, and output visibility were profiled for each
reporter.
In Vivo Characterization and Comparison of Genetic
Reporters. We first tested all chosen genetic reporters within
a sensitive mercury sensor (i.e., J23109-merR-PmerT).
41 This
sensor has a constitutive promoter (J23109) that drives the
expression of the mercury receptor MerR, which would
derepress its cognate promoter PmerT upon mercury (Hg
2+)
binding and trigger the expression of the downstream reporter
gene (Figure 2A).42 Cell phone images, induction fold, and
dose−response curves were obtained postinduction of mercury
(HgCl2) at various concentrations and different incubation
times (Figure 2B−E, Figures S2−S4).
Comparing among the red fluorescent proteins (Figure 2B),
we reported an induction fold over the control of 59.2 and 14.6
for mScarlet-I and mCherry, respectively (Figure S3), and
LOD of 15.63 nM mercury for mCherry and 7.81 nM mercury
for mScarlet-I (Figure S4), suggesting that mScarlet-I performs
better than mCherry as a reporter. We deem this could be due
to faster maturation and higher brightness of mScarlet than
mCherry.43 Comparing GFP and deGFP (Figure 2C), we
reported that GFP had a higher fold of induction (51.3 vs
17.3), lower LOD (7.81 nM vs 125.00 nM of HgCl2, Figure
S4), and faster response (Figures S2,S3).
Both colorimetric reporter LacZ and bioluminescent
reporter NanoLuc under the mercury sensor were monitored
with lysed and nonlysed cells (see Experimental Section). Both
reporters’ performance was improved in cell lysing conditions
in terms of response time, LOD, output dynamic range, and
output visibilities (Figure 2D,E, Figures S2−S4), suggesting
that the cell membrane could limit diffusion and transport of
the substrates. For LacZ, the best LOD (0.49 nM of HgCl2)
with cell lysis was achieved 60 min postinduction, while the
best LOD without cell lysis was 7.81 nM HgCl2 (16-fold
higher) after 6 h induction (Figure S4). For NanoLuc, the best
LOD (5.00 × 10−5 nM HgCl2) with cell lysis was obtained 30
min postinduction, while the best LOD without cell lysis was
three orders higher (0.05 nM HgCl2) and was observed 3 h
postinduction and postincubation.
As concerns lux operons from A. f ischeri and P. luminescens,
only the lux operon from P. luminescens showed notable output
upon mercury induction (Figure 2E, Figure S6). In addition,
the P. luminescens luciferase contributed to a lower LOD (5.00
× 10−4 nM of HgCl2) at early stage after induction (30−90
min), and higher output dynamic range at intermediate stage
(90−120 min) (Figures S4 and S6). However, its overall
performance was not comparable to that of NanoLuc with cell
lysis. Compared to the NanoLuc without cell lysis, it remains a
good bioluminescent reporter due to no requirement of adding
substrates and lysing cells. Similar results were observed when
testing the two operons under the quorum-sensing molecule
sensor (Figures S6 and S7). Previous studies have shown that
the luciferase from A. f ischeri was thermolabile, with enzyme
denaturation occurring above 30 °C, while the luciferase from
P. luminescens was thermostable.44 As all the experiments were
performed at 37 °C, the activity of the luciferase from A.
f ischeri may have been inhibited due to denaturation. This was
confirmed by characterizing the luciferase reporter under
different temperatures, where the A. f ischeri luciferase showed
better activity at lower temperature in LB (Figure S7).
Figure 1. Comprehensive profiling of diverse genetic reporters in whole-cell and cell-free expression biosensor systems. Three categories of genetic
reporters are selected to compare their profiles when applied in whole-cell and cell-free biosensors: (1) green fluorescent reporters (i.e., gfp and
deGFP) and red fluorescent reporters (i.e., mCherry and mScarlet-I), (2) colorimetric reporter (i.e., lacZ), and (3) bioluminescent reporters (i.e.,
NanoLuc and lux operons from A. f ischeri and P. luminescens). Response time, limit of detection (LOD), output dynamic range, and basal expression
(leakiness) are tested for those reporters within both the mercury- and quorum-sensing molecule-responsive sensors.
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Different media (i.e., M9 with glycerol or glucose as carbon
source) were also tested, indicating that salt and glucose levels
could affect the two luciferases’ activities (Figure S7).45
Pros and Cons of Different Reporter Categories
Acting in Vivo. mScarlet-I, GFP, LacZ (with cell lysis), and
NanoLuc (with cell lysis) were selected for further analyses
and investigation, as they showed superior performance in
response time, LOD, and output dynamic range when
compared to other reporters within their own categories.
We first compared the four reporters under the mercury
sensor (Figure 3A). The best dose−responses for each reporter
and the cognate fold of induction were analyzed (Figure
3B,C). The sensors with mScarlet-I and GFP reporter showed
similar LOD and induction fold, both of which were improved
with longer incubation time (Figure 3C, Figure S4). However,
we observed high background level, especially for green
fluorescence, due to autofluorescence from bacterial cells and
LB medium, limiting their use for direct visualization (Figure
S2). In contrast, LacZ and NanoLuc showed very low
background, facilitating their direct visualization by the
naked eye. Moreover, they contributed to faster response (30
min for LacZ and NanoLuc vs 60 min for GFP and mScarlet-
I), much lower LOD (16-fold lower for LacZ and 5 orders of
magnitude lower for NanoLuc) and broader input dynamic
ranges than the fluorescent reporters, which indicates the fast
enzymatic reaction-based reporters are preferable for sensors
requiring a short and sensitive response. This observation is
consistent with previous studies.7,36,38 Nevertheless, both
Figure 2. Characterization of diverse genetic reporters within a mercury-responsive whole-cell biosensor. (A) Schematic of a mercury-responsive
sensor module (J23109-merR-PmerT) coupled to a genetic reporter. (B−E) Dose−response curves and cell phone images of the mercury sensor with
red fluorescent reporters mCherry and mScarlet-I (B), green fluorescent reporters GFP and deGFP (C), colorimetric reporter LacZ with the cells
lysed or not lysed (D), and bioluminescent reporters NanoLuc with cells lysed or not lysed and LuxCDABE from P. luminescens (E). The last well
in each cell phone image shows the reporter-free negative control cultures. Data were collected 360 min postinduction for B and C, and 90 min
postinduction for D and E. Values are mean ± SD (n = 3 biologically independent experiments).
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reporters with cell lysis are only suitable for disposable sensors
with single-time-point readout. In addition, short time
incubation will be required to obtain the best LOD and
output dynamic range (Figure 3C, Figure S4) due to
background activity induced by the sensor’s leakiness, which
is more sensitive toward amplified enzymatic reactions than
fluorescent reporters (Figure S2).
To test the generality of the aforementioned reporters’
performance, we next characterized the same set of reporters
under a different sensing system, i.e., a quorum-sensing
molecule (3OC6HSL)-responsive sensor (J23117-luxR-Plux2,
Figure 3D−F).46 In this sensing system, a constitutive
promoter (J23117) drives the expression of the 3OC6HSL-
responsive LuxR receptor which activates its cognate promoter
Plux2 when bound to 3OC6HSL (Figure 3D).
46 Similar to the
performance of reporters under the mercury sensor, GFP and
mScarlet-I under the quorum-sensing molecule sensor showed
similar dose−response curves and LOD, and both their LOD
and induction fold were improved with longer incubation time
(Figure 3E,F, Figure S5). Similarly, LacZ and NanoLuc
showed much lower LOD (3−4 orders of magnitude lower
than the fluorescent reporters) and faster responses (30 min
for LacZ and NanoLuc vs 60 min for GFP and mScarlet-I)
than the fluorescent reporters. Notably, NanoLuc provided the
lowest LOD (3.81 × 10−4 nM of 3OC6HSL) among all
reporters characterized (Figure S5). Similar high background
Figure 3. Comparing diverse genetic reporters within mercury and quorum-sensing molecule whole-cell biosensors. (A, D) Schematics showing the
mercury- or quorum-sensing molecule sensor module (J23109-merR-PmerT or J23117-luxR-Plux2) coupled to an output genetic reporter. (B, E)
Dose−response of the mercury- and quorum-sensing molecule sensors with different reporters. For mScarlet-I and GFP, data were collected 360
min postinduction and postincubation. For LacZ and NanoLuc, data were collected 90 min postinduction. Dose−responses for the sensors at
different time points are shown in Figures S4 and S5, and the relevant cell phone images are shown in Figures S2 and S8. (C, F) Fold of induction
over time of the mercury- or quorum-sensing molecule sensors with different reporters responding to 0.1 μM HgCl2 (C) and 0.04 μM 3OC6HSL
(F) respectively. Induction fold was calculated using the output with induction divided by the output without induction. Values are mean ± SD (n
= 3 biologically independent experiments).
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leakiness and decreasing induction fold across time were
observed under the quorum-sensing molecule sensor (Figure
3F, Figure S8). In contrast to reporters under the mercury
sensor, the best induction folds of LacZ and NanoLuc under
the quorum-sensing molecule sensor were observed at longer
incubation time. However, it is worth noting that the induction
levels for the two types of sensors are not comparable and their
output kinetics are different.
Interestingly, we observed a biphasic dose−response curve
for the mercury sensor particularly with the NanoLuc reporter
with cell lysis (Figures 2E,3B). Such a response curve was not
observed for the quorum-sensing molecule sensor, suggesting
the biphasic dose−response is largely due to the intrinsic
sensing behavior of the mercury-sensing system. Unlike the
transcriptional activator LuxR, MerR is a repressor-activator.42
Moreover, previous studies suggested that with only one Hg2+
binding to the MerR homodimer, the MerR could activate
transcription but at a moderate rate, while the MerR
homodimer bound with two Hg2+ could fully activate the
transcription.42 Therefore, the mercury sensor may respond to
Figure 4. Profiling diverse genetic reporters within cell-free biosensors. (A, D) Schematics showing the mercury- or quorum-sensing molecule
sensor (J23115-merR-PmerT or J23101-luxR-Plux2) coupled to diverse genetic reporters. (B, E) Dynamic output responses of the sensors responding
to varying concentrations of HgCl2 (B) or 3OC6HSL (E). (C, F) Fold of induction over time of the mercury- or quorum-sensing molecule cell-free
sensors of different reporters responding to 0.1 μM HgCl2 (C) and 0.4 μM 3OC6HSL (F), respectively. Induction fold was calculated using the
sensor output with induction divided by the sensor output without induction. Values are mean ± SD (n = 3 technical replicates). a.u., arbitrary
units.
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.9b04444
Anal. Chem. 2019, 91, 15284−15292
15289
69
low mercury induction at a moderate rate while the response
may be significantly increased in the presence of high mercury.
This may explain why the biphasic dose−response curve
occurred for the mercury sensor, particularly using NanoLuc
reporter with cell lysis (Figures 2E and 3B). If the biphasic
dose−response curve is not preferred, the data can be collected
at an earlier time point postinduction and postincubation to
eliminate such response behavior while maintaining similar
high sensitivity (Figure S4A).
Characterization and Comparison of Genetic Report-
ers in TX-TL CFS. To provide a more comprehensive profiling
of the different genetic reporters for biosensing, we compared
the same reporters in an in vitro TX-TL CFS using cell-free
biosensors. The CFS can be either based on crude cell
extract47 or a system of purified recombinant elements
(PURE) necessary for transcription-translation.48 The former
is cheaper, easier to produce and more widely used in the field
and therefore was selected for the reporter characterization in
this study. Mercury- and quorum-sensing molecule sensors
were also used for the in vitro test to provide a comparable
context to their in vivo performance (Figure 4). To generate
the same sensing activities for each sensor with different
genetic reporters in the CFS, the same molar concentration of
the sensory plasmids for each sensor was tested. Time-course
response curves (Figure 4B,E), fold of induction (Figure 4C,F)
and dose−responses (Figures S9 and S10) were analyzed for
both sensors of different reporters. The experiments have been
repeated at least twice independently (Figure S11).
Overall, the sensors with green fluorescent reporters or
enzymatic reporters responded faster (20 min) and were more
sensitive than the sensors with red fluorescent reporters (60
min) (Figure 4C,F, Figures S9, S10, and S11C,F). This meets
our expectation, as the green fluorescent reporters generally
mature faster than the red fluorescent reporters,49 and the
enzymatic reactions are usually more sensitive and can amplify
the sensor’s output signals. However, additional substrates are
required for the enzymatic reaction, which is costly and
unstable, whereas the high autofluorescence from the cell-free
reagent could affect the measurement of the green fluorescent
reporters. The LacZ substrate X-gal is more stable and cheaper
than the NanoLuc substrate furimazine and can be added into
the cell-free mixture at the beginning of induction. Never-
theless, cell-free sensors with LacZ reporter have low induction
fold due to the sensors’ high background caused by leakiness
and hence low output dynamic range of the cognate color
change. In addition, the commercial CFS we used was made
from a lacZ+ cell strain and hence already contains some
background level of LacZ, thus increasing the background
leakiness and reducing the output dynamic range. Using a
LacZ-free CFS or a more sensitive LacZ substrate may improve
this reporter’s performance in vitro.
Surprisingly, both green fluorescent reporters and NanoLuc
provided the best LOD among all the reporters (Figures S9
and S10) but with a shorter incubation time for the latter
(Figure S10B). For the mercury sensor, the GFP reporter
contributed to an LOD < 1.0 × 10−3 μM mercury, making it
the most sensitive one among all cell-free mercury sensors
constructed to date. For the quorum-sensing molecule sensor,
both deGFP (4 h) and NanoLuc (40 min) contributed to an
LOD < 4.0 × 10−3 μM 3OC6HSL, 5−10 times lower than the
rest of reporters.
When each reporter category was compared, mScarlet-I was
superior to mCherry in terms of response time and induction
fold (Figure 4C,F, Figure S11C,F), similar to their perform-
ance in vivo. However, the comparison of GFP and deGFP was
less conclusive. The fluorescence output of deGFP was much
higher than that of GFP under the quorum-sensing molecule
sensor (Figure 4E, Figure S11E) while it was only true for the
mercury sensor under high mercury induction levels (Figure
4B, Figure S11B). deGFP was designed to be more translatable
in CFS than its original eGFP,50 but its performance against
GFPmut3 (i.e., the GFP we tested here) has not been studied
previously. Because deGFP worked well for both mercury- and
quorum-sensing molecule sensors, it may be a more reliable
reporter for regular cell-free biosensors. Further investigation
would aid an in-depth comparison of their performance as a
reporter, for example, by measuring the reporters’ fluorescent
intensity, maturation, and transcription and translation
efficiency in different genetic contexts.
■ CONCLUSIONS
In summary, we provided a comprehensive profiling of eight
different genetic reporters from three commonly used reporter
categories (i.e., fluorescent, colorimetric, and bioluminescent
detection) within two representative sensor systems both in
vivo and in vitro. The selected reporters have been frequently
used in either whole-cell or cell-free biosensors but barely
compared systematically in terms of their contributions to
sensing features, limiting the biosensors’ development and
applications. NanoLuc luciferase is a noticeable reporter due to
its small size and high luminescent activity. Our study for the
first time showed its characteristics in bacterial whole-cell
biosensors and cell-free biosensors and indicated its superior
reporting performance in both sensing systems. Overall, we
reported that enzymatic reporters (especially bioluminescent
reporter NanoLuc) provided the fastest response and lowest
LOD in vivo. Both green fluorescent reporters and the
enzymatic reporters contributed to the fastest response and
lowest LOD in vitro. Considering the drastic differences and
wide representation of the two sensor systems tested, similar
conclusions obtained from the two sensor systems indicate the
generality of our findings regarding the performance of these
different genetic reporters. Therefore, these results can be
reasonably applied to and inform the development of
biosensors for other targets. However, the choice of sensor
reporters also need to take into account several other
important factors pertinent to their real world application
requirements, such as the background signal level (green
fluorescent reporter has the highest background activity), cost,
and stability of the substrates for enzymatic reporters, whether
an end-point data acquisition is sufficient or a continuous
monitoring is preferred, and whether the cells can be lysed or
not. This study provides new important benchmark for
biosensor reporter gene selection, which will aid the rapid
development of different whole-cell and cell-free biosensors for
a variety of applications in the environment and health.
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Experimental Procedure 
Plasmid circuit construction  
Compared to previously studied plasmids pBW316J101-luxR1 and pXWJ109Hg-gfp2, the constitutive 
promoters with receptors were inverted and oriented in the opposite direction to the inducible 
promoters and reporters by PCR and BioBrickTM assembly. For tuning the intracellular receptor 
densities, the constitutive promoters that drive the expression of the mercury receptor MerR and the 
quorum sensing molecule receptor LuxR were replaced via PCR.   
mCherry was amplified from BioBrickTM part BBa_J06504 by PCR with addition of a ribosome binding 
site (RBS) BBa_B0030. mScarlet-I with BBa_B0030 was synthesized through Integrated DNA 
Technologies (gBlocks® Gene Fragments) and was amplified by PCR. gfp was amplified from a 
previously studied plasmid pXWJ109Hg-gfp2 by PCR. deGFP was amplified from plasmid Pr-deGFP 
(#67743, Addgene) by PCR with addition of BBa_B0030. lacZ was amplified from E. coli MG1655 
genome by PCR with addition of BBa_B0030. NanoLuc was amplified from plasmid pCDNA-
NanoLuc3 with addition of BBa_B0030. lux operons from P. luminescens and A. fischeri were 
amplified from the gift plasmids provided by Prof Belkin Shimshon (Hebrew University of Jerusalem). 
Reporter gene expression assay in vivo 
For reporter gene characterization, the engineered E. coli were first inoculated from a single colony 
on a freshly streaked solid LB plate to 5 mL LB medium, and cultured overnight at 37°C with shaking 
(160 rpm). Then the cells were diluted 100-fold from the overnight culture into fresh LB medium. For 
liquid culture induction, the diluted culture was loaded into a 96-well 2.0 mL deepwell plate with round 
bottom (E2896-2110, Starlab), and induced with 40 L inducers to a final volume of 1.6 mL per well. 
The microplate was sealed with an air permeable film (AXY2006, SLS), and incubated in a shaker 
incubator (MB100-4A, Allsheng) with continuous shaking (1,000 rpm, 37°C). After 30, 60, 90,120, 
180, 240, 300 and 360 min incubation, 200 L of induced culture were dispensed in 96-well 
microplates with clear-bottom (655096, Greiner Bio-One). A plate reader (BMG FLUOstar) was used 
to measure fluorescence (bottom reading), absorbance and bioluminescence (top reading). 485 nm 
excitation and 520 ± 10 nm emission wavelengths were used for measuring green fluorescent 
reporters with Gain = 1,000. For red fluorescent reporters measurement, 584 nm excitation and 620 
± 10 nm emission wavelengths with Gain = 2,000 were used. Bioluminescent signal was acquired 
with 0.1 s of signal integration for each well and Gain = 1,500. Colorimetric signal was acquired by 
absorbance measurement of A650. NanoLuc-conducted bioluminescent and LacZ-conducted 
colorimetric measurements were acquired in lysing and non-lysing conditions using the same 
concentration of substrates (X-gal = 0.04 mg mL1 from 2% X-gal stock solution and 0.2 L of 
furimazine stock solution per 200 L culture). B-PER™ Bacterial Protein Extraction Reagent (78243, 
ThermoFisher Scientific) and PBS (K813-500ML, VWR) were used in lysing and non-lysing 
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conditions respectively to dilute the substrate. A 50 L-volume of diluted substrate was added in 
each well with a final volume of 250 L. NanoLuc-derived bioluminescent kinetics were measured 
for 30 min after substrate addition and the highest signal was chosen for data analysis. Colorimetric 
signal measurement was preceded by 30 min incubation at 37°C, with orbital shaking at 300 rpm in 
the plate reader. To determine the cell density, absorbance (A600) was also read prior to each reporter 
measurement. For lux operon reporter, the bioluminescent signal was measured immediately after 
absorbance measurement without the addition of substrates.  
The plate reader data acquired using Omega MARS 3.20 R2 were exported to Microsoft Excel 2013 
and GraphPad Prism 6.01 for data analysis and presentation. The medium backgrounds of 
fluorescence, absorbance or luminescence were determined from blank wells loaded with LB 
medium and were subtracted from the readings of other wells. The relative fluorescence, absorbance 
or luminescence unit (RFU, RAU or RLU) at different time points for a sample culture was determined 
by the blank corrected output signal divided by A600, and after subtracting its triplicate-averaged 
counterpart of the negative control cultures (reporter-free) at the same time. Unless indicated 
otherwise, each reporter within different sensors was tested with three biological replicates. All the 
data shown are mean values with standard deviation as error bars.  
Fluorescent, bioluminescent and colorimetric signals were also acquired with a cell phone 
(OnePlus5) integrated camera (1/2.8" 16MP Sony IMX 398 sensor, 1.12 μm pixel size and F1.7 
aperture). The microplates with cultured cells after each measurement were placed onto the surface 
of a Safe Imager™ (S37102, Invitrogen) blue-light transilluminator, and were covered with an amber 
filter in a dark environment. Fluorescent signals were acquired with the blue light on while the 
bioluminescent signals were acquired with the light off. The images with fluorescent or 
bioluminescent signals were captured with 30 s integration time. 
Reporter gene expression assay in vitro 
E. coli S30 Extract System for Circular DNA (L1020, Promega) was used for in vitro characterization
of different reporters. Engineered E. coli with different reporters were first inoculated from a single
colony on a freshly streaked solid LB plate to 2 mL terrific broth (TB) medium (12 g L1 peptone, 24
g L1 yeast extract, 12.54 g L1 K2HPO4, 2.31 g L1 KH2PO4, 4 mL L1 glycerol), and cultured for 8 h
at 37°C with shaking (160 rpm). Then 75 L of each culture was diluted into 30 mL of fresh TB, and
was incubated overnight at 37°C with shaking (160 rpm). The cultured cells were used for plasmid
extraction. The plasmids were purified using ZymoPURE IITM Plasmid Midiprep Kit (D4201, Zymo
Research) following the manufacturers’ protocols, and then were further purified using Monarch®
PCR & DNA Cleanup Kit (T1030S, NEB). The plasmids were eluted in nuclease free H2O.
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All cell-free reactions were prepared in a black 384-well microplate with clear bottom (for 
fluorescence and absorbance measurement, 788096, Greiner Bio-One) or a white 384-well 
microplate with clear bottom (for bioluminescence measurement, 788095, Greiner Bio-One) on ice, 
with 4 L cell-free mixture topped with 5 L of Chill-Out Liquid Wax (CHO1411, Bio-Rad) in each 
well. The plate was sealed with a transparent EASYseal plate sealer (676001, Greiner Bio-One) for 
fluorescence (bottom reading) and absorbance measurement, or covered with a transparent lid for 
bioluminescence measurement (bottom reading) to ease the addition of the substrate furimazine. 
The plate was incubated and measured continuously by BMG FLUOstar plate reader at 37˚C without 
shaking. The settings for measuring the fluorescence and bioluminescence were the same as for 
the in vivo characterization. Absorbance (A670) was used for measuring the colorimetric reporter.  
The plate reader data were processed using Omega MARS 3.20 R2, Microsoft Excel 2013 and 
GraphPad Prism 6.01. To calculate the RFU, RAU and RLU at different time points, the background 
of output signals was subtracted from each cell-free reaction by using its triplicate-averaged 
counterpart of the negative control (reporter-free) at the same time. All the data shown are mean 
values with standard deviation as error bars. 
Calculation of sensor detection limit 
The limit of detection (LOD) is the lowest analyte concentration likely to be reliably distinguished 
from the basal signal and at which detection is feasible.4 The calculation has been described 
previously.2  
Mathematical modelling and data fitting 
Biochemical models were developed for individual transcription factor receptor modules to abstract 
their ligand-dependent dose response behaviors. The ordinary differential equation-based 
deterministic model was used for accurately modelling the gene regulation and expression across 
the full input or output range of the sensor systems.5 It has been described previously.1  
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Figure S1: Representative plasmid maps for the sensor genetic circuits constructed and 
tested in vivo and in vitro in this study.  
Plasmids maps showing the mercury (A) and quorum sensing molecule (B) sensor circuits with gfp 
as the output reporter. For the sensors with other reporters (except lux operon), gfp was replaced by 
mCherry, mScarlet-I, degfp, lacZ or NanoLuc. For the sensors using lux operon as output reporter, 
gfp with its RBS was replaced by the lux operon with RBS. Sequence details are listed in Table S1.  
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Figure S2: Cell phone images of diverse reporters within whole-cell mercury sensor. Related 
to Figures 2 and 3BC. 
The last well in each cell phone image shows the reporter-free negative control cultures. 
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Figure S3: Induction fold of different reporters within whole-cell mercury sensor. Related to 
Figures 2 and 3BC. 
The mercury sensors with different reporters were induced with 0.1 M HgCl2. Values are mean ± 
s.d. (n = 3 biologically independent experiments).
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Figure S4: Dose-response curves of whole-cell mercury sensor with diverse genetic 
reporters. Related to Figures 2 and 3BC. 
(A) Dose-response curves of whole-cell mercury sensor with diverse output genetic reporters. Top
left, schematic of the mercury sensor. Values are mean ± s.d. (n = 3 biologically independent
experiments). (B) Limits of detection (LOD) of whole-cell mercury sensors with different reporters.
LacZ-Lys
Hg2+
PmerTPJ23109
merR reporter
A
B
30 min 60 min 90 min 120 min 180 min 240 min 300 min 360 min
mCherry – 250.00 250.00 125.00 125.00 125.00 125.00 15.63
mScarlet-I – 15.63 15.63 7.81 7.81 7.81 7.81 7.81
GFP – 15.63 15.63 15.63 7.81 7.81 7.81 7.81
deGFP – 500.00 250.00 250.00 250.00 250.00 250.00 125
NanoLuc-Lysed 5.00  10-5 5.00  10-5 5.00  10-5 5.00  10-4 5.00  10-4 5.00  10-4 0.50 0.50
NanoLuc-Not 
Lysed – 0.50 0.50 0.50 0.05 0.50 5.00 5.00
LuxCDABE 5.00  10-4 5.00  10-4 5.00  10-4 5.00  10-3 5.00  10-3 0.05 0.05 0.05
LacZ-Lysed 1.95 0.49 0.49 0.49 0.49 7.81 7.81 31.25
LacZ-Not Lysed – – – – 250.00 125.00 125.00 7.81
All data shown have the same unit of nM HgCl2.–: LOD cannot be calculated due to no significant difference observed between the mercury induced and non-induced samples.
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Figure S5: Dose-response curves of whole-cell quorum sensing molecule sensor with diverse 
output genetic reporters. Related to Figure 3EF. 
(A) Dose-response curves of whole-cell quorum sensing molecule sensor with diverse output genetic
reporters. Top left, schematic of the quorum sensing molecule sensor. Values are mean ± s.d. (n =
3 biologically independent experiments). (B) Limits of detection (LOD) of whole-cell quorum sensing
molecule sensors with different reporters.
3OC6HSL
Plux2PJ23117
luxR reporter
No
rm
ali
ze
d o
utp
ut
No
rm
ali
ze
d o
utp
ut
30 min 60 min 90 min 120 min 180 min 240 min 300 min 360 min
mScarlet-I – 100.00 100.00 25.00 25.00 6.25 6.25 6.25
GFP – 100.00 100.00 10.00 25.00 25.00 25.00 6.25
NanoLuc-Lysed 3.81  10-4 3.81  10-4 6.10  10-3 9.77  10-2 1.56 1.56 25.00 25.00
LacZ-Lysed 1.56 6.10  10-3 9.77  10-2 9.77  10-2 1.56 1.56 1.56 –
All data shown have the same unit of nM 3OC6HSL.–: LOD cannot be calculated due to no significant difference observed between the 3OC6HSL induced and non-induced samples.
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Figure S6: Dose-response curves of sensors in vivo with lux operon as reporter.  
(A,B) Dose response curves (A) and normalized response curves (B) of a mercury sensor with lux 
operon from P. luminescens as output reporter. (C,D) Dose response curves (C) and normalized 
response curves (D) of a quorum sensing molecule sensor with lux operon from P. luminescens as 
output reporter. Values are mean ± s.d. (n = 3 biologically independent experiments). a.u., arbitrary 
units.  
A B
C D
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Figure S7: Characterization of lux operon within quorum sensing molecule sensor using 
different media and incubation temperature.  
Lux-Pl, LuxCEABE from P. luminescens. Lux-Af, LuxCEABE from A. fischeri. M9-Gly., M9 medium 
with glycerol as carbon source. M9-Gluc., M9 medium with glucose as carbon source. All data were 
collected 3 h post induction and incubation. Values are mean ± s.d. (n = 2 biologically independent 
experiments). a.u., arbitrary units.  
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Figure S8: Cell phone images of diverse reporters within whole-cell quorum sensing molecule 
sensor. Related to Figure 3EF. 
The last well in each cell phone image shows the reporter-free negative control cultures. 
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Figure S9: Dose-response curves of cell-free mercury sensor with diverse output genetic 
reporters. Related to Figure 4BC. 
(A) Schematic and normalized dose-response curves of cell-free mercury sensors. Values are mean
± s.d. (n = 3 technical replicates). (B) Limit of detection (LOD) of the sensor tested in A. As only a
few concentrations of mercury were tested, the LOD were shown as a range.
Hg2+
PmerTPJ23115
merR reporter
Reporters 20 min 40 min 60 min 120 min 180 min 240 min
mCherry    0.01 – 0.10 0.01 – 0.10 0.01 – 0.10
mScarlet-I   0.01 – 0.10 0.01 – 0.10 0.01 – 0.10 5.00  103 –0.01
GFP 0.01 – 0.10 5.00  103 –0.01
1.00  103 –
5.00  103
1.00  103 –
5.00  103 < 1.00  103 < 1.00  103
deGFP 0.01 – 0.10 5.00  103 –0.01
1.00  103 –
5.00  103
5.00  103 –
0.01
1.00  103 –
5.00  103
1.00  103 –
5.00  103
LacZ 0.10 – 1.00 1.00  103 –5.00  103
1.00  103 –
5.00  103
1.00  103 –
5.00  103
1.00  103 –
5.00  103 0.01 – 0.10
NanoLuc 0.01 – 0.10 1.00  103 –0.01
1.00  103 –
0.01 0.01 – 0.10
1.00  103 –
0.01
1.00  103 –
0.01
All data shown have the same unit of M HgCl2.: LOD cannot be calculated due to no significant difference observed between the mercury induced and non-induced
samples.
A
B
85
S-14
Figure S10: Dose-response curves of cell-free quorum sensing molecule sensor with diverse 
output genetic reporters. Related to Figure 4EF. 
(A) Schematic and normalized dose-response curves of cell-free quorum sensing molecule sensors.
Values are mean ± s.d. (n = 3 technical replicates). (B) Limit of detection (LOD) of the sensor tested
in A. As only a few concentrations of 3OC6HSL were tested, the LOD were shown as a range.
3OC6HSL
Plux2PJ23101
luxR reporter
LacZ
Reporters 20 min 40 min 60 min 120 min 180 min 240 min
mCherry    0.04 – 0.40 0.02 – 0.04 0.02 – 0.04
mScarlet-I   0.40 – 4.00 0.04 – 0.40 0.02 – 0.04 4.00  103 –0.02
GFP  0.40 – 4.00 0.04 – 0.40 0.04 – 0.40 0.40 – 4.00 0.40 – 4.00
deGFP 0.02 – 0.04 4.00  103 –0.02
4.00  103 –
0.02
4.00  103 –
0.02
4.00  103 –
0.02 < 4.00  103
LacZ  0.02 – 0.04 4.00  103 –0.02
4.00  103 –
0.02
4.00  103 –
0.02
4.00  103 –
0.02
NanoLuc 4.00  103 –0.04 < 4.00  103 < 4.00  103 < 4.00  103
4.00  103 –
0.04 < 4.00  103
All data shown have the same unit of M 3OC6HSL.: LOD cannot be calculated due to no significant difference observed between the 3OC6HSL induced and non-induced samples.
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Figure S11: Characterization of diverse genetic reporters within mercury and quorum sensing 
molecule cell-free biosensors. Related to Figure 4.  
(A,D) Schematics of the mercury or quorum sensing molecule sensor modules (J23115-merR-PmerT 
or J23101-luxR-Plux2) coupled to diverse genetic reporters. (B,E) Dynamic output responses of the 
sensors responding to two concentrations of HgCl2 (B) or 3OC6HSL (E). (C,F) Fold of induction over 
time of the mercury or quorum sensing cell-free sensors with different reporters responding to 0.1 
M HgCl2 (C) and 0.4 M 3OC6HSL (F) respectively. Induction fold was calculated using the output 
with induction divided by the output without induction. Values are mean ± s.d. (n = 3 technical 
replicates). a.u., arbitrary units. 
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Table S1: List of genetic parts and sequences used in this study 
Underlined sequences indicate –35 and –10, or –24 and –12 promoter regions. Sequences in blue 
are MerR binding sites, sequences in yellow are LuxR binding sites. 
Name Type DNA sequence (5’-3’) 
J23101 Constitutive promoter1 TTTACAGCTAGCTCAGTCCTAGGTATTATGCTAGC 
J23109 Constitutive promoter2 TTTACAGCTAGCTCAGTCCTAGGGACTGTGCTAGC 
J23115 Constitutive promoter1 TTTATAGCTAGCTCAGCCCTTGGTACAATGCTAGC 
J23117 Constitutive promoter1 TTGACAGCTAGCTCAGTCCTAGGGATTGTGCTAGC 
PmerT Inducible promoter6 
TTCCATATCGCTTGACTACGTACATGAGTACGGAAGTAAGGTTACGCTATCCAAT
CC 
Plux2 Inducible promoter1 
AGACCTGTAGGATCGTACAGGTTTACGCAAGAAAATGGTTTGTTACTTTCGAATA
AA 
B0030 RBS5 ATTAAAGAGGAGAAA 
R0032 RBS5 TCACACAGGAAAG 
B0015 Terminator7 
CCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTAT
CTGTTGTTTGTCGGTGAACGCTCTCTACTAGAGTCACACTGGCTCACCTTCGGGT
GGGCCTTTCTGCGTTTATA 
L3S2P55 Terminator8 CTCGGTACCAAAGACGAACAATAAGACGCTGAAAAGCGTCTTTTTTCGTTTTGGTCC 
merR Gene6 
ATGGAAAATAATTTGGAAAACCTGACCATTGGCGTTTTTGCCAAGGCGGCCGGGG
TCAACGTGGAGACAATCCGCTTCTATCAGCGCAAGGGCCTGTTGCGGGAACCGGA
CAAGCCTTACGGCAGCATCCGCCGCTATGGGGAGGCGGACGTGGTTCGGGTGAAA
TTCGTGAAATCGGCACAGCGGCTGGGGTTCAGTCTGGACGAGATTGCCGAGCTGT
TGCGGCTCGACGATGGCACCCACTGCGAGGAGGCCAGCAGCCTGGCCGAACACAA
GCTCAAGGACGTGCGCGAGAAGATGGCCGACTTGGCGCGCATGGAAACCGTGCTG
TCTGAACTCGTGTGCGCCTGCCATGCACGAAAGGGGAATGTTTCCTGCCCGTTGA
TCGCGTCACTACAGGGCGAAGCAGGCCTGGCAAGGTCAGCTATGCCTTAG 
luxR Gene1 
ATGAAAAACATAAATGCCGACGACACATACAGAATAATTAATAAAATTAAAGCTT
GTAGAAGCAATAATGATATTAATCAATGCTTATCTGATATGACTAAAATGGTACA
TTGTGAATATTATTTACTCGCGATCATTTATCCTCATTCTATGGTTAAATCTGAT
ATTTCAATCCTAGATAATTACCCTAAAAAATGGAGGCAATATTATGATGACGCTA
ATTTAATAAAATATGATCCTATAGTAGATTATTCTAACTCCAATCATTCACCAAT
TAATTGGAATATATTTGAAAACAATGCTGTAAATAAAAAATCTCCAAATGTAATT
AAAGAAGCGAAAACATCAGGTCTTATCACTGGGTTTAGTTTCCCTATTCATACGG
CTAACAATGGCTTCGGAATGCTTAGTTTTGCACATTCAGAAAAAGACAACTATAT
AGATAGTTTATTTTTACATGCGTGTATGAACATACCATTAATTGTTCCTTCTCTA
GTTGATAATTATCGAAAAATAAATATAGCAAATAATAAATCAAACAACGATTTAA
CCAAAAGAGAAAAAGAATGTTTAGCGTGGGCATGCGAAGGAAAAAGCTCTTGGGA
TATTTCAAAAATATTAGGTTGCAGTGAGCGTACTGTCACTTTCCATTTAACCAAT
GCGCAAATGAAACTCAATACAACAAACCGCTGCCAAAGTATTTCTAAAGCAATTT
TAACAGGAGCAATTGATTGCCCATACTTTAAAAATTAATAA 
mCherry Gene* 
ATGGTGAGCAAGGGCGAGGAGGATAACATGGCCATCATCAAGGAGTTCATGCGCT
TCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGCGA
GGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAG
GGTGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCT
CCAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACTTGAAGCTGTCCTT
CCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGGCGGCGTGGTG
ACCGTGACCCAGGACTCCTCCTTGCAGGACGGCGAGTTCATCTACAAGGTGAAGC
TGCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGG
CTGGGAGGCCTCCTCCGAGCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAG
ATCAAGCAGAGGCTGAAGCTGAAGGACGGCGGCCACTACGACGCTGAGGTCAAGA
CCACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACAACGTCAACAT
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CAAGTTGGACATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAA
CGCGCCGAGGGCCGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGTAA 
mScarlet-I Gene9 
ATGGTGAGTAAAGGAGAAGCTGTGATTAAAGAGTTCATGCGCTTCAAAGTTCACA
TGGAGGGTTCTATGAACGGTCACGAGTTCGAGATCGAAGGCGAAGGCGAGGGCCG
TCCGTATGAAGGCACCCAGACCGCCAAACTGAAAGTGACTAAAGGCGGCCCGCTG
CCTTTTTCCTGGGACATCCTGAGCCCGCAATTTATGTACGGTTCTAGGGCGTTCA
TCAAACACCCAGCGGATATCCCGGACTATTATAAGCAGTCTTTTCCGGAAGGTTT
CAAGTGGGAACGCGTAATGAATTTTGAAGATGGTGGTGCCGTGACCGTCACTCAG
GACACCTCCCTGGAGGATGGCACCCTGATCTATAAAGTTAAACTGCGTGGTACTA
ATTTTCCACCTGATGGCCCGGTGATGCAGAAAAAGACGATGGGTTGGGAGGCGTC
TACCGAACGCTTGTATCCGGAAGATGGTGTGCTGAAAGGCGACATTAAAATGGCC
CTGCGCCTGAAAGATGGCGGCCGCTATCTGGCTGACTTCAAAACCACGTACAAAG
CCAAGAAACCTGTGCAGATGCCTGGCGCGTACAATGTGGACCGCAAACTGGACAT
CACCTCTCATAATGAAGATTATACGGTGGTAGAGCAATATGAGCGCTCCGAGGGT
CGTCATTCTACCGGTGGCATGGATGAACTATACAAA 
gfp Gene7 
ATGCGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAG
ATGGTGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGC
AACATACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTT
CCATGGCCAACACTTGTCACTACTTTCGGTTATGGTGTTCAATGCTTTGCGAGAT
ACCCAGATCATATGAAACAGCATGACTTTTTCAAGAGTGCCATGCCCGAAGGTTA
TGTACAGGAAAGAACTATATTTTTCAAAGATGACGGGAACTACAAGACACGTGCT
GAAGTCAAGTTTGAAGGTGATACCCTTGTTAATAGAATCGAGTTAAAAGGTATTG
ATTTTAAAGAAGATGGAAACATTCTTGGACACAAATTGGAATACAACTATAACTC
ACACAATGTATACATCATGGCAGACAAACAAAAGAATGGAATCAAAGTTAACTTC
AAAATTAGACACAACATTGAAGATGGAAGCGTTCAACTAGCAGACCATTATCAAC
AAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCATTACCTGTC
CACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGGTCCTT
CTTGAGTTTGTAACAGCTGCTGGGATTACACATGGCATGGATGAACTATACAAAT
AA 
degfp Gene10 
ATGGAGCTTTTCACTGGCGTTGTTCCCATCCTGGTCGAGCTGGACGGCGACGTAA
ACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAA
GCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACC
CTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACA
TGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCG
CACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTC
GAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGG
ACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTA
TATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCAC
AACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCA
TCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGC
CCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTG
ACCGCCGCCGGGATCTAA 
NanoLuc Gene11 
ATGGTCTTCACACTCGAAGATTTCGTTGGGGACTGGCGACAGACAGCCGGCTACA
ACCTGGACCAAGTCCTTGAACAGGGAGGTGTGTCCAGTTTGTTTCAGAATCTCGG
GGTGTCCGTAACTCCGATCCAAAGGATTGTCCTGAGCGGTGAAAATGGGCTGAAG
ATCGACATCCATGTCATCATCCCGTATGAAGGTCTGAGCGGCGACCAAATGGGCC
AGATCGAAAAAATTTTTAAGGTGGTGTACCCTGTGGATGATCATCACTTTAAGGT
GATCCTGCACTATGGCACACTGGTAATCGACGGGGTTACGCCGAACATGATCGAC
TATTTCGGACGGCCGTATGAAGGCATCGCCGTGTTCGACGGCAAAAAGATCACTG
TAACAGGGACCCTGTGGAACGGCAACAAAATTATCGACGAGCGCCTGATCAACCC
CGACGGCTCCCTGCTGTTCCGAGTAACCATCAACGGAGTGACCGGCTGGCGGCTG
TGCGAACGCATTCTGGCGTAA 
LacZ 
Gene 
(Amplified 
from E. coli 
MG1655 by 
PCR) 
ATGACCATGATTACGGATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAA
ACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTG
GCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTG
AATGGCGAATGGCGCTTTGCCTGGTTTCCGGCACCAGAAGCGGTGCCGGAAAGCT
GGCTGGAGTGCGATCTTCCTGAGGCCGATACTGTCGTCGTCCCCTCAAACTGGCA
GATGCACGGTTACGATGCGCCCATCTACACCAACGTGACCTATCCCATTACGGTC
AATCCGCCGTTTGTTCCCACGGAGAATCCGACGGGTTGTTACTCGCTCACATTTA
ATGTTGATGAAAGCTGGCTACAGGAAGGCCAGACGCGAATTATTTTTGATGGCGT
TAACTCGGCGTTTCATCTGTGGTGCAACGGGCGCTGGGTCGGTTACGGCCAGGAC
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AGTCGTTTGCCGTCTGAATTTGACCTGAGCGCATTTTTACGCGCCGGAGAAAACC
GCCTCGCGGTGATGGTGCTGCGCTGGAGTGACGGCAGTTATCTGGAAGATCAGGA
TATGTGGCGGATGAGCGGCATTTTCCGTGACGTCTCGTTGCTGCATAAACCGACT
ACACAAATCAGCGATTTCCATGTTGCCACTCGCTTTAATGATGATTTCAGCCGCG
CTGTACTGGAGGCTGAAGTTCAGATGTGCGGCGAGTTGCGTGACTACCTACGGGT
AACAGTTTCTTTATGGCAGGGTGAAACGCAGGTCGCCAGCGGCACCGCGCCTTTC
GGCGGTGAAATTATCGATGAGCGTGGTGGTTATGCCGATCGCGTCACACTACGTC
TGAACGTCGAAAACCCGAAACTGTGGAGCGCCGAAATCCCGAATCTCTATCGTGC
GGTGGTTGAACTGCACACCGCCGACGGCACGCTGATTGAAGCAGAAGCCTGCGAT
GTCGGTTTCCGCGAGGTGCGGATTGAAAATGGTCTGCTGCTGCTGAACGGCAAGC
CGTTGCTGATTCGAGGCGTTAACCGTCACGAGCATCATCCTCTGCATGGTCAGGT
CATGGATGAGCAGACGATGGTGCAGGATATCCTGCTGATGAAGCAGAACAACTTT
AACGCCGTGCGCTGTTCGCATTATCCGAACCATCCGCTGTGGTACACGCTGTGCG
ACCGCTACGGCCTGTATGTGGTGGATGAAGCCAATATTGAAACCCACGGCATGGT
GCCAATGAATCGTCTGACCGATGATCCGCGCTGGCTACCGGCGATGAGCGAACGC
GTAACGCGAATGGTGCAGCGCGATCGTAATCACCCGAGTGTGATCATCTGGTCGC
TGGGGAATGAATCAGGCCACGGCGCTAATCACGACGCGCTGTATCGCTGGATCAA
ATCTGTCGATCCTTCCCGCCCGGTGCAGTATGAAGGCGGCGGAGCCGACACCACG
GCCACCGATATTATTTGCCCGATGTACGCGCGCGTGGATGAAGACCAGCCCTTCC
CGGCTGTGCCGAAATGGTCCATCAAAAAATGGCTTTCGCTACCTGGAGAGACGCG
CCCGCTGATCCTTTGCGAATACGCCCACGCGATGGGTAACAGTCTTGGCGGTTTC
GCTAAATACTGGCAGGCGTTTCGTCAGTATCCCCGTTTACAGGGCGGCTTCGTCT
GGGACTGGGTGGATCAGTCGCTGATTAAATATGATGAAAACGGCAACCCGTGGTC
GGCTTACGGCGGTGATTTTGGCGATACGCCGAACGATCGCCAGTTCTGTATGAAC
GGTCTGGTCTTTGCCGACCGCACGCCGCATCCAGCGCTGACGGAAGCAAAACACC
AGCAGCAGTTTTTCCAGTTCCGTTTATCCGGGCAAACCATCGAAGTGACCAGCGA
ATACCTGTTCCGTCATAGCGATAACGAGCTCCTGCACTGGATGGTGGCGCTGGAT
GGTAAGCCGCTGGCAAGCGGTGAAGTGCCTCTGGATGTCGCTCCACAAGGTAAAC
AGTTGATTGAACTGCCTGAACTACCGCAGCCGGAGAGCGCCGGGCAACTCTGGCT
CACAGTACGCGTAGTGCAACCGAACGCGACCGCATGGTCAGAAGCCGGGCACATC
AGCGCCTGGCAGCAGTGGCGTCTGGCGGAAAACCTCAGTGTGACGCTCCCCGCCG
CGTCCCACGCCATCCCGCATCTGACCACCAGCGAAATGGATTTTTGCATCGAGCT
GGGTAATAAGCGTTGGCAATTTAACCGCCAGTCAGGCTTTCTTTCACAGATGTGG
ATTGGCGATAAAAAACAACTGCTGACGCCGCTGCGCGATCAGTTCACCCGTGCAC
CGCTGGATAACGACATTGGCGTAAGTGAAGCGACCCGCATTGACCCTAACGCCTG
GGTCGAACGCTGGAAGGCGGCGGGCCATTACCAGGCCGAAGCAGCGTTGTTGCAG
TGCACGGCAGATACACTTGCTGATGCGGTGCTGATTACGACCGCTCACGCGTGGC
AGCATCAGGGGAAAACCTTATTTATCAGCCGGAAAACCTACCGGATTGATGGTAG
TGGTCAAATGGCGATTACCGTTGATGTTGAAGTGGCGAGCGATACACCGCATCCG
GCGCGGATTGGCCTGAACTGCCAGCTGGCGCAGGTAGCAGAGCGGGTAAACTGGC
TCGGATTAGGGCCGCAAGAAAACTATCCCGACCGCCTTACTGCCGCCTGTTTTGA
CCGCTGGGATCTGCCATTGTCAGACATGTATACCCCGTACGTCTTCCCGAGCGAA
AACGGTCTGCGCTGCGGGACGCGCGAATTGAATTATGGCCCACACCAGTGGCGCG
GCGACTTCCAGTTCAACATCAGCCGCTACAGTCAACAGCAACTGATGGAAACCAG
CCATCGCCATCTGCTGCACGCGGAAGAAGGCACATGGCTGAATATCGACGGTTTC
CATATGGGGATTGGTGGCGACGACTCCTGGAGCCCGTCAGTATCGGCGGAGTTTC
AGCTGAGCGCCGGTCGCTACCATTACCAGTTGGTCTGGTGTCAAAAATAA 
lux operon (P. 
luminescens) 
Gene with 
RBS** 
AGGAGGGGCAAATATGACTAAAAAAATTTCATTCATTATTAACGGCCAGGTTGAA
ATCTTTCCCGAAAGTGATGATTTAGTGCAATCCATTAATTTTGGTGATAATAGTG
TTTACCTGCCAATATTGAATGACTCTCATGTAAAAAACATTATTGATTGTAATGG
AAATAACGAATTACGGTTGCATAACATTGTCAATTTTCTCTATACGGTAGGGCAA
AGATGGAAAAATGAAGAATACTCAAGACGCAGGACATACATTCGTGACTTAAAAA
AATATATGGGATATTCAGAAGAAATGGCTAAGCTAGAGGCCAATTGGATATCTAT
GATTTTATGTTCTAAAGGCGGCCTTTATGATGTTGTAGAAAATGAACTTGGTTCT
CGCCATATCATGGATGAATGGCTACCTCAGGATGAAAGTTATGTTCGGGCTTTTC
CGAAAGGTAAATCTGTACATCTGTTGGCAGGTAATGTTTCATTATCTGGGATCAT
GTCTATATTACGCGCAATTTTAACTAAGAATCAGTGTATTATAAAAACATCGTCA
ACCGATCCTTTTACCGCTAATGCATTAGCGTTAAGTTTTATTGATGTAGACCCTA
ATCATCCGATAACGCGCTCTTTATCTGTTATATATTGGCCCCACCAAGGTGATAC
ATCACTCGCAAAAGAAATTATGCGACATGCGGATGTTATTGTCGCTTGGGGAGGG
CCAGATGCGATTAATTGGGCGGTAGAGCATGCGCCATCTTATGCTGATGTGATTA
AATTTGGTTCTAAAAAGAGTCTTTGCATTATCGATAATCCTGTTGATTTGACGTC
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CGCAGCGACAGGTGCGGCTCATGATGTTTGTTTTTACGATCAGCGAGCTTGTTTT
TCTGCCCAAAACATATATTACATGGGAAATCATTATGAGGAATTTAAGTTAGCGT
TGATAGAAAAACTTAATCTATATGCGCATATATTACCGAATGCCAAAAAAGATTT
TGATGAAAAGGCGGCCTATTCTTTAGTTCAAAAAGAAAGCTTGTTTGCTGGATTA
AAAGTAGAGGTGGATATTCATCAACGTTGGATGATTATTGAGTCAAATGCAGGTG
TGGAATTTAATCAACCACTTGGCAGATGTGTGTACCTTCATCACGTCGATAATAT
TGAGCAAATATTGCCTTATGTTCAAAAAAATAAGACGCAAACCATATCTATTTTT
CCTTGGGAGTCATCATTTAAATATCGAGATGCGTTAGCATTAAAAGGTGCGGAAA
GGATTGTAGAAGCAGGAATGAATAACATATTTCGAGTTGGTGGATCTCATGACGG
AATGAGACCGTTGCAACGATTAGTGACATATATTTCTCATGAAAGGCCATCTAAC
TATACGGCTAAGGATGTTGCGGTTGAAATAGAACAGACTCGATTCCTGGAAGAAG
ATAAGTTCCTTGTATTTGTCCCATAATAGGTAAAAAGTATGGAAAATGAATCAAA
ATATAAAACCATCGACCACGTTATTTGTGTTGAAGGAAATAAAAAAATTCATGTT
TGGGAAACGCTGCCAGAAGAAAACAGCCCAAAGAGAAAGAATGCCATTATTATTG
CGTCTGGTTTTGCCCGCAGGATGGATCATTTTGCTGGTCTGGCGGAATATTTATC
GCGGAATGGATTTCATGTGATCCGCTATGATTCGCTTCACCACGTTGGATTGAGT
TCAGGGACAATTGATGAATTTACAATGTCTATAGGAAAGCAGAGCTTGTTAGCAG
TGGTTGATTGGTTAACTACACGAAAAATAAATAACTTCGGTATGTTGGCTTCAAG
CTTATCTGCGCGGATAGCTTATGCAAGCCTATCTGAAATCAATGCTTCGTTTTTA
ATCACCGCAGTCGGTGTTGTTAACTTAAGATATTCTCTTGAAAGAGCTTTAGGGT
TTGATTATCTCAGTCTACCCATTAATGAATTGCCGGATAACCTAGATTTTGAAGG
CCATAAATTGGGTGCTGAAGTCTTTGCGAGAGATTGTCTTGATTTTGGTTGGGAA
GATTTAGCTTCTACAATTAATAACATGATGTATCTTGATATACCGTTTATTGCTT
TTACTGCAAATAACGATAATTGGGTCAAGCAAGATGAAGTTATCACATTGTTATC
AAATATTCGTAGTAATCGATGCAAGATATATTCTTTGTTAGGAAGTTCGCATGAC
TTGAGTGAAAATTTAGTGGTCCTGCGCAATTTTTATCAATCGGTTACGAAAGCCG
CTATCGCGATGGATAATGATCATCTGGATATTGATGTTGATATTACTGAACCGTC
ATTTGAACATTTAACTATTGCGACAGTCAATGAACGCCGAATGAGAATTGAGATT
GAAAATCAAGCAATTTCTCTGTCTTAAAATCTATTGAGATATTCTATCACTCAAA
TAGCAATATAAGGACTCTCTATGAAATTTGGAAACTTTTTGCTTACATACCAACC
TCCCCAATTTTCTCAAACAGAGGTAATGAAACGTTTGGTTAAATTAGGTCGCATC
TCTGAGGAGTGTGGTTTTGATACCGTATGGTTACTGGAGCATCATTTCACGGAGT
TTGGTTTGCTTGGTAACCCTTATGTCGCTGCTGCATATTTACTTGGCGCGACTAA
AAAATTGAATGTAGGAACTGCCGCTATTGTTCTTCCCACAGCCCATCCAGTACGC
CAACTTGAAGATGTGAATTTATTGGATCAAATGTCAAAAGGACGATTTCGGTTTG
GTATTTGCCGAGGGCTTTACAACAAGGACTTTCGCGTATTCGGCACAGATATGAA
TAACAGTCGCGCCTTAGCGGAATGCTGGTACGGGCTGATAAAGAATGGCATGACA
GAGGGATATATGGAAGCTGATAATGAACATATCAAGTTCCATAAGGTAAAAGTAA
ACCCCGCGGCGTATAGCAGAGGTGGCGCACCGGTTTATGTGGTGGCTGAATCAGC
TTCGACGACTGAGTGGGCTGCTCAATTTGGCCTACCGATGATATTAAGTTGGATT
ATAAATACTAACGAAAAGAAAGCACAACTTGAGCTTTATAATGAAGTGGCTCAAG
AATATGGGCACGATATTCATAATATCGACCATTGCTTATCATATATAACATCTGT
AGATCATGACTCAATTAAAGCGAAAGAGATTTGCCGGAAATTTCTGGGGCATTGG
TATGATTCTTATGTGAATGCTACGACTATTTTTGATGATTCAGACCAAACAAGAG
GTTATGATTTCAATAAAGGGCAGTGGCGTGACTTTGTATTAAAAGGACATAAAGA
TACTAATCGCCGTATTGATTACAGTTACGAAATCAATCCCGTGGGAACGCCGCAG
GAATGTATTGACATAATTCAAAAAGACATTGATGCTACAGGAATATCAAATATTT
GTTGTGGATTTGAAGCTAATGGAACAGTAGACGAAATTATTGCTTCCATGAAGCT
CTTCCAGTCTGATGTCATGCCATTTCTTAAAGAAAAACAACGTTCGCTATTATAT
TAGCTAAGGAGAAAGAAATGAAATTTGGATTGTTCTTCCTTAACTTCATCAATTC
AACAACTGTTCAAGAACAAAGTATAGTTCGCATGCAGGAAATAACGGAGTATGTT
GATAAGTTGAATTTTGAACAGATTTTAGTGTATGAAAATCATTTTTCAGATAATG
GTGTTGTCGGCGCTCCTCTGACTGTTTCTGGTTTTCTGCTCGGTTTAACAGAGAA
AATTAAAATTGGTTCATTAAATCACATCATTACAACTCATCATCCTGTCCGCATA
GCGGAGGAAGCTTGCTTATTGGATCAGTTAAGTGAAGGGAGATTTATTTTAGGGT
TTAGTGATTGCGAAAAAAAAGATGAAATGCATTTTTTTAATCGCCCGGTTGAATA
TCAACAGCAACTATTTGAAGAGTGTTATGAAATCATTAACGATGCTTTAACAACA
GGCTATTGTAATCCAGATAACGATTTTTATAGCTTCCCTAAAATATCTGTAAATC
CCCATGCTTATACGCCAGGCGGACCTCGGAAATATGTAACAGCAACCAGTCATCA
TATTGTTGAGTGGGCGGCCAAAAAAGGTATTCCTCTCATCTTTAAGTGGGATGAT
TCTAATGATGTTAGATATGAATATGCTGAAAGATATAAAGCCGTTGCGGATAAAT
ATGACGTTGACCTATCAGAGATAGACCATCAGTTAATGATATTAGTTAACTATAA
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CGAAGATAGTAATAAAGCTAAACAAGAGACGCGTGCATTTATTAGTGATTATGTT
CTTGAAATGCACCCTAATGAAAATTTCGAAAATAAACTTGAAGAAATAATTGCAG
AAAACGCTGTCGGAAATTATACGGAGTGTATAACTGCGGCTAAGTTGGCAATTGA
AAAGTGTGGTGCGAAAAGTGTATTGCTGTCCTTTGAACCAATGAATGATTTGATG
AGCCAAAAAAATGTAATCAATATTGTTGATGATAATATTAAGAAGTACCACATGG
AATATACCTAATAGATTTCGAGTTGCAGCGAGGCGGCAAGTGAACGAATCCCCAG
GAGCATAGATAACTATGTGACTGGGGTGAGTGAAAGCAGCCAACAAAGCAGCAGC
TTGAAAGATGAAGGGTATAAAAGAGTATGACAGCAGTGCTGCCATACTTTCTAAT
ATTATCTTGAGGAGTAAAACAGGTATGACTTCATATGTTGATAAACAAGAAATTA
CAGCAAGCTCAGAAATTGATGATTTGATTTTTTCGAGCGATCCATTAGTGTGGTC
TTACGACGAGCAGGAAAAAATCAGAAAGAAACTTGTGCTTGATGCATTTCGTAAT
CATTATAAACATTGTCGAGAATATCGTCACTACTGTCAGGCACACAAAGTAGATG
ACAATATTACGGAAATTGATGACATACCTGTATTCCCAACATCGGTTTTTAAGTT
TACTCGCTTATTAACTTCTCAGGAAAACGAGATTGAAAGTTGGTTTACCAGTAGC
GGCACGAATGGTTTAAAAAGTCAGGTGGCGCGTGACAGATTAAGTATTGAGAGAC
TCTTAGGCTCTGTGAGTTATGGCATGAAATATGTTGGTAGTTGGTTTGATCATCA
AATAGAATTAGTCAATTTGGGACCAGATAGATTTAATGCTCATAATATTTGGTTT
AAATATGTTATGAGTTTGGTGGAATTGTTATATCCTACGACATTTACCGTAACAG
AAGAACGAATAGATTTTGTTAAAACATTGAATAGTCTTGAACGAATAAAAAATCA
AGGGAAAGATCTTTGTCTTATTGGTTCGCCATACTTTATTTATTTACTCTGCCAT
TATATGAAAGATAAAAAAATCTCATTTTCTGGAGATAAAAGCCTTTATATCATAA
CCGGAGGCGGCTGGAAAAGTTACGAAAAAGAATCTCTGAAACGTGATGATTTCAA
TCATCTTTTATTTGATACTTTCAATCTCAGTGATATTAGTCAGATCCGAGATATA
TTTAATCAAGTTGAACTCAACACTTGTTTCTTTGAGGATGAAATGCAGCGTAAAC
ATGTTCCGCCGTGGGTATATGCGCGAGCGCTTGATCCTGAAACGTTGAAACCTGT
ACCTGATGGAACGCCGGGGTTGATGAGTTATATGGATGCGTCAGCAACCAGTTAT
CCAGCATTTATTGTTACCGATGATGTCGGGATAATTAGCAGAGAATATGGTAAGT
ATCCCGGCGTGCTCGTTGAAATTTTACGTCGCGTCAATACGAGGACGCAGAAAGG
GTGTGCTTTAAGCTTAACCGAAGCGTTTGATAGTTGATATCCTTTGCCTAATTGT
AAGTGGAATGCTTGCGTTATATAAATCTGAATGACATCTACACTTTACAAAATTC
TCCAAAACATCCACATTTGGGTACTTGATAGAGGTTTATGGGGTTGGCTTAACAT
TGTTCTCATTGTTATTATTGGCTCAAAGCAAAAGGAGATAACATGAAAAAATTGG
CAGTTATGCTTGCATTGGGAATGATTAGCTTTGGTGCAATGGCAGTTGATGGGTA
TAAAGATGCAAAGTTTGGCATGACAGAAGAAGAGTTTCTTTCGAAGAGGTTATGT
GATTTTGAAAAATTTGAGGGAGATTCTCGAATAGAAGAAGTATCACTTTATTCAT
GTTCTGACTTTTCGTTTGCTAACAAAAAGCGTGAAGCAATGGCATTTTTTTTAAA
TGGGAAATTTAAAAGATTAGAGATTAATATTGGCAGACTTGTGAAGCCAGTAAGC
AAATCGTTAACGAAAAAGTACGGAGATGGATCATCGTATCCATCAAAAGAAGAAT
TTGAGAACGCGCTAAAATACAATGGAACTATGTCTATAGGTTATGATAATAATAC
GGTATTAGTTGATATACATATAATATGTGGCAAAGAAGGCATAGAAACCAGTCAA
CTGATTTATACGAGTCCAGATGTTTATACGCTCCCAGATTTCGGAGAAAAAATCC
AGGAATTAAAGGGATTAAAGGAATTTGCCCTATAG 
lux operon (A. 
fischeri) 
Gene with 
RBS** 
AGGAGGGGCAAATATGAATAAATGTATTCCAATGATAATTAATGGAATGATTCAA
GATTTTGATAATTATGCATATAAAGAAGTTAAACTAAATAATGATAATAGAGTAA
AATTATCTGTCATTACTGAAAGTTCAGTTTCAAAAACATTAAATATCAAAGATAG
AATTAATCTAAATTTAAATCAGATTGTGAATTTTTTATATACCGTTGGTCAACGA
TGGAAAAGTGAAGAATATAATCGGCGACGAACCTATATCCGTGAGTTAAAAACAT
ATCTTGGTTATTCTGATGAAATGGCAAGATTAGAAGCGAATTGGATTGCAATGTT
ATTGTGCTCTAAAAGTGCTTTGTATGACATTGTTAATTATGATTTGGGCTCTATA
CACGTATTAGATGAATGGCTTCCACGTGGTGATTGCTATGTTAAAGCACAACCGA
AAGGTGTTTCTGTTCACTTGTTAGCTGGTAATGTTCCATTATCAGGAGTGACATC
TATTTTGCGTGCTATTTTAACAAAAAATGAGTGCATTATTAAAACTTCGTCTTCA
GATCCTTTTACTGCAAACGCTTTAGTTTCCAGTTTTATTGATGTTAATGCAGACC
ATCCAATAACCAAATCAATGTCTGTTATGTATTGGCCGCATGATGAAGATATGAC
TCTATCTCAAAGAATAATGAATCATGCCGACGTGGTTATTGCTTGGGGTGGAGAC
GAGGCGATTAAATGGGCGGTAAAATATTCACCACCGCATGTCGATATTCTGAAAT
TTGGACCAAAGAAAAGCTTAAGTATTATTGAAGCTCCTAAAGATATAGAAGCCGC
AGCAATGGGGGTTGCTCATGATATTTGTTTCTATGACCAGCAAGCCTGCTTCTCT
ACTCAAGACGTTTATTATATAGGAGATAATTTACCTTTATTTTTAAATGAACTTG
AAAAACAGCTAGATCGATACGCGAAAATTTTACCAAAAGGTTCAAATAGTTTTGA
TGAAAAAGCGGCGTTTACTCTTACTGAAAAAGAAAGTCTATTTGCTGGATATGAA
GTGAGAAAGGGAGATAAGCAAGCTTGGTTAATAGTCGTATCACCTACAAATAGCT
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TTGGAAATCAACCGCTATCACGAAGTGTGTATGTTCATCAAGTATCTGATATTAA
AGAGATAATTCCTTTTGTTAATAAAAATAGAACACAAACTGTTTCTATTTATCCT
TGGGAAGCGTCATTAAAATATCGAGATAAATTAGCAAGAAGTGGAGTTGAAAGAA
TTGTTGAATCAGGCATGAATAATATTTTCAGAGTTGGAGGGGCTCATGATTCATT
ATCTCCTCTCCAGTACCTAGTTAGGTTTGTATCGCATGAGAGACCATTTAATTAT
ACGACAAAAGATGTTGCGGTTGAAATCGAACAAACACGTTACTTAGAGGAAGATA
AGTTTTTAGTTTTTGTCCCATAGTTAAAGGAAATTATATGAAAGATGAAAGTGCT
TTTTTTACGATTGATCACATCATCAAGCTTGATAATGGTCAGTCTATCCGAGTTT
GGGAAACACTCCCTAAAAAGAACGTACCAGAGAAAAAACATACAATACTTATTGC
TTCGGGTTTTGCTAGAAGAATGGATCATTTTGCAGGTCTTGCTGAGTATTTATCT
ACTAACGGTTTTCATGTCATTCGCTACGATTCTTTGCATCATGTTGGATTAAGCA
GTGGATGTATAAATGAATTTACGATGTCGATTGGAAAAAATAGCCTGCTTACAGT
CGTAGATTGGCTTACAGATCATGGTGTCGAACGAATAGGGCTGATTGCTGCTAGT
TTGTCAGCGAGAATCGCCTATGAGGTAGTAAATAAAATTAAATTATCATTTTTAA
TTACGGCCGTAGGTGTCGTTAATCTTAGAGATACATTAGAAAAAGCATTGGAGTA
TGACTATTTGCAATTACCTATTTCAGAGTTACCAGAAGATCTTGACTTTGAAGGT
CATAATTTAGGATCGGAGGTCTTTGTTACAGATTGCTTTAAACATAATTGGGACA
CGTTAGACTCGACACTTAATAGTGTTAAAGGATTAGCGATTCCATTTATTGCTTT
TACTGCAAACGATGATAGTTGGGTAAAGCAAAGTGAAGTTATAGAGCTCATTGAT
AGCATTGAATCTAGTAATTGTAAGCTCTATTCGCTAATTGGAAGTTCACATGATC
TTGGGGAAAATTTGGTTGTATTAAGAAATTTTTATCAATCAGTGACGAAGGCAGC
CTTAGCATTAGATGATGGTTTATTGGATTTAGAGATAGACATTATTGAACCTCGA
TTTGAGGACGTTACAAGTATTACTGTTAAGGAGCGTAGATTAAAAAATGAAATTG
AAAATGAATTATTAGAATTGGCTTAAATAAACAGAATCACCAAAAAGGAATAGAG
TATGAAGTTTGGAAATATTTGTTTTTCGTATCAACCACCAGGTGAAACTCATAAG
CAAGTAATGGATCGCTTTGTTCGGCTTGGTATCGCCTCAGAAGAGGTAGGGTTTG
ATACATATTGGACCTTAGAACATCATTTTACAGAGTTTGGTCTTACGGGAAATTT
ATTTGTTGCTGCGGCTAACCTGTTAGGAAGAACTAAAACATTAAATGTTGGCACT
ATGGGGGTTGTTATTCCGACAGCACACCCAGTTCGACAGTTAGAAGACGTTTTAT
TATTAGATCAAATGTCGAAAGGTCGTTTTAATTTTGGAACCGTTCGAGGGCTATA
CCATAAAGATTTTCGAGTATTTGGTGTTGATATGGAAGAGTCTCGAGCAATTACT
CAAAATTTCTACCAGATGATAATGGAAAGCTTACAGACAGGAACCATTAGCTCTG
ATAGTGATTACATTCAATTTCCTAAGGTTGATGTATATCCCAAAGTGTACTCAAA
AAATGTACCAACCTGTATGACTGCTGAGTCCGCAAGTACGACAGAATGGCTAGCA
ATACAAGGGCTACCAATGGTTCTTAGTTGGATTATTGGTACTAATGAAAAAAAAG
CACAGATGGAACTCTATAATGAAATTGCGACAGAATATGGTCATGATATATCTAA
AATAGATCATTGTATGACTTATATTTGTTCTGTTGATGATGATGCACAAAAGGCG
CAAGATGTTTGTCGGGAGTTTCTGAAAAATTGGTATGACTCATATGTAAATGCGA
CCAATATCTTTAATGATAGCAATCAAACTCGTGGTTATGATTATCATAAAGGTCA
ATGGCGTGATTTTGTTTTACAAGGACATACAAACACCAATCGACGTGTTGATTAT
AGCAATGGTATTAACCCTGTAGGCACTCCTGAGCAGTGTATTGAAATCATTCAAC
GTGATATTGATGCAACGGGTATTACAAACATTACATGCGGATTTGAAGCTAATGG
AACTGAAGATGAAATAATTGCTTCCATGCGACGCTTTATGACACAAGTCGCTCCT
TTCTTAAAAGAACCTAAATAAATTACTTATTTGATACTAGAGATAATAAGGAACA
AGTTATGAAATTTGGATTATTTTTTCTAAACTTTCAGAAAGATGGAATAACATCT
GAAGAAACGTTGGATAATATGGTAAAGACTGTCACGTTAATTGATTCAACTAAAT
ATCATTTTAATACTGCCTTTGTTAATGAACATCACTTTTCAAAAAATGGTATTGT
TGGAGCACCTATTACCGCAGCTGGTTTTTTATTAGGGTTAACAAATAAATTACAT
ATTGGTTCATTAAATCAAGTAATTACCACCCATCACCCTGTACGTGTAGCAGAAG
AAGCCAGTTTATTAGATCAAATGTCAGAGGGACGCTTCATTCTTGGTTTTAGTGA
CTGCGAAAGTGATTTCGAAATGGAATTTTTTAGACGTCATATCTCATCAAGGCAA
CAACAATTTGAAGCATGCTATGAAATAATTAATGACGCATTAACTACAGGTTATT
GTCATCCCCAAAACGACTTTTATGATTTTCCAAAGGTTTCAATTAATCCACACTG
TTACAGTGAGAATGGACCTAAGCAATATGTATCCGCTACATCAAAAGAAGTCGTC
ATGTGGGCAGCGAAAAAGGCACTGCCTTTAACATTTAAGTGGGAGGATAATTTAG
AAACCAAAGAACGCTATGCAATTCTATATAATAAAACAGCACAACAATATGGTAT
TGATATTTCGGATGTTGATCATCAATTAACTGTAATTGCGAACTTAAATGCTGAT
AGAAGTACGGCTCAAGAAGAAGTGAGAGAATACTTAAAAGACTATATCACTGAAA
CTTACCCTCAAATGGACAGAGATGAAAAAATTAACTGCATTATTGAAGAGAATGC
AGTTGGGTCTCATGATGACTATTATGAATCGACAAAATTAGCAGTGGAAAAAACA
GGGTCTAAAAATATTTTATTATCCTTTGAATCAATGTCCGATATTAAAGATGTAA
AAGATATTATTGATATGTTGAACCAAAAAATCGAAATGAATTTACCATAATAAAA
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TTAAAGGCAATTTCTATATTAGATTGCCTTTTTAAATTTCTGTTGATATTAGGTA
TTACTGGAGAGGGTATGACTGTCCATACTGAATATAAAAGAAATCAAATCATTGC
TAGTTCAGAAATTGATGATCTTATCTTTATGACGAAACCACAAGAGTGGTCATTT
GAAGAGCAAAAAGAAATACGGGATAAATTAGTTCGTGAGGCTTTTTATTTTCACT
ACAATAGAAATGAAGAATATAGAAATTATTGTATCAATCAGCATGTGAGTGATAA
TTTACACACTATTGATGAAATACCCGTGTTTCCAACATCTGTTTTTAAATATAAG
AAATTACATACTGTCACAGCCGAGGACATTGAAAATTGGTATACAAGTAGTGGAA
CTCGTGGAGTAAAAAGTCATATTGCACGTGATCGTCTTAGCATTGAACGCTTGCT
TGGTTCTGTCAACTTCGGAATGAAATACGTTGGAGATTGGTTTGAGCATCAAATG
GAATTGATAAATTTAGGACCAGATAGATTCAATACAAATAATATTTGGTTTAAAT
ATGTCATGAGTTTGGTCGAGTTACTTTATCCGACTGAATTTACAGTTGATAATGA
CAAAATAGATTTTGAAAAAACAGTAAAACATCTATTTAGAATTAAGAATAGTAAA
AAAGACATTTGCTTAATTGGGCCACCATTTTTTGTGTATCTTTTGTGCCAATATA
TGAAAGAAAACAATATTGAATTTAAAGGAGGAGATAGAGTACATATTATTACTGG
TGGAGGATGGAAATCTAATCAGAATGACTCTTTAGATCGTGCTGATTTTAATCAA
TTATTAATGGATACTTTCCAACTCGACAAGATTAATCAAATTAGAGATACCTTTA
ATCAAGTTGAGCTTAATACTTGTTTTTTTGAAGATGAATTTCAAAGAAAACATGT
TCCACCGTGGGTATATGCTCGGGCTCTTGATCCTGAAACCTTGAAACCCGTAGCA
GATGGTGAGATCGGGTTGTTAAGTTATATGGACGCCTCATCAACTGCTTACCCTG
CTTTTATTGTTACTGATGATATCGGTATTGTAAAAGAAATTAGAGAACCAGATCC
TTACCCAGGGGTAACTGTTGAGATTGTTCGGCGCTTAAATACACGTGCGCAAAAA
GGATGCGCGCTCTCTATGGCTAATGTCATACAAAAGAATATCAAGGATTAAGTTA
TGATTGTTGATGGTAGAGTTTCAAAAATAGTATTAGCGTCAATAAGAAATAATAT
ATATAAGGTATTTATTACTGTAAATTCACCAATAAAGTTCATCGCTGGACAATTT
GTAATGGTCACGATTAATGGGAAAAAATGCCCTTTTTCAATTGCGAATTGCCCGA
CAAAAAATTACGAAATAGAATTGCATATTGGTAGTTCGAATAGAGACTGCTCATT
GGATATTATCGAATATTTTGTCGATGCTCTTGTTGAGGAAGTCGCAATTGAGTTA
GATGCTCCCCATGGAAACGCTTGGTTACGGTCTGAAAGTAATAACCCATTGCTAT
TAATTGCGGGAGGTACAGGTTTATCATATATAAATAGCATTCTAACAAATTGCTT
AAATAGGAATATACCTCAAGATATTTATCTTTACTGGGGAGTAAAAGACAGTTCT
CTTTTGTATGAAGATGAAGAGTTACTAAACTTATCACTAAACAACAAAAACTTTC
ATTATATTCCTGTTATTGAAGATAAAAGTGAAGAATGGATAGGGAGAAAAGGCAC
TGTTCTTGATGCTGTCATGGAAGATTTTACTGATCTTACTTATTTTGATATTTAT
GTTTGTGGACCCTTCATGATGGCTAAAACAGCAAAAGAAAAATTAATTGAAGAGA
AAAAAGCAAAGTCAGAACAGATGTTTGCCGATGCTTTTGCATACGTATAA 
*: http://parts.igem.org/Part:BBa_J06504 
**: gift from Prof Belkin Shimshon (Hebrew University of Jerusalem) 
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Table S2: List of oligonucleotides used in this study 
Underlined sequences are the enzyme cutting site and the sequences in bold are the coding sequence regions of the reporter genes. 
Primer (set) Sequence (5’– 3’) Usage 
mCherry_F CGTCTAGAGATTAAAGAGGAGAAATACTAGATGGTGAGCAAGG   To add XbaI cutting site and B0030 to the front of mCherry 
mCherry_R GCACTAGTATTATTACTTGTACAGCTCGTCCATGCCGC To add SpeI cutting site to the end of mCherry  
ScarLet-I_F CGTCTAGAGATTAAAGAGGAGAAATACTAGATGGTGAGTAAAGG To add XbaI cutting site and B0030 to the front of mScarlet-I 
ScarLet-I_R GCACTAGTATTATTAGTATAGTTCATCCATGCCACCTTAGTATAGTTCATCCATGCCACC To add SpeI cutting site to the end of mScarlet-I   
GFP_F CGGAATTCGCGGCCGCTCTAGAGATTAAAGAGGAGAAATACTAGATGGAGCTTTTCACTGGCGTTGTTCCC  To insert BioBrick prefix and B0030 to the front of gfp  
GFP_R GCACTAGTATTATTAGATCCCGGCGGCGGTCACG To add SpeI cutting site to the end of gfp  
deGFP_F CGGAATTCGCGGCCGCTCTAGAGATTAAAGAGGAGAAATACTAGATGGAGCTTTTCACTGGCGTTGTTCCC  To insert BioBrick prefix and B0030 to the front of degfp  
deGFP_R GCACTAGTATTATTAGATCCCGGCGGCGGTCACG To add SpeI cutting site to the end of degfp  
NanoLuc_F CGGAATTCGCGGCCGCTCTAGAGATTAAAGAGGAGAAATACTAGATGGTCTTCACACTCGAAGATTTCGTTGGG     
To insert BioBrick prefix and 
B0030 to the front of NanoLuc 
NanoLuc_R GCACTAGTATTATTACGCCAGAATGCGTTCGCACAGC To add SpeI cutting site to the end of NanoLuc 
Rbs30_spacer_F CTGGAATTCGCGGCCGCTTCTAGAGATTAAAGAGGAGAAATACTAG To introduce B0030 Rbs30_spacer_R ATTACCGCCTTTGAGTGAGC 
PmerT_J23115_F GCTACTAGTATTTATAGCTAGCTCAGCCCTTGG 
To introduce PmerT PmerT_R GGAATTCGCGGCCGCTTCTAGAGATATAAACGCAGAAAGGCCC PmerT_J23109_F GCTACTAGTATTTACAGCTAGCTCAGTCCTAGG 
Additional B0015 
Terminator 
GCTTCTAGAGCTCGGTACCAAAGACGAACAATAAGACGCTGAAAAGCGTCTTTTTTCGTTTTGGTCCTACT
AGAGTTCCATATCGCTTGACTACG 
To introduce the additional 
B0015 terminator 
mCherry_F CGTCTAGAGATTAAAGAGGAGAAATACTAGATGGTGAGCAAGG   To add XbaI cutting site and B0030 to the front of mCherry 
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mCherry_R GCACTAGTATTATTACTTGTACAGCTCGTCCATGCCGC To add SpeI cutting site to the end of mCherry  
J23101_fromJ23117_F CCTAGGACTGAGCTAGCTGTAAATCACACTGGCTCACCTTC To mutate J23117 to J23101 promoter by point mutation 
J23101_fromJ23117_R GCTAGCTCAGTCCTAGGTATTATGCTAGCTACTAGAGATTAAAGAGG To mutate J23117 to J23101 promoter by point mutation 
E_X_r30_lacZ_fwd CCGGAATTCGCGGCCGCTTCTAGAGATTAAAGAGGAGAAATACTAGATGACCATGATTACGGATTCACTGGCC For amplifying lacZ from E. coli 
MG1655 genome S_lacZ_rev GCTACTAGTATTATTTTTGACACCAGACCAACTGGTAATGGTAGCGACCGGCGCTCAGCTGAAACTCCGCCGATACTGACGGGCTCC 
GB_ORF8-B15_fwd2 GCCCTATAGTAATACTAGAGCCAGGC 
For amplifying the sensor 
circuits and lux operon for 
AQUA cloning12 
GB_Plux2_rev ATTTGCCCCTCCTCTCTAGTTTTATTCGAAAG 
GB_PmerT_rev ATTTGCCCCTCCTCTCTAGTAGGATTGGATAGCGTAACC 
GB_LuxC_fwd ACTAGAGAGGAGGGGCAAATATGACTAAAAAAATTTC 
GB_ORF8_rev CTCTAGTATTACTATAGGGCGAATTCCTTTAATC 
GB_VFLuxC_fwd ACTAGAGAGGAGGGGCAAATATGAATAAATGTATTCCAATG 
GB_VFLuxG_rev CTCTAGTATTATTATACGTATGCAAAAGCATC 
GB_VFLuxG-B15_fwd CATACGTATAATAATACTAGAGCCAGGC 
-XbaI_luxD_fwd TGCCGGATAACCTAGATTTTGAAGGC For removing the XbaI and 
EcoRI sites in the lux operon 
(P. luminescens) using AQUA 
cloning12 
-XbaI_luxD_rev TGGCCTTCAAAATCTAGGTTATCCGGC 
-EcoRI_ORF8_rev CTATAGGGCAAATTCCTTTAATCCC 
-EcoRI_ORF8_fwd GGATTAAAGGAATTTGCCCTATAG 
97
S-26
Table S3: List of abbreviations used in this study 
Abbreviation Full name / explanation 
3OC6HSL N-(β-ketocaproyl)-L-homoserine lactone  
CFS cell-free system  
deGFP a GFP derived from an enhanced GFP with optimized translation ability in CFS 
DMSO dimethyl sulfoxide  
fM femtomolar 
GFP green fluorescent protein 
GFPmut3 a GFP derived from Aequorea victoria with improved fluorescence emission at excitation 488 nm 
HgCl2 mercury (II) chloride  
LacZ β-galactosidase 
LB lysogeny broth  
LOD limit of detection  
LucFF firefly luciferase 
LuxCDABE/LuxAB bacterial luciferase operon 
LuxR quorum sensing molecule-responsive transcription activator 
mCherry a monomeric RFP derived from Discosoma sp. 
MerR mercury (II)-responsive transcription activator-repressor 
mScarlet-I a monomeric RFP derived from synthetic construct based on mCherry and multiple other naturally occurring RFPs and chromo proteins 
NanoLuc luciferase engineered by directed evolution from the deep sea shrimp Oplophorus gracilirostris 
PBS phosphate-buffered saline 
PURE purified recombinant elements 
RFP red fluorescent protein 
TX-TL transcription-translation 
X-gal 5-Bromo-4-chloro-3-indolyl β-D-galactopyranoside
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Abstract The presence of chemicals with estrogenic activity
in surface, groundwater, and drinking water poses serious
concerns for potential threats to human health and aquatic life.
At present, no sensitive portable devices are available for the
rapid monitoring of such contamination. Here, we propose a
cell-based mobile platform that exploits a newly developed
bioluminescent yeast-estrogen screen (nanoYES) and a low-
cost compact camera as light detector. Saccharomyces
cerevisiae cells were genetically engineered with a yeast
codon-optimized variant of NanoLuc luciferase (yNLucP) un-
der the regulation of human estrogen receptor α activation.
Ready-to-use 3D-printed cartridges with immobilized cells
were prepared by optimizing a new procedure that enables
to produce alginate slices with good reproducibility. A porta-
ble device was obtained exploiting a compact camera and
wireless connectivity enabling a rapid and quantitative evalu-
ation (1-h incubation at room temperature) of total estrogenic
activity in small sample volumes (50 μL) with a LOD of
0.08 nM for 17β-estradiol. The developed portable analytical
platform was applied for the evaluation of water samples
spiked with different chemicals known to have estrogen-like
activity. Thanks to the high sensitivity of the newly developed
yeast biosensor and the possibility to wireless connect the
camera with any smartphone model, the developed configu-
ration is more versatile than previously reported smartphone-
based devices, and could find application for on-site analysis
of endocrine disruptors.
Keywords Bioluminescence . NanoLuc luciferase .
Endocrine disruptors . Effect-based analysis . Estrogenic
activity . Yeast-based biosensor
Introduction
The monitoring of micropollutants in the aquatic environment
represents both a key technical and regulatory challenge that
has been addressed in the EU Directive 2008/105/EC (the
Environmental Quality Standards Directive, EQSD), later
amended with the Directive 2013/39/EU under the European
WFD [1]. In particular, several environmental contaminants are
known to affect endocrine functions resulting in adverse health
effects in humans and wildlife. These compounds, falling under
the umbrella of endocrine-disrupting chemicals (EDCs), interfere
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at different levels with the endocrine system, e.g., by binding to
the receptors of several hormones (e.g., estrogens, androgens and
progestogens, corticosteroids, and thyroid hormones). Different
unrelated molecules have been classified as EDCs, including
synthetic hormones, polycyclic aromatic hydrocarbons (PAHs),
polychlorinated biphenyls (PCBs), dioxins, dibenzofurans, and
alkylphenols [2]. This high heterogeneity in chemical structure
and physicochemical properties poses significant technical issues
for the development of analytical methods and for the identifica-
tion of a harmonized regulatory framework [3, 4]. Although there
are no legal discharge limits in the environment, some
micropollutants have been recently prioritized at EU level ac-
cording to their suspected health risks and to the current unavail-
ability of adequate monitoring methods [5]. In 2015, the Joint
Research Center published a technical report with the first Watch
List containing the following substances: diclofenac, 17β-
estradiol (E2), Estrone (E1), 17α-ethinylestradiol (EE2),
oxadiazon,methiocarb, 2,6-ditert-butyl-4-methylphenol, triallate,
imidacloprid/thiacloprid/thiamethoxam/clothianidin/acetamiprid,
erythromycin/clarithromycin/azithromycin, and 2-ethylhexyl 4-
methoxycinnamate. Of these ten substances, three compounds,
i.e., E2, E1, and EE2, share the same mechanism of action, i.e.,
via activation of estrogen receptor α (ERα) [6]. The monitoring
of these chemicals is challenging and only expensive and sophis-
ticated laboratory equipment (e.g., mass spectrometry) can pro-
vide suitable detection limits for their detection.
An approach complementary to chemical analysis is repre-
sented by effect-based analysis, relying on the evaluation of
actual biological activity of a sample, measured as the ability
to activate receptors or other molecular targets [7–9].
Receptor-mediated effects are generally measured with bioas-
says or cell-based assays in which cells are re-programmed to
express a reporter protein as a consequence of activation of a
specific receptor. Cell-based assay have proven highly valu-
able tools to understand the level of estrogenic contamination
in water bodies [3, 10] and for eco-toxicological studies [11,
12]. In particular, assays based on both human cell lines and
yeasts have been developed by engineering living cells with
the human estrogen α or β receptor, whose activation drives
the expression of a reporter protein such as a luciferase or a
green fluorescent protein [13–22].
As an alternative to reporter gene technology, [23]
achieved detection at sub-ppb levels of estradiol and ppm
levels of bisphenol A by engineering Escherichia coli cells
to express on the surface native estrogen receptors and
exploiting impedance. These assays are able to assess the ef-
fective biological activity of a sample taking into account
mixture effects and even the presence of unidentified and un-
known chemicals. Such information is crucial in the analysis
of complex samples containing a high number of chemicals,
for example to rapidly detect tap water contamination. Other
biosensing approaches have been also explored to develop
new tools able to measure estrogenic activity in environmental
samples; for example, [24] proposed receptor-based optical
biosensors that can be reused for up to 300 sensing cycles.
Among cell-based assays for estrogen-like activity, the most
applied are ER-CALUX based on human U2-OS osteosarcoma
cell line [25], E-SCREEN based on MCF-7 human breast ade-
nocarcinoma cell line [26], and the yeast estrogen screen (YES)
developed by Routledge and Sumpter [27]. In particular, YES
assay is based on a recombinant Saccharomyces cerevisiae yeast
strain expressing the human estrogen receptor hER and a reporter
plasmid carrying the reporter gene lac-Z encoding the enzymeβ-
galactosidase for colorimetric detection.
Despite their widespread use in laboratory settings, these
assays have not yet been implemented in portable formats.
The availability of new methods enabling the on-site analysis
would be an extremely helpful tool for routine screening and
for providing a rapid alert in case of accidental disasters in
order to rapidly undertake proper countermeasures [6].
We previously reported proof-of-principle devices integrat-
ing yeast cells for endocrine disruptors, nevertheless the low
bioluminescence (BL) emission of the cells required highly
sensitive light detectors such as cooled charge-coupled device
(CCD) cameras for astrophotography [28]. We recently re-
ported the obtainment of general toxicity cell biosensors
exploiting the smartphone-integrated camera as detector [29,
30]. Yet these biosensors integrated mammalian cell lines,
with the well-known limitations related to cell handling and
shelf-life. A 3D-printed cartridge was fabricated to integrate
cells with a smartphone, simplifying the device itself but lim-
iting its applicability to a single smartphone model.
Considering the high number of commercial smartphones
and their short lifespan, this represents a serious limitation
for real-life applications. Therefore, taking advantage of our
experience, we addressed main limitations of previous porta-
ble cell biosensors in terms of detectability, universality of the
device, and shelf-life of the cells. To increase detectability, we
developed a new yeast biosensor by exploiting NanoLuc lu-
ciferase [31] as reporter protein, to develop a device of general
use we replaced the smartphone with a compact wireless cam-
era that can be connected to any smartphone, and we opti-
mized a novel strategy for obtaining reproducible ready-to-
use alginate slices with embedded cells.
Materials and methods
Chemicals and reagents
All the reagents required for yeast cell culture maintenance
were from Sigma-Aldrich (St. Louis, MO). Synthetic com-
plete (SC) liquid medium was prepared by adding 6.7 g yeast
nitrogen base w/o amino acids, 1.4 g yeast synthetic drop-out
medium supplement, 10 mL adenine hemisulfate solution to
1 L of H2O. The solution was autoclaved and then 40 mL of
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glucose 50% w/v solution (0.22 μm filter sterilized) was
added. SC-ura- t rp- leu medium was prepared by
supplementing SC medium with L-histidine (2 g/L). SC (-
Ura-Trp-Leu-His) medium was supplemented with L-histidine
(0.02 g/L), L-leucine (0.1 g/L), L-tryptophan (0.02 g/L), and
uracil (0.02 g/L). 17β-estradiol (E2), 17α-ethynylestradiol
(EE2), diethylstilbestrol (DES), estrone (E1), and bisphenol
A (BPA) were from Sigma-Aldrich. Dialysis tubing cellulose
membrane and the kit for plasmid extraction and purification
were from Sigma-Aldrich. FastDigest restriction enzymes,
FastAP, and T4 DNA Ligase required for cloning and yeast
protein extraction reagent (YPER) were from Thermo Fisher
Scientific (Waltham, MA, USA). The bioluminescent sub-
strate furimazine was from Promega (Madison, WI, USA).
All other chemicals were purchased form Sigma-Aldrich (St.
Louis, MO, USA).
Obtainment of NanoLuc estrogen responsive S. cerevisiae
strain
Yeast expression plasmid pRSII426 and pBEVY-L were form
Addgene (Cambridge, Massachusetts, USA). The yeast codon
optimized version of the NanoLuc-PEST luciferase (yNLucP)
was a kind gift from Prof. C. Andréasson (Stockholm
University, Sweden) [32]. The sequence encoding the human
estrogen receptor was amplified with polymerase chain reac-
tion (PCR) using pSP72hERα as template and cloned into
pBEVY-L (Leu2 marker) vector under the control of consti-
tutive ADH1 promoter, using KpnI and EcoRI sites. The gen-
erated vector was called pBEVY-L-ERα.
The reporter vector was created by cloning, into a
pRSII426 plasmid (Ura3 marker), five copies of an ERE re-
sponse element (-AGGTCAgagTGACCT-) [33] upstream of a
minimal cytochrome C promoter (CYCmin) driving the ex-
pression of the yNLucP coding sequence, giving the plasmid
pRSII426-ERE-yNLucP. The correctness of sequences and
vectors was confirmed by restriction analysis and sequencing.
The yeast S. cerevisiae BMA64-1A (MATa, ura 3-52,
trp1Δ2 leu2-3 112his3-11 ade2-1, can1-100) wild-type strain
was used as recipient strain [34] and transformed with plas-
mids pBEVY-L-ERα and pRSII426-ERE-yNLucP using the
LiAc/SS-DNA/PEG method [35]. Colonies harboring both
vectors were selected in SC-ura-leu plates after incubation at
30 °C for 4 days. Fifteen percent glycerol stocks of the recom-
binant strain were prepared and stored at −80 °C.
Laboratory-based assay procedure and luminescence
measurements
The novel NanoLuc yeast estrogen screen (nanoYES) assay was
carried out in a type II laminar flow cabinet to reduce aerosol
formation. Before running an assay, a single colony from an agar
plate containing the selective medium was used to inoculate
3.0 mL of SC medium. This culture was grown overnight at
30 °C with orbital shaking at 200 rpm in selective SC medium.
Briefly, a 3 mL overnight yeast culture was diluted in fresh
SC medium to optical density (OD600) of 0.6 and grown for
about 4 h until OD600 = 1 was reached. Then, 150 μL of
culture was dispensed in 96-well microplates and incubated
at 25 °C with different concentrations of E2 (from 0.001 to
100 nM) at 1% ethanol final concentration, for 1 h. Control
wells (CTR) were incubated with 1% ethanol final concentra-
tion. BL emission kinetics were recorded using a Varioskan
Flash multimode reader (5 min with 300 ms integration time)
after addition of 50 μL of an optimized BL substrate contain-
ing 10 μM furimazine diluted in YPER reagent (YPER-
Nano). Light emissions were expressed as relative light units
(RLU). The detection limit is defined as the E2 concentration
that corresponds to the blank signal plus three times the stan-
dard deviation. All experiments were performed in triplicate
and repeated at least three times.
Fabrication of the mobile platform 3D-printed cartridges
and GoProHero5 adaptors
The compact GoPro HERO 5 video camera (GoPro, Inc., San
Mateo, CA, USA) was chosen as light detector. A cartridge of
60 × 40 mm, 7 mm high, containing an array of 16 square
wells (5 mm wide and 5 mm deep each) was created with a
desktop 3D printer (Makerbot Replicator 2X) using black and
white thermoplastic polymer acrylonitrile butadiene styrene
(ABS) (FormFutura, Nijmegen, NL) using the dual extrusion
option. The GoProHero5 adaptors and dark-box were printed
using black ABS. All pieces were printed at 300 μm layer
resolution, 30% infill.
Preparation of cartridges with immobilized yeast
biosensors.
An overnight culture of yeast cells was diluted in 30 mL of
fresh medium to optical density (OD600) of 0.6 and grown for
about 4 h until an OD600 = 1 was reached. The culture was
centrifuged and resuspended in 3 mL SC-ura-leu medium
containing 10% trehalose and 1.5% sodium alginate.
This mixture was then poured into a dialysis tubing cellu-
lose membrane (avg. flat width 10 mm, molecular weight cut-
off = 14 kDa) and immersed in a 0.2 M CaCl2 solution for 1 h
at room temperature (25 °C) to allow the formation of the gel
inside the membrane. Using a 3D-printed Bmicrotome-like^
device, that has a slot for a surgical blade placed at 2 mm from
the edge, the obtained gel (about 12 cm length, avg. diameter
5 mm) was repeatedly cut in several slices, then placed into the
wells of the 3D-printed cartridges. A 50 μL volume of SC
medium was added to each well and the cartridges were cov-
ered with Parafilm M® and stored at 4 °C until use.
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The stability of the yeast biosensor kept at 4 °C was daily
tested by incubating the cells in duplicate with 10 nM E2
(50 μL) for 1-h incubation at room temperature; a 50 μL vol-
ume of YPER-Nano substrate was added to each well and
image was acquired with the GoProHero5 in night mode
(30 s, ISO 800) equipped with the 3D-printed black-box ac-
cessory. Images were analyzed with ImageJ software and data
plotted using GraphPad Prism v.5 (GraphPad Software, Inc.
La Jolla, CA). BL emission was normalized with respect to
BL signal obtained at day 0 (freshly immobilized cells). All
measurements were performed in duplicate and repeated at
least three times with different cell cartridges.
Analytical performance of the GoPro-based yeast estrogen
screen
The analytical performance of the developed platform was per-
formed by incubating yeast estrogen biosensors with increasing
concentrations (from 0.05 to 10 nM) of E2, selected as model
estrogenic analyte. Briefly, a cell-cartridge containing
immobilized yeast cells stored at 4 °C was equilibrated at room
temperature for 15min, then a 50μL volume of E2 dilutions (1%
ethanol final concentration) were added in duplicate wells.
Control wells were incubated with 1% ethanol final concentration
(50 μL). After 1-h incubation at room temperature, a 50 μL vol-
ume of YPER-Nano substrate was added to each well, then the
cartridge was inserted into the 3D-printed black-box accessory,
and BL emission was acquired with the GoProHero5 in night
mode (30 s, ISO 800). Images were quantified with ImageJ soft-
ware by selecting a square region of interest (ROI) around each
well and measuring the BL emission of duplicate wells. E2 dose-
response curves were obtained by calculating the fold response
with respect to control and plotted using GraphPad Prism. Non-
linear regression was performed by fitting the experimental data
using a four-parameters sigmoidal curve, then the EC50 value for
E2 was calculated as the effective concentration which produces
the midpoint y value (50%) of the dose-response curve. All mea-
surements were performed in duplicate and repeated three times
with different cell cartridges.
Yeast-estrogen cartridge configuration for effect-based
analysis
To obtain yeast-estrogen biosensors for real sample analysis,
easy-to-use cartridges with immobilized cells were prepared
as follows: half of the cartridge was used to test in duplicate
the yeast bioreporter response to 0.5, 1, and 5 nM E2 or 1%
EtOH as control, while the remaining wells were incubated in
duplicate with tap water samples (25 μL) spiked with different
concentrations of diethylstilbestrol (0.1 and 10 nM) and
bisphenol A (10 nM). Sample wells were also co-incubated
with 0.5 nM E2 (25 μL). Dilution of estrogenic compounds
were prepared to provide a 1% ethanol final concentration in
every well.
Cartridges were incubated for 1 h at room temperature, then
a 50 μL volume of YPER-Nano substrate was added to each
well and BL emission was acquired with the GoProHero5 as
described above. Images were quantified with ImageJ soft-
ware by selecting a square ROI around each well and measur-
ing the mean BL emission of duplicate wells. BL signal were
then normalized with respect to 0.5 nM E2 (selected as refer-
ence and set to 100%) and plotted using GraphPad Prism. All
measurements were performed in duplicate and repeated three
times with different cell cartridges.
Results and discussion
The possibility to use the smartphone camera to detect the
BL emission from living whole-cell biosensors has been
previously demonstrated by us exploiting genetically
engineered mammalian cell lines [29, 30]. Despite adequate
analytical performance, one of the main limitations of this
approach is surely related to the short shelf life of mam-
malian cells when maintained outside an incubator with
controlled temperature and humidity. In addition, consider-
ing the short life span of smartphones, mainly due to short
battery life and software updates changes, the general ap-
plicability of such devices is questionable with the necessi-
ty of upgrading and fabricating new devices, with subse-
quent assay optimization and calibration, for each
smartphone model.
In this scenario, a mobile platform based on the use
of a compact camera, such as the GoProHero camera,
and robust yeast cells as living biosensors could repre-
sent a suitable solution to overcome these issues.
Indeed, yeast cells are particularly suitable for the de-
velopment of whole-cell biosensors integrated into a
portable mobile platform as they provide the analytical
robustness typical of bacterial cells, with the possibility
to express functional human receptors and regulatory
elements to obtain predictive information about actual
biological activity of samples [36].
The GoProHero5, optimized for sport and outdoor
activities, represents a robust, waterproof CMOS camera
(12 MP, UHD 4K) which can be directly controlled
using the built-in touch-screen display or can be con-
nected to any smartphone via dedicated GoPro-App
(paired wireless network), making it a very versatile
light sensor for the development of portable devices.
In addition, the long exposure time (up to 30 s at ISO
800) makes this camera a powerful choice for low-light
imaging applications, including bioluminescence
measurements.
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Development of a novel yeast-estrogen screen exploiting
NanoLuc luciferase (nanoYES)
The novel yeast-estrogen strain (Fig. 1a) was obtained by
genetically engineering S. cerevisiae cells with two vectors:
(i) a plasmid for the expression of the human estrogen receptor
α (hERα) under the control of the constitutive ADH1 promot-
er and (ii) a reporter plasmid containing five copies of an ERE
response element (-AGGTCAgagTGACCT-) upstream of a
minimal cytochrome C promoter (CYCmin) which drives
the expression of the yeast codon-optimized NanoLuc lucifer-
ase coding sequence (yNLucP). Both vectors contain the 2 μ
origin, thus ensuring consistent replication of the two plas-
mids during cell division and maintaining each plasmid at
about 50 copies/cell. Due to the high copy number, the expres-
sion of the human estrogen receptor was placed under a weak
promoter to avoid strong overexpression that may lead to ar-
tifacts in the biosensor response. Indeed, the high copy num-
ber of reporter vector allows consistent production of yNLucP
reporter enzyme upon induction.
The small size (19 kDa) and the absence of post-
translational modifications and disulfide bonds of NanoLuc
luciferase enable its rapid synthesis and folding, thus reducing
total assay time; moreover, the use of its destabilized version
provides a half-life of 5 min in yeast, compared to 40 min of
the yNluc [32], thus faithfully reflecting mRNA levels. Yeast
cells were sequentially transformed with the two plasmids and
single colonies screened for their responsiveness with 10 nM
E2. A new BL substrate composition was formulated to opti-
mize BL emission in yeast cells. The NanoGlo® substrate
(containing a lysis buffer optimized for mammalian cells)
showed suitable for yeast cells [32]. However, to increase light
output, we formulated an alternative substrate by diluting
furimazine (10 μM) in YPER buffer, a specific yeast-cell lysis
reagent used for the extraction of functionally active solubi-
lized proteins from yeast. The use of this formulation (YPER-
Nano) provides both an increased BL emission (20%) and
more stable emission kinetics (signal half-life > 20 min) com-
pared to NanoGlo® substrate or furimazine alone (signal half-
life < 2 min). Dose-response curve for E2 (0.001–100 nM)
were obtained using liquid cultures of three positive clones in
96-well microplate format and benchtop luminometer. The
yeast-estrogen biosensor incubated for 1 h with different con-
centra t ions of E2 shows a l imit of detect ion of
0.010 ± 0.002 nM and an EC50 of 0.6 ± 0.1 nM (Fig. 1b).
The nanoYES shows a LOQ of 0.020 ± 0.005 nM E2 and
mean recovery rate of 93 ± 11%. The nanoYES response to
other estrogenic compounds was also evaluated (Fig. 1b) and
corresponding limit of detection and EC50s are shown in
Table 1. The developed yeast estrogen bioassay shows com-
parable results in terms of ranking of estrogenic activity
(E2 > EE2 > DES > E1) and EC50 values, obtained by pre-
vious works based on recombinant yeast cells [37, 38].
Design and 3D-printing fabrication of the mobile platform
based on GoPro Hero camera
The mobile platform was designed to create an all-in-one de-
vice based on the GoPro Hero5 camera (see Electronic
Supplementary Material (ESM) Fig. S1). A series of modular
adaptors were fabricated with black ABS using a desktop 3D
printer, providing a dark box of compact size (65 × 65 mm,
Fig. 1 a Schematic representation of the bioluminescent yeast-estrogen
strain. S. cerevisiae cells were transformed with a plasmid for the
expression of the human estrogen receptor α (hERα) under the control
of the weak constitutive ADH1 promoter. Cells were also transformed
with a vector containing five copies of estrogen response element (ERE)
and the cDNA encoding for the yeast codon optimized NanoLuc
luciferase destabilized variant (yNLucP). Both vectors contain a 2 μ
replication origin for their propagation during yeast growth. The
binding of estrogens such as 17β-estradiol (E2) to hERα activates the
intracellular signaling pathway (receptor dimerization) which leads to the
expression of yNLucP luciferase. Light emission is obtained after
addition of an optimized substrate solution containing furimazine (2-
furanylmethyl-deoxy-coelenterazine). b Dose-response curves for
different estrogenic compounds (E2: 17β-estradiol; EE2: 17α-
ethinylestradiol; DES: diethylstilbestrol; E1: estrone) obtained using the
nanoYES performed in 96-well microplate format and benchtop
instrumentation. Data represent the mean values ± the standard
deviation (SD) obtained with three replicates and repeating the
experiments three times
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60 mm height) for the acquisition of BL emission. This acces-
sory also includes a slot to insert a 3D-printed cell-cartridge
containing the immobilized nanoYES. The multi-well car-
tridges (60 × 40 mm), containing 16 wells of 5 × 5 mm
(150 μL volume each), were printed with white and black
ABS using the dual extrusion option provided by the
Makerbot Replicator 2X. In particular, the bottom of the wells
was printed using white ABS, while black ABS was used for
the remaining parts. This configuration allowed to increase the
intensity of acquired BL signal by reflection while avoiding
crosstalk between adjacent wells, outperforming cartridges
printed with only white or black ABS that suffered of higher
crosstalk and lower signals, respectively.
Immobilization procedure and stability of nanoYES
To obtain ready-to-use cartridges, the nanoYESwas immobilized
into alginate slices. Cells at OD = 1 (about 1.8 × 107 cells/mL)
were tenfold concentrated in culture medium to achieve a suffi-
cient BL emission for a sensitive detection with the GoPro cam-
era. The immobilizationmedium also contains 10%w/v trehalose
to increase the shelf life of yeast cells [39].
A straightforward procedure was developed to generate
yeast-alginate slices of defined and reproducible dimension
(2.1 ± 0.2 mm) (see ESM Fig. S2).
To evaluate the reproducibility of immobilized nanoYES, a
whole cell-cartridge (Fig. 2a) was incubated with 10 nM E2
for 1 h, and BL image acquired with the GoPro camera (Fig.
2b). The quantification of BL emission of 16 slices provided a
coefficient of variation (CV%) of 11%, which is comparable
to previously reported whole-cell bioassays [40].
The efficacy of our procedure was compared to conven-
tional method for obtaining alginate beads. A 50 μL volume
nanoYES/alginate mixture, containing the same cell number
for each slice, was added dropwise into a CaCl2 solution and
let to harden for 1 h. Individual beads of about 4.5 ± 0.3 mm
diameter were obtained, placed into the cell-cartridge wells,
and treated as for the slices, with 10 nM E2 for 1 h. The mean
BL signal using alginate beads is 8.5 times lower and less
reproducible than those obtained with slices, most probably
due to a slower and non-uniform distribution of analyte and
BL substrate inside the beads (see ESM Fig. S3).
The stability and responsiveness of yeast-estrogen
bioreporters immobilized into alginate slices stored at 4 °C
in the 3D-printed cartridges was evaluated. Each day, dupli-
cate wells were incubatedwith 1 nME2 for 1 h and BL images
were acquired with the GoPro camera. As shown in Fig. 2c,
the nanoYES response was consistently maintained within
7 days (85% of initial response at day 7) and even after
2 weeks, the nanoYES maintains about 70% of the respon-
siveness obtained at day 0 (freshly immobilized cells). To
guarantee good analytical performance in terms of LOD and
sensitivity, we decided to use cell-cartridges not older than
10 days, which still provide a BL emission over the 75% of
initial response (arbitrarily selected threshold).
Analytical performance of GoPro-based nanoYES
The assay in optimized conditions consists of incubation of
50 μL of E2 dilutions (concentration range from 0.05 to
10 nM) per each cartridge well containing (about 9.0 × 105
Fig. 2 a Picture of a 3D-printed cartridge containing 16 alginate slices of
yeast-estrogen bioreporters. b BL image of 16 yeast-estrogen biosensors
slices induced with 10 nM E2, acquired with the GoProHero5 camera in
night mode (30 s at ISO 800), after addition of 50 μL YPERNano
solution. c Responsiveness of immobilized yeast-bioreporters stored at
4 °C. Each day, duplicate wells were treated with 1 nM E2 and BL
emissions were acquired with the GoPro camera. BL signals are
normalized with respect to day 0 (freshly immobilized cells)
Table 1 nanoYES response to estrogenic compounds, obtained using
liquid cultures, in 96-well plate format and benchtop luminometer
Compound LOD (nM) EC50 (nM)
17β-estradiol (E2) 0.010 ± 0.002 0.6 ± 0.1
17α-ethynylestradiol (EE2) 0.05 ± 0.01 1.2 ± 0.3
Diethylstilbestrol (DES) 0.019 ± 0.005 5.2 ± 0.5
Estrone (E1) 0.5 ± 0.1 17 ± 2
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cells/slice) for 1 h at room temperature. Cell cartridge is then
imaged with the GoProHero5 camera in night mode for 30 s at
ISO 800, after addition of 50 μLYPER-Nano substrate (Fig.
3a). Since cells are lysed during BL emission acquisition, the
cartridges are single-use. Figure 3b shows a detailed BL image
corresponding to the dose-response curve for E2 acquired
10 min after substrate addition. Dose-response curves obtain-
ed with three different cartridges showed a LOD of
0.08 ± 0.02 nM and EC50 of 0.7 ± 0.1 nM E2 (Fig. 3c). In
the GoPro-based platform, the limit of detection is about one
order of magnitude higher compared to those obtained with
the nanoYES using conventional benchtop luminometer while
the EC50 is comparable (0.6 ± 0.2 nM E2). Conversely, the
LOD is comparable to other previously reported yeast estro-
gen bioassays, such as those reported by Leskinen et al.
(0.03 nM for E2) [15]. Also, the EC50 value is consistent with
those obtained with similar yeast-based screening assays per-
formed in laboratory settings, such as the conventional YES
(EC50: 0.32 nM) [7]. These results confirmed the suitability
of this configuration for the straightforward and quantitative
detection of estrogenic activity in water samples.
GoPro-based nanoYES: analysis of spiked samples
As a proof of concept, tap water samples spiked with
different concentrations of diethylstilbestrol (DES) and
bisphenol A (BPA) were analyzed with the GoPro-
based nanoYES to explore its actual feasibility for on-
site testing, especially for monitoring of sites affected
by high pollution such as downstream of industrial
manufacturing plants and agricultural areas.
BPA was selected because of its ability to act as weak ER
binder and interfere with the endogenous E2, causing severe
effects on the reproductive system [41, 42] while DES is a
synthetic nonsteroidal estrogen widely encountered in influents
and effluents from municipal water treatment plants with con-
centrations levels in the range of 4–12 ng/L for primary influ-
ents [43, 44]. BPA is present at relatively high concentrations in
several site areas, for example according to a recent reviewBPA
concentrations in groundwater vary between 1 ng/L and
20 μg/L [45]. Each disposable cartridge also contains a calibra-
tion curve obtained by inducing the nanoYES with 0.5, 1, and
5 nM E2 allowing a rapid evaluation and subsequent interpola-
tion of estrogenic activity of the samples (Fig. 4a). Control
wells (CTR) were also included and incubated with 1% EtOH
final concentration. Sample-wells were also induced with
0.5 nM E2, a concentration near the EC50, to evaluate both
estrogenic and anti-estrogenic activity of samples.
Mean BL emission of each sample was quantified and nor-
malized with respect to 0.5 nM E2, set to 100% (Fig. 4b).
Sample no. 1, which contains 10 nM BPA (simulating a high
contaminated sample), shows a remarkable decrease (35%) of
BL emission. At this concentration, BPA (a weak hERα bind-
er) interferes with the transactivation induced by 0.5 nM E2,
thus decreasing BL emission. Acting as partial agonist, BPA
competes with E2 (full agonist) for receptor occupancy, thus
producing a net decrease in the receptor activation compared
to that observed with the E2 alone.
Sample no. 2, which contains a very high concentration of
a potent estrogen (10 nM DES), shows a remarkable increase
compared to 0.5 nM E2 and was selected to simulate a strong
estrogenic effect as in samples containing mixtures of
Fig. 3 a Picture of a typical yeast
estrogen assay performed
by incubating the cell-cartridge
containing immobilized yeast
bioreporters with 50μL of sample
and by acquiring BL emission
with a GoProHero5 camera in
night mode (30 s at ISO 800),
after addition of 50 μL
YPERNano solution. b BL image
obtained by incubating the yeast-
bioreporters with 17β-estradiol
(concentration range from 0.05 to
10 nM) and c corresponding dose-
response curve for 17β-estradiol
obtained after quantification of
BL emission with ImageJ
software. Data are plotted as fold
response with respect to control
(1% EtOH)
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estrogenic compounds. Sample no. 3, spiked with 0.1 nM
DES (whose concentration does not produce a significantly
increased BL signal), and sample no. 4, containing only tap
water, do not show any alteration with respect to 0.5 nM E2-
induced transactivation.
It must be pointed out that the envisaged application of the
platform is for rapid monitoring of effluents of wastewater and
critical areas, such as agricultural and industrial sites, in which
a high concentration of EDCs is expected. Moreover, future
studies will be aimed at evaluating the analytical performance
of the nanoYES in the presence of EDCs mixtures.
Conclusion
In this work, we proposed a mobile platform for effect-based
analysis of endocrine disruptors, based on bioluminescent
yeast estrogen biosensors and a compact wireless camera as
light detector.
The newly developed yeast estrogen biosensors exploit a
yeast codon optimized variant of Nanoluc luciferase to
achieve rapid and sensitive detection of estrogen-like com-
pounds within 1 h. A straightforward procedure to immobilize
the yeast biosensors into 3D-printed cartridges was also de-
veloped, obtaining reproducible ready-to-use disposable car-
tridges that can stored for 10 days at 4 °C without significant
decrease in analytical performance.
The GoPro camera proved suitable for the sensitive detec-
tion of light emission from bioluminescent yeast biosensors,
using the night mode setup with 30-s integration time. In ad-
dition, thanks to the possibility to connect this sensor with any
smartphone model via dedicated GoProApp, the developed
configuration results in a more standardized and versatile plat-
form, compared to smartphone-based devices. A custom ap-
plication (APP) running on different operative systems could
be developed to either provide instructions to the user and for
the quantification of BL images to obtain immediate results
about estrogenic activity of samples.
In the proposed configuration, the mobile platform, containing
robust microbial bioluminescent whole-cell bioreporters, allows a
rapid evaluation of estrogenic activity in water samples and could
find application for on-site analysis of EDCs.
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Fig. S1 a) 3D printed accessory designed to hold a GoPro Hero5 creating a self-supporting device. 
The adaptor (65 x 65 mm, 60 mm height) provides a dark box for acquisition of bioluminescent 
emission and integrates a slot to house the cell-cartridge. b) Multi-well cartridge (60 x 40 mm) 
printed with white and black ABS containing 16 wells of 5 x 5 mm (150 µL volume each) to house 
the cell-alginate slices 
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3 
Fig. S2 Immobilization of nanoYES in alginate slices. a) Yeast cultures at OD600=1 (about 1.8x10
7 
cells/mL) were concentrated 10X in culture medium containing trehalose (10% w/v) and poured (3 
mL of yeast culture) into a dialysis tubing cellulose membrane (avg. flat width 10 mm, molecular 
weight cut-off = 14 KDa). b) The membrane was then immersed into a CaCl2 solution to allow the 
formation of the gel inside the membrane. c) After 1 h incubation at room temperature (25°C) the 
yeast-bioreporter are immobilized into calcium alginate matrix and ready for the next steps. d) The 
obtained gel (about 12 cm length, avg. diameter 5mm) is inserted in a 3D printed “microtome-like” 
device fabricated for the straightforward production of slices with defined dimension. e) The 
microtome has a slot for a surgical blade placed at 2 mm from the edge, allowing to repeatedly cut 
the gel by simply realigning it to the edge after each slice. f) Using this technique about 48 slices of 
2.1±0.2 mm were obtained, which are sufficient for the production of three cartridges 
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4 
Fig. S3 Comparison with yeast immobilized in alginate beads. a) Picture of alginate beads obtained 
with the conventional procedure by dripping 50 µL of nanoYES-alginate mixture into a 0.1 M 
CaCl2 agitated solution. b) Picture of the alginate beads (avg. diameter 4.5 mm) into a 3D printed 
cartridge.  c) BL emission intensities and distribution of nanoYES immobilized in alginate slices or 
beads and induced with 10 nM E2. d) BL image of nanoYES immobilized in alginate beads and 
induced with 10 nM E2 
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Abstract
Cell-based assays utilizing reporter gene technology have been widely exploited for biosensing, as they provide useful informa-
tion about the bioavailability and cell toxicity of target analytes. The long assay time due to gene transcription and translation is
one of the main drawbacks of cell biosensors. We report the development of two yeast biosensors stably expressing human
estrogen receptors α and β and employing NanoLuc as the reporter protein to upgrade the widely used yeast estrogen screening
(YES) assays. A viability control strain was also developed based on a chimeric green-emitting luciferase, PLG2, expressed for
the first time in Saccharomyces cerevisiae. Thanks to their brightness, NanoLuc and PLG2 provided excellent sensitivity,
enabling the implementation of these biosensors into low-cost smartphone-based devices. The developed biosensors had a rapid
(1 h) response and reported on (anti)estrogenic activity via human estrogen receptors α and β as well as general sample toxicity.
Under optimized conditions, we obtained LODs of 7.1 ± 0.4 nM and 0.38 ± 0.08 nM for E2 with nanoYESα and nanoYESβ,
respectively. As a proof of concept, we analyzed real samples from plants showing significant estrogenic activity or known to
contain significant amounts of phytoestrogens.
Keywords Bioluminescence . Biosensor . Luciferase . Smartphone . Estrogen receptor
Introduction
Endocrine-disrupting compounds (EDCs) are chemicals able to
disrupt normal endocrine function, thus causing adverse effects
on human and animal health [1]. Many of these compounds,
either of natural and synthetic origin, affect the hormone sys-
tems of living organisms through very different mechanisms of
action. Long-term exposure to these substances, even at low
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doses, may lead to severe pathological conditions includ-
ing obesity, endometriosis, infertility, and cancer [2].
Several pathways are involved, including androgens, estro-
gens, and thyroid axes. In particular, interaction of EDCs
with the estrogenic receptors ERα and ERβ alters the nor-
mal hormone biosynthesis, signaling, or metabolism, af-
fecting the growth and differentiation of many organs such
as the ovary, mammary gland, prostate, nervous system,
cardiovascular system, and bones [3]. The cost of EDC-
associated diseases in the European Union was estimated
to be in the range of € 81–269 billion per year. The most
considerable costs were associated with IQ loss and intel-
lectual disability after prenatal organophosphate exposure
and adult obesity attributed to phthalate exposure [4].
Therefore, there is a growing demand for new, fast, and
reliable methods suitable for EDC detection both in laboratory
settings and for on-site analyses [5]. Many analytical methods
such as high-performance liquid chromatography associated
with mass spectrometry (HPLC-MS) have been used in recent
years, providing low limits of detection and high reproducibil-
ity. However, these techniques require sophisticated equip-
ment and extensive sample processing. Furthermore, they do
not provide information about bioactivity of the detected sub-
stances and are unsuitable for real-time, cost-effective on-field
testing [6].
Such information can be obtained using biosensors
employing a properly chosen biological recognition ele-
ment [7]. Indeed, whole-cell biosensors relying on living
cells provide information about the bioavailability of
analytes or classes of analyte that is the fraction of analyte
that is able to permeate the cell membrane and interact with
specific molecular targets. Cell-based assays or bioassays
are able to measure receptor-mediated effects due to the re-
programming of cells to express a reporter protein after
activation of a specific receptor. Several bioluminescent
(BL) bioassays and biosensors have been developed by
genetically engineering cells with reporter proteins, pro-
viding a BL signal proportional to the activation of the
target molecular pathway [8]. Furthermore, advances in
light detection technology have made it possible to inte-
grate these BL biosensors into portable analytical devices
[9–12] suitable for environmental monitoring, food con-
trol, and anti-doping screening [13–16].
Moreover, such systems are able to detect chemicals ac-
cording to their mechanism of action, irrespective of their
chemical structure, and also to provide information on their
combined effect (synergistic and/or antagonist and toxicity).
This capability is highly valuable considering that new mole-
cules are added every year to the watch list of EDCs, with
many compounds still unclassified. Also, the US
Environmental Protection Agency (EPA) highlighted the im-
portance of high-throughput screening (HTS) with the
Toxicity ForeCaster (ToxCast™) Program, obtaining data
about thousands of chemicals in hundreds of mammalian-
based HTS assays [17].
Mammalian-based HTS are formidable tools to provide
data about toxicity and biological activity; however, it is well
known that these assays can be highly demanding in terms of
assay cost and time. Laboratories need to be equipped with
cell culture facilities and incubation times from 5 to 48 h may
be necessary for the production of reporter protein [18].
Although mammalian cells provide highly valuable data,
yeast cells have many advantages, such as increased robust-
ness, low cost of reagent, absence of endogenous estrogen
receptor, and easier handling. Yeast-based assays and biosen-
sors for EDCs generally show lower sensitivity with limits of
detection about one order of magnitude higher than those of
analogous assays using vertebrate cells [19]. Extraction and
pre-concentration of the samples is thus generally required for
EDC monitoring in environmental samples with yeast-based
assays. Inevitably, this pre-analytical step increases the assay
time and may cause higher aspecific cytotoxicity that, if not
correctly assessed, could cause artifacts.
We tried to address these limitations in terms of the
sensitivity, portability, and response time of yeast biosen-
sors for EDCs by exploiting a newly developed luciferase,
NanoLuc, to obtain a set of robust biosensors capable of
detecting EDCs acting on estrogen receptors α and β. The
applicability of a yeast codon–optimized variant of
NanoLuc luciferase (yNLucP) as a reporter protein for
yeast biosensors has been previously demonstrated [20,
21]. We immobilized the yeast biosensors in a 3D-printed
cartridge and implemented the assay in a portable config-
uration by exploiting a compact camera as the detector
[20]. Here, we report on the development of a new
engineered strain expressing the yNLucP under the regula-
tion of ERβ. We also engineered a second reporter strain
with a chimeric luciferase, named PLG2, containing the N-
domain of Photinus pyralis luciferase joined to the C-
domain of Luciola italica luciferase [22]. PLG2 is a ther-
mostable luciferase that produces a bright BL signal and is
resistant to low pH shifting, making it well suited for cell-
based assays. The second reporter strain constitutively ex-
pressing PLG2 luciferase was used as a viability reporter to
correct the analytical signal according to cell viability.
We demonstrated the suitability of these recombinant
strains for high-throughput sensitive analysis both inside and
outside the laboratory using a luminometer and a mobile
phone camera as detectors. We obtained good analytical per-
formance and very rapid response times with incubation times
ranging from 30 min to 1 h. The suitability of these biosensors
for the analysis of real samples was also investigated using
soybean and alfalfa extracts. Estrogenic activity of plant ex-
tracts determined with the smartphone biosensor well corre-
lated with estrogenic activity measured with benchtop
instrumentation.
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Materials and methods
Chemicals and reagents
All the reagents required for yeast cell culture maintenance
were purchased from Sigma-Aldrich (St. Louis, MO).
Synthetic complete (SC) liquidmediumwas prepared contain-
ing 6.7 g/L yeast nitrogen base w/o amino acids, 1.4 g/L yeast
synthetic drop-out medium supplement, and 10 mL/L adenine
hemisulfate solution. The solution was autoclaved and then
40 mL/L of glucose 50% w/v solution (0.22-μm filter steril-
ized) was added. SC medium was supplemented with the re-
quired amino acids L-histidine (2 g/L), L-leucine (0.1 g/L), L-
tryptophan (0.02 g/L), and uracil (0.02 g/L). The chemicals
required for validation, all of analytical grade, and all reagents
required for bacterial cell culture, the kit for plasmid extrac-
tion, and Escherichia coli (JM-109)-competent cell were pur-
chased from Sigma-Aldrich (St. Louis, MO). FastDigest re-
striction enzymes, FastAP, and T4 DNA ligase required for
cloning and yeast protein extraction reagent (YPER) were
from Thermo Fisher Scientific (Waltham, MA, USA). The
bioluminescent substrate furimazine was from Promega
(Madison, WI, USA). All other chemicals were purchased
from Sigma-Aldrich.
NanoLuc estrogen α and β responsive Saccharomyces
cerevisiae
The reporter vector pRSII426-ERE-yNLucP containing five
copies of an ERE response element (-AGGTCAgagTGACCT-)
upstream of a minimal cytochrome C promoter (CYCmin) driv-
ing the expression of the yNLucP coding sequence has been
described elsewhere [20]. The yeast expression plasmid
pBEVY-L (Leu2 marker) was from Addgene (Cambridge,
MA,USA). The sequence encoding the human estrogen receptor
βwas amplifiedwith polymerase chain reaction (PCR) using the
template pSG5hERβ [23]. The sequence was cloned into
pBEVY-L vector under the control of constitutive ADH1 pro-
moter, using KpnI and EcoRI sites. The generated vector was
called pBEVY-ERβ-L.
The yeast codon–optimized version of the NanoLuc-PEST
luciferase (yNLucP) has been previously described in [21].
The sequences were confirmed by restriction analysis and
sequencing. The yeast S. cerevisiae BMA64-1A (MATa,
ura3-52, trp1Δ2, leu2-3, 112his3-11, ade2-1, can1-100)
wild-type strain [24] was transformed with plasmids
pRSII426-ERE-yNLucP and pBEVY-ERβ-L using the
LiAc/SS-DNA/PEG method [25]. Colonies were selected in
SC-ura-leu plates after incubation at 30 °C for 4 days; 15%
glycerol stocks of the recombinant strain were prepared and
stored at − 80 °C. The procedure for obtaining S. cerevisiae
harboring plasmids pBEVY-L-ERα and pRSII426-ERE-
yNLucP is described elsewhere [20]. The NanoLuc yeast
estrogen screen α and β strains were named nanoYESα and
nanoYESβ, respectively.
Laboratory-based nanoYESα and nanoYESβ assays
For the nanoYESα and nanoYESβ assays, an overnight cul-
ture of a single colonywas used to inoculate 5 mL SCmedium
containing the selected amino acids to optical density (OD600)
of 0.6. This culture was grown at 30 °C with orbital shaking at
200 rpm for about 4 h until OD600 = 1 was reached. Then,
160 μL of the culture was dispensed in 96-well microplates
and incubated at 30 °C with different concentrations of E2
(from 0.001 to 100 nM) at 1% ethanol final concentration.
One percent ethanol final concentration was used as control
(CTR). Different incubation times (from 5 to 120 min) were
tested. Then, 50 μL of YPER-Nano BL substrate [20] was
added and BL emission kinetics were recorded using a
Varioskan Flash multimode reader (300-ms integration time).
Light emission was expressed as relative light units (RLU).
The detection limit is defined as the E2 concentration that
corresponds to the blank signal plus three times the standard
deviation. All experiments were performed in triplicate and
repeated at least three times.
In-house validation of nanoYESα and nanoYESβ
assays
The Endocrine Disruptor Screening Program Test Guidelines
from the EPA (https://www.regulations.gov/document?D=
EPA-HQ-OPPT-2009-0576-0006) were used as guidelines for
in-house validation. We tested 17β-estradiol (50-28-2; ≥ 97%),
17α-estradiol (57-91-0; ≥ 98%), 17α-methyltestosterone (58-
18-4; ≥ 97.0%), diethylstilbestrol (56-53-1; 99.5%), 17α-
ethinylestradiol (57-63-6; ≥ 98%), hexestrol (84-16-2; ≥ 98%),
genistein (446-72-0; ≥ 98%), estrone (53-16-7; ≥ 99%), butyl
paraben (94–26-8; ≥ 99%), 1,3,5-Tris(4-hydroxyphenyl)ben-
zene (15797-52-1; 97%), dibutyl phthalate (84-74-2; 99%), at-
razine (1912-24-9; 97.4%), and tamoxifen (10540-29-1; ≥
99%).
Stock solutions of all reagents required for validation were
prepared in ethanol (final vehicle concentration 1%) directly
before use. Each plate contains wells treated with 1-nM final
concentration of 17β-estradiol as positive controls, and a neg-
ative control (CTR) of 1% ethanol (final concentration). For
the anti-estrogenic activity screening, chemicals were co-
incubated with 1 nM of 17β-estradiol. All chemicals were
tested as shown above, with an incubation time of 30 min.
The detection limit is defined as the concentration that corre-
sponds to the blank signal plus three times the standard devi-
ation. All experiments were performed in triplicate and repeat-
ed at least three times.
Prêt-à-porter nanoYESα and nanoYESβ bioluminescent cell biosensors for ultrarapid and sensitive screening... 4939
118
Construction of BL S. cerevisiae strain constitutively
expressing PLG2
The yeast expression plasmid pRSII425 (Leu2 marker) and
p405TEF1 were from Addgene (Cambridge, MA, USA).
The TEF1 promoter was cloned from p405TEF1 into
pRSII425 with SacI and XbaI. PLG2 luciferase was amplified
by polymerase chain reaction (PCR) and cloned into
pRSII425 using BamHI and XhoI. The final vector was named
pRSII425-TEF1-PLG2. The sequences and vectors were con-
firmed by restriction analysis and sequencing. Yeast
S. cerevisiae BMA64-1A (MATa, ura3-52, trp1Δ2, leu2-3,
112his3-11, ade2-1, can1-100) wild-type strain was used as
the recipient strain [24] and transformed with plasmid
pRSII425-TEF1-PLG2 using the LiAc/SS-DNA/PEG meth-
od. Colonies were selected from SC-leu plates after incubation
at 30 °C for 4 days, and 15% glycerol stocks of the recombi-
nant strain were prepared and stored at − 80 °C. The obtained
strain was named ToxYLuc.
Laboratory-based toxicity assay with ToxYluc
An overnight culture from a single colony was used to inoc-
ulate SC-leumedium at an optical density (OD600) of 0.6. This
culture was grown at 30 °Cwith orbital shaking at 200 rpm for
about 4 h until OD600 = 1 was reached. Then, 160 μL of cell
culture was incubated with different concentrations of all
chemicals at 30 °C for 30 min, in 96-black well microplates.
The BL signal was acquired using a Varioskan Flash multi-
mode reader (5 min with 300-ms integration time) after the
addition of 50 μL of YPER-Bright-Glo™ BL substrate, con-
taining 500 μL of Bright-Glo™ diluted in 500 μL of YPER
lysing reagent (YPER-Glo). Light emissions were expressed
as RLU. All experiments were performed in triplicate and
repeated at least three times.
Smartphone-based biosensor with 3D-printed cell
minicartridge and smartphone adaptor fabrication
The minicartridge and smartphone adaptors were fabricated
using a desktop 3D printer Makerbot Replicator 2X
(Makerbot, Boston, MA, USA) using thermoplastic acrylo-
nitrile butadiene styrene (ABS) polymer as previously de-
scribed [20]. The open-source Tinkercad browser-based 3D
design platform (Autodesk, Inc.) was used to create 3D
models. MakerWare v. 2.4 software was used to set up print-
ing options. The cartridge contains an array of 16 wells of
50 μL each (3.5 mm × 3.5 mm × 4.5 mm). The adaptor, pro-
viding a dark box to avoid ambient light interference, was
designed to fit the OnePlus 5 smartphone (OnePlus,
Shenzhen, China).
Smartphone-based biosensor procedure
The OnePlus 5-based platform have been used for integration
of nanoYESα, nanoYESβ, and ToxYluc into a portable de-
vice for ultrarapid on-field analysis. Briefly, nanoYESα,
nanoYESβ, and ToxYluc overnight cultures were diluted in
the morning to optical density (OD600) of 0.6 and grown for
about 4 h until an OD600 = 1 was reached. To prepare a car-
tridge integrating nanoYESα, nanoYESβ, and ToxYluc, the
cultures were centrifuged and concentrated 10× in SC medi-
um. Subsequently, 90 μL of cell suspension (about 9.0 ×
105 cells/well) and 10 μL of samples (0.1% ethanol final con-
centration) were added in each well and incubated for 1 h at
room temperature (24 °C). A 50-μL volume of YPER-Nano
was added to wells containing nanoYESα, nanoYESβ, and a
50-μL volume of YPER-Glo substrate was added to wells
containing ToxYluc. BL emission was acquired with
OnePlus 5 camera for 30 s, ISO 3200. ImageJ software was
used for BL signal measurement by selecting square regions
of interest (ROI) around each well.
Analytical performance of the developed platform was
assessed by incubating yeast estrogen biosensorsα andβwith
increasing concentrations (from 0.001 to 40 nM) of E2, se-
lected as themodel estrogenic analyte. All measurements were
performed in duplicate and repeated at least three times with
different cell cartridges.
Real samples
Nine plant samples were analyzed for (anti)estrogenic activity
with nanoYESα and nanoYESβ.
Five were soybean (Glycine max L.) samples: A, 95%
methanol (v/v) extract of the same liquid cell culture previous-
ly analyzed by Sansanelli et al. [26] (2014); B, 95% methanol
(v/v) extract analogues of a freshly grown liquid cell culture;
C, 95%methanol (v/v) extract of callus culture grown on solid
media; SE, industrial water-based seed extract, and DSE, in-
dustrial water-based digested seed extract (Phenbiox Srl,
Bologna, Italy), treated for 24 h at room temperature with
xylanase, α-amylase and glucosidase, as previously reported
[26].
In addition, four alfalfa (Medicago sativa L.) samples were
obtained from an industrial alfalfa aqueous extraction obtain-
ed after a double-screw press and squeezing at high pressure
(Alfavita Srl, Ravenna, Italy): D, not treated extract, incubated
for 2 h at 60 °C; E, extract treated with 1% (g enzyme/g dry
weight) Neutrase 0.8 L (Novozymes A/S, Denmark) for 2 h at
60 °C and pH 7.0; F, extract treated with 1% Alcalase 2.4 L
(Novozymes A/S, Denmark) for 2 h at 60 °C and pH 7.0; and
G, extract treated with 1% papain (Sigma-Aldrich, Milan,
Italy) for 2 h at 60 °C and pH 7.0.
Estrogenic and anti-estrogenic activity of all samples were
carried out both with the laboratory-based nanoYESα and
4940 A. Lopreside et al.
119
nanoYESβ assays and the smartphone biosensor with an in-
cubation time of 30 min, at 30 °C. Sample toxicities were also
evaluated using at least two dilutions for each sample (1:10
and 1:1000) as described in the BLaboratory-based toxicity
assay with ToxYluc^ section. Real samples analysis with
smartphone-based platform was performed as described for
E2 samples, in duplicate with nanoYESα, nanoYESβ, and
ToxYluc. The toxicity strain was integrated with nanoYESα/
nanoYESβ into the same cartridge for simultaneous evalua-
tion of cell viability and (anti)estrogenic activity of real sam-
ples with co-incubation with 1 nM of E2.
Then, different concentrations of E2 were added to tap
water to prepare the spiked samples with low, medium, and
high E2 concentrations. The spiked samples were analyzed
using both nanoYESα and nanoYESβ laboratory-based as-
says as previously described.
Data analysis
All calculations were performed using Microsoft Office Excel
2016 and plotted using GraphPad Prism v.5 (GraphPad
Software, Inc. La Jolla, CA). Non-linear regression was per-
formed by fitting the experimental data using a four-parameter
sigmoidal curve; EC50 values were calculated by the software
as the effective concentration that produces the midpoint y
value (50%) of the dose-response curve. The detection limit
was calculated as the concentration that corresponded to the
blank signal plus three times the standard deviation.
The fold induction (FI) of the nanoYES by the sample was
calculated as:
FI ¼ BLS=BLB
where BLS and BLB are the bioluminescence of the nanoYES
with sample and blank solvent, respectively (measured in at
least three replicates). At least three independent experiments
were used to calculate mean FI values. To consider aspecific
effects on cell viability, and correct the analytical signal ac-
cordingly, a control strain, ToxYLuc, was developed and used
to calculate a correction factor (CF):
CF ¼ BB=BS
where BB is the BL of the control strain ToxYLuc with blank
solvent (1% ethanol) and BS is the BL of the control strain
with the sample. When CF was in the range 0.5–2.0, the in-
duction coefficient of the nanoYES with the samples was
corrected according to the formula:
CFI ¼ CF FI
where corrected fold induction (CFI) is the fold induction
corrected for sample toxicity.
When the CF was higher than 2.0, the sample toxicity was
considered too high and an additional sample dilution was
performed before the measurement All experiments were per-
formed in quadruplicate and repeated at least three times.
Results and discussion
Luciferase selection and assay design
In the present work, we addressed some of the main draw-
backs of yeast-based bioreporters for detection and monitor-
ing of endocrine disruptors, i.e., assay time, sensitivity, and
portability. This study was prompted by promising results
obtained by a recently developed BL yeast-estrogen screen,
named nanoYES [20]. Here, we exploited a low-cost, compact
camera as a light detector and 3D-printed cartridges and report
the development of two new BL yeast strains: a strain for
detection of (anti)estrogenic compounds acting on ERβ and
a viability control strain for correcting the analytical signal
according to aspecific effects on cell viability.
The newly developed yeast-estrogen strain was obtained
by genetically engineering S. cerevisiae with plasmid
pBEVY-ERβ-L for constitutive expression of hERβ under
the regulation of ADH1 promoter and pRSII426-ERE-
yNLucP carrying the constitutive pRSII426-ERE-yNLucP
containing five copies of an ERE response element upstream
of minimal cytochrome C promoter (CYCmin) which drives
the expression of the yeast codon-optimized NanoLuc lucifer-
ase coding sequence (yNLucP). The vectors contain the 2μ
origin for high copy number replication during cell division
(50 copies/cell) and consistent production of yNLucP and
hERβ. To avoid unrelated toxicity and artifacts in the biosen-
sor response, the expression of the human ERβ was placed
under a weak promoter (ADH1) and the destabilized version
of yNanoLuc luciferase was chosen as the reporter gene. The
use of destabilized luciferases enables detection of rapid
changes in gene expression (both increases and decreases)
which may not be detectable with stable luciferases that accu-
mulate in living cells due to their long half-life [27].
Therefore, yNanoLuc, which has a half-life of 5 min when
expressed in yeast cells [21], and was previously demonstrat-
ed suitable for implementation into portable devices with mo-
bile camera detection, was selected as the reporter protein. We
then selected another bright luciferase, PLG2, as the constitu-
tive reporter for the viability control strain. PLG2 contains
amino acid changes providing activity enhancement in com-
parison to the chimeric PpyLit, partial protection against red-
shifting at low pH, and extended glow emission kinetics. The
PLG2 luciferase provided about 3.0-fold greater sensitivity
than luciferase from P. pyralis when expressed in mammalian
cell lines (Hek293); however, the expression of this luciferase
has not been reported yet in yeast [22]. Figure 1 shows the
bioluminescence emission spectrum and kinetics obtained in
yeast cells in lysing and non-lysing conditions. A maximum
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emission peak was obtained at 554 nm, consistent with previ-
ously reported characterization of this luciferase when
expressed in other cell models. Using a commercially avail-
able Bright-Glo™ BL substrate, optimized for mammalian
cell lines, the kinetic measurements showed non-optimal ki-
netics, whereas in lysing condition kinetics with a customized
YPER-Bright-Glo™ substrate, we obtained a stable measure-
ment that decreases about 50 min after substrate. An optimal
acquisition time window was identified between 108 and
192 s, when the mean BL signal is 97 ± 3% of maximum
emission.
Laboratory-based assay procedure analytical
performance
Dose-response curves for 17β-estradiol (E2) (concentration
range 0.0001 to 100 nM) were obtained with different incu-
bation times, from 5 to 120 min, using nanoYESα and
nanoYESβ, to identify the best assay conditions (Fig. 2 and
Electronic Supplementary Material (ESM) Fig. S1).
Unexpectedly, even after 5 min, a dose-response curve was
obtained showing a LOD of 1.08 ± 0.02 nM and 0.015 ±
0.001 nM for nanoYESα and nanoYESβ, respectively. It
was observed that dose-response curves after 30-min incuba-
tion provided similar LOD than those obtained with 120-min
incubation with analyte. Longer incubation times lowered the
EC50, but did not provide better LOD. Under optimized assay
conditions and 30-min incubation times, a LOD of 0.016 ±
0.001 nM and an EC50 of 1.47 ± 0.06 nM were obtained for
the ERα strain, while a LOD of 0.0011 ± 0.0002 nM and EC50
of 0.10 ± 0.01 nM were found for the ERβ strain (Table 1).
Values for ERαwere similar to those obtained with analogous
yeast-based assays. To the best of our knowledge, this re-
sponse time is the fastest reported to date in yeast-based
transactivation assays. In fact, the YES assay requires 72-h
incubation at 32 °C with the analyte according to the original
protocol based on colorimetric detection developed by
Routledge and Sumpter [28] and modified by Rajapakse
et al. [29]. Thanks to implementation of chemiluminescent
β-galactosidase substrates, the sensitivity and timing of the
assay were improved by Balsiger et al., leading to a 4-h assay
with yeast bioreporters expressing ERα with a LOD for E2 of
0.7 nM and an EC50 of 0.15 ± 0.01 nM [30]. Concerning yeast
bioassays with ERα, recent yeast-based bioreporters based on
bioluminescence (lux operon) or fluorescence detection pro-
vided similar LOD and EC50 values with incubation times
ranging from 2.5 to 6 h [31–34].
With the nanoYESβ strain, we significantly improved the
LOD in comparison with previously reported assays. Our re-
sults agree with those previously obtained by Bovee et al. who
reported a maximal activation of the ERβ cytosensor of about
40% of that obtained with the analogous ERα cytosensor [31].
As a result, the EC50 values for E2 decreased (0.06 nM in ref.
[31]). The nanoYESβ sensitivity could be explained by the
emission properties of the NanoLuc. The use of a customized
substrate provided a 20% increase in BL emission when com-
pared to furimazine, with glow-type kinetics (signal half-life
> 20 min) compared to NanoGlo® substrate or furimazine
alone (signal half-life < 2 min) [20].
Specificity of the nanoYESα and nanoYESβ
The analytical performance was first assessed by measuring
the response of the nanoYES to E2 and other molecules ac-
cording to EPA Endocrine Disruptor Screening Program Test
Guidelines (OPPTS 890.1300: Estrogen Receptor
Transcriptional Activation - Human Cell Line HeLa 9903)
(https://www.regulations.gov/document?D=EPA-HQ-OPPT-
2009-0576-0006). Table S1 (see ESM) shows LOD and EC50
values for reference chemicals used in the proficiency test. For
the acceptability criteria, we first analyzed positive and
negative reference chemicals to verify the responsiveness of
the nanoYESα and nanoYESβ using the appropriate
Fig. 1 a Bioluminescent emission spectrum obtained with S. cerevisiae
expressing the PLG2 luciferase. b Emission kinetics of PLG2
constitutively expressed in S. cerevisiae obtained with YPER-Bright-
Glo™ BL substrate (solid line) and Bright-Glo™ BL substrate (dotted
line) (see the BMaterials and methods^ section for experimental details)
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concentrations of a strong estrogen E2, a weak estrogen (17α-
estradiol), a very weak agonist (17α-methyltestosterone) and
a negative compound (dibutyl phthalate).
We reported atypical response for some compounds like
1,3,5-Tris(4-hydroxyphenyl)benzene, whose activity, also ac-
cording to the Endocrine Disruptor Screening Program [1],
has a dual estrogenic/antagonistic behavior. Due to this
activity, a non-conventional dose-response curve was obtain-
ed, and LOD and EC50 could not be calculated.
Obtained results (shown in Fig. 3) were within the accept-
able range values of the guideline. We calculated the inter- and
intra-assay variability (%CV) of the EC50 values from individ-
ual E2 standard curves and reported%CVof 23.9% and 17.4%
for nanoYESα and nanoYESβ, respectively. Anti-estrogenic
Fig. 2 Dose-response curves for 17β-estradiol obtained using the
nanoYESα (a, b) and nanoYes β (c, d) at different incubation times (5,
15, 30, 60, 90, and 120 min). Experiments were performed in 96-black
well microplate format and benchtop instrumentation using 160 μL of
cells and 40 μL of 17β-estradiol solution (concentration range from
0.0001 to 100 nM). Data represent the mean values ± the standard
deviation (SD) obtained with three replicates
Table 1 Limit of detection and
half maximal effective
concentration obtained with
nanoYESα and nanoYESβ in a
96-black well plate format with a
benchtop luminometer
Time LOD ERα (nM) LOD ERβ (nM)
EC50 EC50
5 min 1.08 ± 0.02 4.06 ± 0.03 0.015 ± 0.001 0.27 ± 0.03
10 min 0.71 ± 0.08 3.05 ± 0.5 0.012 ± 0.001 0.23 ± 0.02
15 min 0.038 ± 0.004 1.69 ± 0.09 0.0007 ± 0.0001 0.27 ± 0.03
30 min 0.016 ± 0.001 1.47 ± 0.06 0.001 ± 0.0001 0.1 ± 0.01
60 min 0.024 ± 0.003 0.83 ± 0.07 0.002 ± 0.0003 0.12 ± 0.01
90 min 0.021 ± 0.003 0.71 ± 0.06 0.0005 ± 0.0003 0.095 ± 0.011
120 min 0.01 ± 0.02 0.32 ± 0.06 0.0011 ± 0.0001 0.077 ± 0.006
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activity of some well-known anti-estrogenic compounds (i.e.,
atrazine and 17α-methyltestosterone) was also evaluated (as
shown in Fig. 3a and c) by co-incubating nanoYESα and
nanoYESβ with 1 nM of 17β-estradiol and different concen-
trations of the compounds. A decrease of the BL signal in-
versely proportional to the concentration of the anti-
estrogenic compounds was reported for both strains, being
more pronounced with nanoYESα. These results confirmed
the potential applicability of nanoYESα and nanoYESβ for
detecting anti-estrogenic compounds.
As shown in Fig. 3b and d, in agreement with previously
published yeast bioassays biosensors, several compounds
have different ERα or ERβ agonist activities, such as genis-
tein, a phytoestrogen with a high affinity for estrogen receptor
ERβ [35, 36]. We obtained a LOD for genistein of 849 ±
25 nM and 4.68 ± 0.08 nM with nanoYESα and nanoYESβ,
respectively. For some chemicals, the relative potencies dif-
fered from previous reporter strains. Concerning estrone,
which is included in the surface water watch list adopted by
the European Commission, we reported a LOD of 7.1 ± 0.5
and 0.009 ± 0.001 with nanoYESα and nanoYESβ, respec-
tively. As an example, we reported a REPβ, calculated as the
ratio between the EC50 of E2 and the EC50 of the compound
with ERβ strain, of 0.1 for diethylstilbestrol (ESM Table S1)
whereas Bovee et al. reported a REPβ of 2.0 [31]. Despite
these discrepancies, that are usually reported for cell-based
assays, the LOD for E2 obtained with the nanoYESβ, i.e.,
0.0011 ± 0.0002 nM (corresponding to 0.27 ng/L), corrobo-
rates the possible use of this biosensor as a rapid screening
tool of pharmaceuticals in surface waters according to the
European Directive 2013/39/EU, which included E2, estrone,
and 17α-estradiol on the watch list. In fact, according to a
recent proposal for amending the priority substance list
(European Commission 2011), the proposed environmental
quality standards (EQS) for E2 of inland surface water are
0.4 ng/L [37, 38].
Smartphone-based biosensor integrating nanoYESα,
nanoYESβ, and ToxYLuc
The suitability of using the smartphone camera to detect the
BL emitted by living cells has been previously reported by us
and others with mammalian cells lines and bacteria [39–41];
however, to date, yeast biosensors have been integrated into
devices with portable detectors (e.g., cooled CCD,
GoProHero5 CMOS camera) but not coupled with
smartphones. Despite yeast’s great peculiarities, such as rela-
tively short assay times and the possibility to analyze
Fig. 3 Evaluation of anti-estrogenic activity of atrazine (a) and 17α-
methyltestosterone (c) obtained by co-incubating nanoYESα and
nanoYESβ in 96-black well plate with atrazine (from 0.0001 to
103 nM) and 17α-methyltestosterone (from 0.001 to 104 nM) with
1 nM of 17β-estradiol for 30 min. BL measurements were obtained
after the addition of YPER-Nano BL substrate. Dose-response curves
for different chemicals used for the validation of nanoYESα (b) and
nanoYESβ (d) according to EPA Endocrine Disruptor Screening
Program Test Guidelines
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environmental complex samples directly without extraction,
sterilization, and/or concentration, their implementation in
Bprêt-à-porter^ devices is still an open issue. Therefore, we
focused our effort on the development of a very straightfor-
ward smartphone-based assay. We adapted a protocol previ-
ously developed with a biosensor exploiting the GoPro cam-
era with some changes. The procedure includes incubation of
10 μL of sample (or E2 dilutions in the concentration range
from 0.05 to 10 nM) per cartridge well containing 90 μL of
cells (about 9.0 × 105 cells/well) for 1 h at room temperature.
After the addition of 50 μLYPER-Nano substrate or YPER-
Bright-Glo, the cartridge is snapped into the 3D-printed ac-
cessory and acquisition is performed with the OnePlus 5 inte-
grated camera, a 1/2.8^ 16-MP Sony IMX 398 sensor, using
3200 ISO sensitivity and 30-s acquisition (Fig. 4).We selected
the OnePlus 5 smartphone because the shutter speed can be
controlled over a longer period time (up to 30 s) and, with our
in-house comparison of different smartphone cameras (data
not shown), we were able to obtain the best results for
low-light applications. This finding was in agreement with
a recent inter-smartphone comparison performed by Kim
et al. who reported a device and an imaging-processing al-
gorithm to improve the sensitivity of smartphone cameras
for low-light detection [40].
To demonstrate the biosensor capabilities and assess the
feasibility of the smartphone-integrated CMOS for BL light
detection, we integrated in the same cartridge the three strains:
nanoYESα, nanoYESβ, and the viability control strain
ToxYLuc. Under optimized conditions, we obtained a LOD
of 7.1 ± 0.4 nM and 0.38 ± 0.08 nM for E2 with nanoYESα
and nanoYESβ, respectively (Fig. 5a, b).
We assessed the reproducibility of the nanoYESα and
nanoYESβ biosensors by testing the same concentration of
E2 (1nM) and intra-assay variability of 18% and 13% was
obtained using the same cartridge for nanoYESα and
nanoYESβ, respectively, while an inter-assay variability of
25% and 18% was obtained with different cartridges prepared
starting from different cultures.
Real sample analysis
To test the proposed smartphone-based biosensor integrating
nanoYESα, nanoYESβ, and ToxYLuc on real samples, we
assessed the estrogenic activity of industrial soybean seed ex-
tracts and cell suspensions (Fig. 5), previously characterized
using the standard analytical technique HPLC–DAD [26], as
well as alfalfa extracts.
Sansanelli et al. reported that soybean cell suspensions con-
tain higher amounts of free isoflavones in comparison to seed
extracts (i.e., 93.5% vs 16.8%) and they are more bioactive
than the glycoside forms. Figure 6 shows results corrected for
toxicity obtained with the nanoYESα and nanoYESβ using
benchtop instrumentation. Toxicity effects used for correcting
the estrogenic activity are shown in ESM Fig. S2. As an ex-
ample, sample A, containing extract of soybean cell suspen-
sions (dilution 1:100) with a prevalence of aglycones such as
Fig. 4 Schematic representation of the smartphone biosensor principle.
The 3D-printed cartridge integrates the three strains: nanoYESα,
nanoYESβ expressing the reporter protein Nanoluc under the regulation
of estrogen receptor α or estrogen receptor β activation, and the viability
control strain ToxYLuc constitutively expressing the green-emitting
PLG2 luciferase as reporter protein
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genistein and daidzein, showed a fold induction corrected for
sample toxicity (CFI) of 11.0 ± 0.3 and 51.3 ± 0.3 for ERα and
ERβ, respectively.
Conversely, alfalfa extracts (Medicago sativa L.) showed
estrogenic activity towards both ERα and ERβ due to the
presence of phytoestrogens in agreement to Boue et al. [42].
An interesting result was reported for the alfalfa sample
digested with 1% Alcalase (Fig. 6b, sample F) which showed
a significant increase in estrogenic activity with a CFI of 28.9
± 0.7 and 28.4 ± 0.5 for ERα and ERβ in comparison to the
non-digested extract (Fig. 6b, sample D). A possible explana-
tion for the increase in estrogenic activity could be related to
the generation of bioactive peptides, as previously reported for
other plant derivatives and extracts with high biotechnological
potential [43].
Unexpected results were obtained with some samples, i.e.,
B and DSE, for which lower dilutions provided higher estro-
genic activity than more concentrated solutions, due to high
variability in cell viability signals. For example, a normalized
estrogenic activity corrected for cell viability of 0.68 ± 0.06
(ERα) and 1.01 ± 0.03 (ERβ) for sample B (1:100) and 1.45
± 0.10 (ERα) and 2.10 ± 0.03 (ERβ) for sample B (1:1000)
was reported. Although cell viability (see ESM) was taken
into account for calculating the corrected normalized estro-
genic activity, we believe that the high variability of sample
B (1:1000) viability signal could have masked the expected
decrease in estrogenic activity at higher dilution.
Moreover, to evaluate the ability of nanoYESα and
nanoYESβ to detect unknown concentrations of estrogenic
compounds, we performed recovery test of spiked 17β-
estradiol as a reference compound in tap water samples.
Table 2 reports the recovery values obtained when deionized
water (blank) and different tap water samples, spiked with
low, medium, and high 17β-estradiol concentrations, were
analyzed with the nanoYESα and nanoYESβ strains.
Satisfactory recoveries were obtained with nanoYESα show-
ing average recovery values ranging from 95 to 116%, while
the nanoYESβ from 80 to 90% (Table 2).
As concerns the results obtained with the new smartphone
biosensor, a quantitative analysis for both (anti)estrogenic ac-
tivity and cytotoxicity was obtained by co-incubating the sam-
ples with 1 nM E2. Figure 5c shows a typical cartridge used
for analyzing two different dilutions (1:10 and 1:100) of sam-
ple D (alfalfa aqueous extract) in duplicate with nanoYESβ
Fig. 5 Dose-response curves for 17β-estradiol with nanoYESα (a) and
nanoYESβ (b) obtained after quantification of BL emissions with ImageJ
software. BL images were obtained by incubating the cell-cartridge
containing 90 μL of yeast bioreporters with 10 μL 17β-estradiol
(concentration range from 0.001 to 100 nM) and by acquiring BL
emission with OnePlus camera (30 s at ISO 3200), after addition of
50 μL YPERNano solution. Data are plotted as fold response with
respect to control (1% EtOH). (c) Picture of assembled device
composed by smartphone adaptor and cell cartridge comprising of yeast
bioreporters nanoYESβ (in duplicate, left part of the cartridge) and
ToxYLuc (in duplicate, right part of the cartridge). Yeast estrogen
assays were performed by incubating the cell-cartridge containing
90 μL of nanoYESβ and ToxYLuc with 10 μL of sample. BL signals
were obtained with a OnePlus camera acquiring for 30 s at ISO 3200,
after addition of either 50 μLYPERNano substrate or YPERBrightGlo.
(d) Graphical elaboration of sample analysis. Blank sample for estrogenic
activity and for cell toxicity was obtained by incubating cells with 1%
EtOH. Both BL signals of control wells were set at 1 to normalize results
and enable both evaluation of estrogenic activity and toxicity
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and ToxYLuc strain. The cartridge also included two refer-
ence samples in duplicate wells: 1 nM E2 and blank (vehicle),
either water for aqueous extracts or 1%methanol for methanol
extracts. The apparent anti-agonistic activity of sample D
(1:10 dilution) was due to a significant loss in cell viability
(55 ± 2%); conversely, a cell viability of 94 ± 4% was ob-
served with incubation of sample D (1:100) dilution, with
significant estrogenic activity (fold response 5.9 ± 0.1).
Further characterizations will be required to better understand
the bioactive molecules that are responsible for this activity.
These results confirm the importance of including the via-
bility control strain in the same cartridge to correct the analyt-
ical signal and avoid artifacts due to sample or matrix-
aspecific effects.
Conclusion
Here, we report the development and optimization of a rapid
screening assay based on nanoYESα and nanoYESβ and its
Fig. 6 (a) Evaluation of
estrogenic activity of industrial
soybean seed and (b) alfalfa
(Medicago sativa L.) extracts
incubated with nanoYESα
(green) and nanoYESβ (violet) in
96-black well plates for 30 min.
Data represent the mean values of
CFI ± the standard deviation (SD)
obtained with three replicates
(details of data elaboration are in
the BMaterials and methods^
section)
Table 2 Recovery obtained by
analyzing tap water samples
spiked with low, medium, and
high concentrations of 17β-
estradiol using nanoYESα and
nanoYESβ
Sample Spiked concentration E2 (nM) Detected concentration E2 (nM) Recovery% E2 (nM)a
α β α β
1 0 n.d. n.d. – –
2 1.00 × 10−5 n.d. n.d. – –
3 1.00 × 10−3 1.16 ± 0.03 × 10−3 0.90 ± 0.06 × 10−3 116% 90%
4 0.10 0.11 ± 0.01 × 10−3 0.08 ± 0.02 × 10−3 110% 80%
5 1.00 0.97 ± 0.07 0.81 ± 0.05 97% 81%
6 10.00 9.52 ± 0.09 8.78 ± 0.90 95% 88%
aObtained by interpolating the corrected signal on a corrected dose-response curve for 17β-estradiol
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implementation into a smartphone-based biosensor for on-site
analysis. The low limit of detection allows the use of the
developed yeast estrogen assay for the quantitative detection
of estrogenic activity in complex biological samples and water
samples. Those limits of detection and EC50 are comparable or
better than those already reported for yeast estrogen bioassays.
We integrated these three strains in a smartphone-based bio-
sensing platform which could provide a first-level bioactivity
and toxicity screening for rapid detection of EDCs in environ-
mental and biological samples. Furthermore, those results
were achieved with, as far as we know, the shortest incubation
time ever used for a yeast biosensor. We envisage potential
applications of such biosensor in different scenarios, such as
for the analysis of environmental and food samples, and secu-
rity applications for rapid monitoring of potentially harmful
contaminants.
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2 
Fig. S1 Comparison, at different incubation times, between dose-response curves for 17β-estradiol obtained 
using nanoYESα and nanoYESβ: a. 5 min; b. 15 min; c. 30 min; d. 60 min; e. 90 min; f. 120 min. 
Experiments were performed in 96-black well microplate format and benchtop instrumentation using 180 µL 
of cells and 20 µL of 17β-estradiol solution (concentration range from 0.0001 nM to 100 nM). Data represent 
the mean values ± the standard deviation (SD) obtained with three replicates 
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3 
Table S1 In house validation with proficiency chemicals. LOD and EC50 were calculated for a set of reference 
chemicals using nanoYESα and nanoYESβ in 96- black well plate format and a benchtop luminometer. Reference 
compounds to verify the responsiveness of the system include strong estrogenic compound (E2), a weak estrogen (17α-
estradiol), a very weak agonist (17α-methyltestosterone) and a negative compound (corticosterone). Values represent 
mean ± SD of 3 separate experiments, each performed in triplicate 
ERα ERβ 
LOD 
(nM) 
EC50 
(nM) 
LOD 
(nM) 
EC50 
(nM) 
EPA 
Classification 
17β-estradiol 0.016 ± 0.001 1.47 ± 0.06 
0.001 ± 
0.0002 
0.12 ± 0.01 Strong 
17α-estradiol 0.21 ± 0.03 95.9 ± 0.9 
0.0031 ± 
0.0003 
537 ± 15 Weak 
17α-methyltestosterone* _ _ _ _ Very weak 
Corticosterone* _ _ _ _ Negative 
Diethylstilbestrol 0.08 ± 0.01 7.4 ± 0.8 0.14 ± 0.02 1.1 ± 0.2 Positive 
17α-ethinyl estradiol* 0.79 ± 0.07 108 ± 5 
0.011 ± 
0.007 
_ Positive 
Hexestrol 2.25 ± 0.08 80 ± 4 0.42 ± 0.01 13.3 ± 0.8 Positive 
Genistein* 849 ± 25 4.68 ± 0.08 106 ± 7 Positive 
Estrone 7.1 ± 0.5 1839 ± 44 
0.009 ± 
0.001 
137 ± 11 Positive 
Butyl Paraben _ 
1.5x104 ± 
0.1 
270 ± 14 
1.0x103 ± 
0.04 
Positive 
1,3,5-Tris (4-
hydroxyphenyl) Benzene* 
_ _ _ _ Positive 
Dibutyl phthalate* _ _ _ _ Negative 
Atrazine* _ _ _ _ Negative 
Tamoxifen* _ _ _ _ Negative 
*For some compounds, i.e., negative compounds and very weak estrogenic agonists LOD and EC50 were not calculated.
All these chemicals were analyzed at the EPA test concentration range.
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4 
Fig. S2 Real samples toxicity evaluation with ToxYLuc biosensor with 30 min incubation time at 30°C 
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6 
Smartphone-based multicolour 
bioluminescent 3D spheroid biosensors 
for monitoring inflammatory activity
Reproduced from: “Smartphone-based multicolor bioluminescent 3D spheroid biosensors 
for monitoring inflammatory activity” 
Elisa Michelini, Maria Maddalena Calabretta, Luca Cevenini, Antonia Lopreside, Tara 
Southworth, Danielle D. Fontaine, Patrizia Simoni, Bruce R. Branchini, Aldo Roda 
Biosensors and Bioelectronics, 123, 269-77. 
Reproduced by permission of Elsevier 
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7 Conclusion and Future Perspectives
During this PhD work, whole-cell and transcriptional and translational cell-free biosensors 
for point-of-need rapid routine monitoring have been developed. These biosensors could be 
suitable for environmental monitoring and point-of-care applications. Compared to other 
analytical tools, these biosensors do not require sample treatment steps, sophisticated 
equipment or trained personnel. Indeed, thanks to the specificity of the biological 
recognition element, an analyte of interest, or a class of analytes, can be selectively detected 
in complex matrices (i.e. body fluids, wastewater). Moreover, whole-cell biosensors offer 
unique features as they are able to provide information about the bioavailable fraction and 
synergic effects, being able to detect also unknown compounds.   
Thanks to synthetic biology and genetic engineering tools, several optical reporter proteins 
(colorimetric, fluorescent and bioluminescent) have been exploited in order to find the best 
candidate for our purpose. Optimizing different parameters and experimental conditions, 
including coding sequences, promoters and plasmids, the analytical performance of the 
biosensors, in terms of dynamic range, limit of detection and response time, have been 
improved providing fast and sensitive whole-cell biosensors. Taking advantage of 
bioluminescence spectral separation, multiplexing detection was achieved within the same 
cell, increasing the robustness of the developed biosensors for on-field applications. 
Different chassis cells (bacteria, yeast and mammalian cell lines) have been exploited to 
improve analytical performance and predictivity of the biosensors. Bacterial cells provided 
easy and robust host for fast environmental monitoring; while yeast and 3D mammalian cell 
biosensors were used as they are more predictive for toxicant effect on human health. 
Recent studies have pointed out that conventional laboratory 2D cell cultures often do not 
reflect the morphology and functionality of living organisms, limiting the predictive value. 
Therefore, 3D cell cultures of HEK293T cell have been selected for developing more 
predictive biosensor. 3D cell cultures have indeed the capability to generate the extracellular 
matrix and restore cell‐to‐cell communications, thus being the most suitable model to mimic 
in vivo physiology. 
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Different immobilization methods and 3D printing technology have been also investigated 
to integrate the newly developed biosensors into portable platforms. Several user-friendly 
devices, like smartphone and action cameras, have been exploited as light detectors for real 
setting applications. 
As future perspective, in order to provide a more predictive and comprehensive information 
about sample toxic effects on humans and animal wildlife, a combination of the developed 
cell biosensors based on different cell types could be developed. To increase the 
multiplexing, different bioluminescent reporter proteins could be also implemented and 
combined into the same cartridge.  Each colour could be associated with a biological effect, 
i.e., general toxicity, inflammation, or to a target analyte. To this end, numerous challenges 
will have to be faced, such as cross contamination issues, the use of a single buffer for all 
cell lines, bioluminescent signal acquisition and cells’ shelf-life. 
Recent development in genetically modified biosensors field have allowed biosensors to 
become one of the most promising tools for several analytical applications. Nevertheless, 
improvements are needed for biosafety issues, in particular for on-field applications by non-
trained users. Thanks to synthetic biology tools several strategies have already been 
evaluated such as conditionally lethal mutations and self-killing pathway, but there is still a 
long way to go. 
The development of ready to be used cartridge that can be stored for a long period of time 
is a further point that need to be solved for real-life applications of whole-cell biosensors. 
Another important future perspective is the optimization of in vitro transcriptional and 
translational systems. Till now, the analytical performance of these systems is not yet 
comparable to that achieved with whole-cell biosensors, however this approach could solve 
problems related to safety issues connected with unintentional spreading of genetically 
modified organisms in the environment.  
Compared to conventional cell-free systems, transcriptional and translational cell-free 
systems based on reporter gene technology offers the unique opportunity to monitor the 
integration of different metabolic cell pathway and converging stimuli of complex samples. 
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Bioluminescent proteins among others provide a suitable alternative to monitor several 
mechanisms at the same time by mean of multiplexed detection. 
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